{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Pymaceuticals Inc.\n",
    "---\n",
    "\n",
    "### Analysis\n",
    "\n",
    "- In this analysis, we can see the results of several different drugs and their effects on mouse tumor development. These drugs are Capomulin, Ramicane, Infubinol, and Ceftamin.\n",
    "1. The only drug with an outlier is Infubionol; this could be due to errors in testing, or a unique reaction dependent on a unique genetic makeup of the rats in question that produced the result. Looking into this result could provide further details into the mechanisms of action for the drug in mice with this genetic makeup, or potentially highlight the specific issue with testing leading to the outlier.\n",
    "2. We can see a siginifcant reduction in tumor volume occur around halfway through the treatment of the mouse on Capomulin; this drop in tumor volume seems to remain mostly consistent through the rest of the treatment, providing potential evidence that this drug does in fact meaningfully reduce the tumor volume for this mouse.\n",
    "3. There is a high level of correlation between tumor volume and mouse weight; as mouse weight increases, so does tumor volume. This could be due to the mice having larger mass overall leading to a larger tumor mass, but could also potentially mean the drugs may be less effective as mouse weight increases if not properly scaled to their weight. \n",
    "\n",
    "With more data, the connection between drug type, dosage amount, tumor volume and length of treatment may become more apparent. Treatment start time in terms of onset of tumor detetion, tumor aggresivity, mouse genetics, and dosage variables depdent on these could help provide more insight into the nature of the drugs MOA and potential efficacy in a range of situations, helping to explain both outliers and potential treatment implementations, as well as implications for a wider audience of clinical trials.\n",
    " "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Combined Data:\n",
      "Mouse ID  Timepoint  Tumor Volume (mm3)  Metastatic Sites Drug Regimen    Sex  Age_months  Weight (g)\n",
      "    b128          0           45.000000                 0    Capomulin Female           9          22\n",
      "    f932          0           45.000000                 0     Ketapril   Male          15          29\n",
      "    g107          0           45.000000                 0     Ketapril Female           2          29\n",
      "    a457          0           45.000000                 0     Ketapril Female          11          30\n",
      "    c819          0           45.000000                 0     Ketapril   Male          21          25\n",
      "    h246          0           45.000000                 0     Ketapril   Male          13          30\n",
      "    p189          0           45.000000                 0     Ketapril   Male           8          28\n",
      "    n923          0           45.000000                 0     Ketapril   Male          19          30\n",
      "    q119          0           45.000000                 0     Ketapril   Male          17          30\n",
      "    f993          0           45.000000                 0     Naftisol   Male          21          28\n",
      "    z234          0           45.000000                 0     Naftisol Female          19          27\n",
      "    b559          0           45.000000                 0     Naftisol   Male          20          26\n",
      "    y260          0           45.000000                 0     Ketapril Female           7          25\n",
      "    x930          0           45.000000                 0     Naftisol   Male          13          26\n",
      "    o725          0           45.000000                 0     Naftisol   Male           4          26\n",
      "    z969          0           45.000000                 0     Naftisol   Male           9          30\n",
      "    v835          0           45.000000                 0     Naftisol   Male           7          29\n",
      "    r604          0           45.000000                 0     Naftisol   Male           7          30\n",
      "    n304          0           45.000000                 0     Naftisol   Male           9          26\n",
      "    l700          0           45.000000                 0     Naftisol Female          18          27\n",
      "    x336          0           45.000000                 0     Naftisol Female           4          29\n",
      "    l725          0           45.000000                 0     Naftisol Female           8          26\n",
      "    m133          0           45.000000                 0     Naftisol Female           2          26\n",
      "    v295          0           45.000000                 0     Naftisol Female           2          27\n",
      "    a818          0           45.000000                 0     Naftisol Female          12          28\n",
      "    y601          0           45.000000                 0     Naftisol Female          23          25\n",
      "    t724          0           45.000000                 0     Naftisol Female           2          25\n",
      "    k382          0           45.000000                 0     Ketapril   Male          22          29\n",
      "    w422          0           45.000000                 0     Ketapril Female          18          26\n",
      "    c326          0           45.000000                 0    Infubinol Female          18          25\n",
      "    c139          0           45.000000                 0    Infubinol   Male          11          28\n",
      "    v339          0           45.000000                 0    Infubinol   Male          20          26\n",
      "    a577          0           45.000000                 0    Infubinol Female           6          25\n",
      "    y163          0           45.000000                 0    Infubinol Female          17          27\n",
      "    k483          0           45.000000                 0    Infubinol Female          20          30\n",
      "    k804          0           45.000000                 0    Infubinol Female          23          29\n",
      "    o809          0           45.000000                 0    Infubinol   Male           3          25\n",
      "    z581          0           45.000000                 0    Infubinol Female          24          25\n",
      "    a251          0           45.000000                 0    Infubinol Female          21          25\n",
      "    i386          0           45.000000                 0    Infubinol Female          23          29\n",
      "    c580          0           45.000000                 0     Ketapril   Male          22          25\n",
      "    q132          0           45.000000                 0    Infubinol Female           1          30\n",
      "    u327          0           45.000000                 0     Ketapril   Male          17          25\n",
      "    v603          0           45.000000                 0     Ketapril Female          22          30\n",
      "    f278          0           45.000000                 0     Ketapril   Male          12          30\n",
      "    g497          0           45.000000                 0     Ketapril   Male          19          28\n",
      "    d474          0           45.000000                 0     Ketapril   Male          18          27\n",
      "    o973          0           45.000000                 0     Ketapril Female          11          29\n",
      "    c832          0           45.000000                 0     Ketapril   Male          18          29\n",
      "    o331          0           45.000000                 0     Ketapril   Male          24          30\n",
      "    m650          0           45.000000                 0     Ketapril   Male          15          27\n",
      "    v289          0           45.000000                 0     Ketapril Female           3          26\n",
      "    m550          0           45.000000                 0     Ketapril   Male          18          28\n",
      "    h428          0           45.000000                 0     Ketapril Female           1          27\n",
      "    r701          0           45.000000                 0     Naftisol   Male          21          25\n",
      "    v199          0           45.000000                 0     Naftisol Female          17          29\n",
      "    x264          0           45.000000                 0     Naftisol Female          21          27\n",
      "    f234          0           45.000000                 0     Stelasyn   Male          14          28\n",
      "    c458          0           45.000000                 0     Ramicane Female          23          20\n",
      "    q610          0           45.000000                 0     Ramicane Female          18          21\n",
      "    j913          0           45.000000                 0     Ramicane Female           4          17\n",
      "    a411          0           45.000000                 0     Ramicane   Male           3          22\n",
      "    a444          0           45.000000                 0     Ramicane Female          10          25\n",
      "    d251          0           45.000000                 0     Ramicane Female           8          19\n",
      "    j989          0           45.000000                 0     Ramicane   Male           8          19\n",
      "    y449          0           45.000000                 0     Ramicane   Male          19          24\n",
      "    k403          0           45.000000                 0     Ramicane   Male          21          16\n",
      "    c758          0           45.000000                 0     Ramicane   Male           9          17\n",
      "    x402          0           45.000000                 0     Stelasyn   Male          21          28\n",
      "    r811          0           45.000000                 0     Ramicane   Male           9          19\n",
      "    a644          0           45.000000                 0     Ramicane Female           7          17\n",
      "    i177          0           45.000000                 0     Ramicane   Male          10          18\n",
      "    g791          0           45.000000                 0     Ramicane   Male          11          16\n",
      "    a520          0           45.000000                 0     Ramicane   Male          13          21\n",
      "    u196          0           45.000000                 0     Ramicane   Male          18          25\n",
      "    m546          0           45.000000                 0     Ramicane   Male          18          16\n",
      "    w678          0           45.000000                 0     Ramicane Female           5          24\n",
      "    n364          0           45.000000                 0     Ramicane   Male           4          17\n",
      "    s508          0           45.000000                 0     Ramicane   Male           1          17\n",
      "    e662          0           45.000000                 0     Ramicane   Male           8          24\n",
      "    z578          0           45.000000                 0     Ramicane   Male          11          16\n",
      "    r921          0           45.000000                 0     Ramicane Female           5          25\n",
      "    a492          0           45.000000                 0     Stelasyn   Male          20          25\n",
      "    w540          0           45.000000                 0     Stelasyn Female           8          26\n",
      "    v764          0           45.000000                 0     Stelasyn Female           5          30\n",
      "    z795          0           45.000000                 0     Naftisol Female          13          29\n",
      "    e291          0           45.000000                 0     Naftisol Female          14          29\n",
      "    e584          0           45.000000                 0     Naftisol   Male           9          27\n",
      "    e213          0           45.000000                 0     Naftisol   Male           8          27\n",
      "    j755          0           45.000000                 0     Naftisol   Male          23          27\n",
      "    s565          0           45.000000                 0     Stelasyn Female           3          29\n",
      "    a366          0           45.000000                 0     Stelasyn Female          16          29\n",
      "    p387          0           45.000000                 0     Stelasyn   Male           3          30\n",
      "    b879          0           45.000000                 0     Stelasyn Female           4          26\n",
      "    i901          0           45.000000                 0     Stelasyn   Male          23          29\n",
      "    k862          0           45.000000                 0     Stelasyn Female          13          25\n",
      "    g867          0           45.000000                 0     Stelasyn Female           9          25\n",
      "    s619          0           45.000000                 0     Stelasyn   Male          22          30\n",
      "    w697          0           45.000000                 0     Stelasyn Female          14          30\n",
      "    j984          0           45.000000                 0     Stelasyn Female           2          30\n",
      "    c402          0           45.000000                 0     Stelasyn Female           1          27\n",
      "    h333          0           45.000000                 0     Stelasyn   Male          21          27\n",
      "    k510          0           45.000000                 0     Stelasyn Female           8          27\n",
      "    p981          0           45.000000                 0     Stelasyn   Male          20          29\n",
      "    t451          0           45.000000                 0     Stelasyn   Male           8          29\n",
      "    a963          0           45.000000                 0     Stelasyn Female          23          27\n",
      "    m269          0           45.000000                 0     Stelasyn Female          22          28\n",
      "    g989          0           45.000000                 0     Propriva Female          21          26\n",
      "    z314          0           45.000000                 0     Stelasyn Female          21          28\n",
      "    o848          0           45.000000                 0     Stelasyn Female          14          27\n",
      "    v719          0           45.000000                 0    Infubinol Female          17          30\n",
      "    q597          0           45.000000                 0     Ramicane   Male          20          25\n",
      "    c895          0           45.000000                 0    Infubinol Female           7          29\n",
      "    a203          0           45.000000                 0    Infubinol Female          20          23\n",
      "    f394          0           45.000000                 0    Zoniferol   Male          19          30\n",
      "    c264          0           45.000000                 0    Zoniferol Female          11          27\n",
      "    n967          0           45.000000                 0    Zoniferol   Male          11          27\n",
      "    f545          0           45.000000                 0    Zoniferol Female          20          26\n",
      "    k894          0           45.000000                 0    Zoniferol Female          13          29\n",
      "    k754          0           45.000000                 0    Zoniferol Female           8          26\n",
      "    g296          0           45.000000                 0    Zoniferol Female          14          29\n",
      "    d164          0           45.000000                 0    Zoniferol   Male          21          28\n",
      "    w575          0           45.000000                 0    Zoniferol Female          16          28\n",
      "    x613          0           45.000000                 0    Zoniferol Female           2          29\n",
      "    q633          0           45.000000                 0    Zoniferol   Male          12          25\n",
      "    b313          0           45.000000                 0    Zoniferol   Male          12          27\n",
      "    f129          0           45.000000                 0    Zoniferol Female          11          29\n",
      "    j365          0           45.000000                 0    Zoniferol   Male          24          28\n",
      "    p136          0           45.000000                 0    Zoniferol Female           5          28\n",
      "    c559          0           45.000000                 0    Zoniferol Female          19          28\n",
      "    a788          0           45.000000                 0    Zoniferol   Male           5          30\n",
      "    s337          0           45.000000                 0    Zoniferol   Male          14          27\n",
      "    q511          0           45.000000                 0    Zoniferol Female           2          28\n",
      "    m331          0           45.000000                 0    Zoniferol Female          19          26\n",
      "    o926          0           45.000000                 0    Zoniferol   Male          15          29\n",
      "    d133          0           45.000000                 0    Zoniferol   Male           5          30\n",
      "    n630          0           45.000000                 0     Propriva Female          15          29\n",
      "    g989          0           45.000000                 0     Propriva Female          21          26\n",
      "    a401          0           45.000000                 0    Zoniferol Female           8          25\n",
      "    w350          0           45.000000                 0     Propriva   Male           7          26\n",
      "    c302          0           45.000000                 0    Zoniferol Female          10          29\n",
      "    a897          0           45.000000                 0      Placebo   Male           7          28\n",
      "    j235          0           45.000000                 0      Placebo   Male           6          30\n",
      "    q787          0           45.000000                 0      Placebo   Male          17          27\n",
      "    a262          0           45.000000                 0      Placebo Female          17          29\n",
      "    r850          0           45.000000                 0      Placebo   Male           5          30\n",
      "    i669          0           45.000000                 0      Placebo Female          18          27\n",
      "    n763          0           45.000000                 0      Placebo Female          16          25\n",
      "    s152          0           45.000000                 0      Placebo Female           4          30\n",
      "    c766          0           45.000000                 0      Placebo Female          13          26\n",
      "    e227          0           45.000000                 0      Placebo   Male           1          30\n",
      "    c282          0           45.000000                 0      Placebo   Male          12          27\n",
      "    v989          0           45.000000                 0      Placebo   Male           4          25\n",
      "    w140          0           45.000000                 0    Zoniferol Female          19          30\n",
      "    v409          0           45.000000                 0      Placebo Female          16          25\n",
      "    l872          0           45.000000                 0      Placebo   Male          19          30\n",
      "    o795          0           45.000000                 0      Placebo Female          20          26\n",
      "    y478          0           45.000000                 0      Placebo Female           3          25\n",
      "    q582          0           45.000000                 0      Placebo   Male           5          30\n",
      "    s166          0           45.000000                 0      Placebo   Male          19          27\n",
      "    x773          0           45.000000                 0      Placebo Female          21          30\n",
      "    w167          0           45.000000                 0      Placebo Female           6          28\n",
      "    t718          0           45.000000                 0      Placebo Female          10          30\n",
      "    o302          0           45.000000                 0      Placebo Female           2          29\n",
      "    i477          0           45.000000                 0      Placebo Female           3          30\n",
      "    c757          0           45.000000                 0      Placebo   Male           9          27\n",
      "    t994          0           45.000000                 0      Placebo   Male          14          30\n",
      "    p310          0           45.000000                 0     Propriva   Male           6          26\n",
      "    a699          0           45.000000                 0     Propriva Female           5          28\n",
      "    k603          0           45.000000                 0     Propriva   Male           2          27\n",
      "    x822          0           45.000000                 0     Ceftamin   Male           3          29\n",
      "    l558          0           45.000000                 0     Ceftamin Female          13          30\n",
      "    l733          0           45.000000                 0     Ceftamin Female           4          30\n",
      "    f436          0           45.000000                 0     Ceftamin Female           3          25\n",
      "    l490          0           45.000000                 0     Ceftamin   Male          24          26\n",
      "    b759          0           45.000000                 0     Ceftamin Female          12          25\n",
      "    l471          0           45.000000                 0     Ceftamin Female           7          28\n",
      "    y865          0           45.000000                 0     Ceftamin   Male          23          26\n",
      "    y769          0           45.000000                 0     Ceftamin Female           6          27\n",
      "    l661          0           45.000000                 0     Ceftamin   Male          18          26\n",
      "    j296          0           45.000000                 0     Ceftamin Female          24          30\n",
      "    u149          0           45.000000                 0     Ceftamin   Male          24          29\n",
      "    u153          0           45.000000                 0     Ceftamin Female          11          25\n",
      "    w151          0           45.000000                 0     Ceftamin   Male          24          25\n",
      "    h531          0           45.000000                 0     Ceftamin   Male           5          27\n",
      "    a685          0           45.000000                 0    Infubinol   Male           8          30\n",
      "    o813          0           45.000000                 0    Infubinol   Male          24          28\n",
      "    m756          0           45.000000                 0    Infubinol   Male          19          30\n",
      "    n671          0           45.000000                 0    Infubinol   Male          18          25\n",
      "    s121          0           45.000000                 0    Infubinol   Male          23          26\n",
      "    v766          0           45.000000                 0    Infubinol   Male          16          27\n",
      "    w193          0           45.000000                 0    Infubinol   Male          22          30\n",
      "    e476          0           45.000000                 0    Infubinol   Male          23          26\n",
      "    w584          0           45.000000                 0    Infubinol   Male           3          29\n",
      "    b447          0           45.000000                 0     Ceftamin   Male           2          30\n",
      "    k210          0           45.000000                 0     Ceftamin   Male          15          28\n",
      "    a275          0           45.000000                 0     Ceftamin Female          20          28\n",
      "    x581          0           45.000000                 0     Ceftamin Female          19          28\n",
      "    n482          0           45.000000                 0     Propriva Female           4          29\n",
      "    t198          0           45.000000                 0     Propriva   Male          22          26\n",
      "    l215          0           45.000000                 0     Propriva   Male          10          29\n",
      "    s141          0           45.000000                 0     Propriva   Male           8          25\n",
      "    o523          0           45.000000                 0     Propriva Female           6          25\n",
      "    i635          0           45.000000                 0     Propriva   Male          21          26\n",
      "    w746          0           45.000000                 0     Propriva   Male           1          26\n",
      "    r107          0           45.000000                 0     Propriva Female           2          28\n",
      "    s187          0           45.000000                 0     Propriva   Male          22          25\n",
      "    g570          0           45.000000                 0     Propriva   Male          16          29\n",
      "    x209          0           45.000000                 0     Propriva Female           7          29\n",
      "    x111          0           45.000000                 0     Propriva Female          24          27\n",
      "    z435          0           45.000000                 0     Propriva Female          12          26\n",
      "    n678          0           45.000000                 0     Propriva   Male           5          29\n",
      "    g558          0           45.000000                 0     Propriva   Male           8          29\n",
      "    u946          0           45.000000                 0     Propriva   Male           5          30\n",
      "    o562          0           45.000000                 0     Propriva Female           4          25\n",
      "    v991          0           45.000000                 0     Propriva Female          10          30\n",
      "    c927          0           45.000000                 0     Propriva Female           4          26\n",
      "    x226          0           45.000000                 0     Ceftamin   Male          23          28\n",
      "    p438          0           45.000000                 0     Ceftamin Female          11          26\n",
      "    b487          0           45.000000                 0     Ceftamin Female           6          28\n",
      "    o287          0           45.000000                 0     Ceftamin   Male           2          28\n",
      "    q483          0           45.000000                 0     Ceftamin   Male           6          26\n",
      "    t573          0           45.000000                 0     Ceftamin Female          15          27\n",
      "    f345          0           45.000000                 0    Infubinol   Male          23          26\n",
      "    i334          0           45.000000                 0     Ramicane Female           8          20\n",
      "    l264          0           45.000000                 0     Ketapril Female          15          30\n",
      "    j246          0           45.000000                 0    Capomulin Female          21          21\n",
      "    r554          0           45.000000                 0    Capomulin Female           8          17\n",
      "    s185          0           45.000000                 0    Capomulin Female           3          17\n",
      "    b742          0           45.000000                 0    Capomulin   Male           7          21\n",
      "    x401          0           45.000000                 0    Capomulin Female          16          15\n",
      "    l509          0           45.000000                 0    Capomulin   Male          17          21\n",
      "    s710          0           45.000000                 0    Capomulin Female           1          23\n",
      "    r157          0           45.000000                 0    Capomulin   Male          22          25\n",
      "    u364          0           45.000000                 0    Capomulin   Male          18          17\n",
      "    j119          0           45.000000                 0    Capomulin Female           7          23\n",
      "    v923          0           45.000000                 0    Capomulin Female          19          21\n",
      "    w914          0           45.000000                 0    Capomulin   Male          24          21\n",
      "    i738          0           45.000000                 0    Capomulin Female          23          20\n",
      "    r944          0           45.000000                 0    Capomulin   Male          12          25\n",
      "    y793          0           45.000000                 0    Capomulin   Male          17          17\n",
      "    g316          0           45.000000                 0    Capomulin Female          22          22\n",
      "    g288          0           45.000000                 0    Capomulin   Male           3          19\n",
      "    l897          0           45.000000                 0    Capomulin   Male          17          19\n",
      "    w150          0           45.000000                 0    Capomulin   Male          23          23\n",
      "    t565          0           45.000000                 0    Capomulin Female          20          17\n",
      "    i557          0           45.000000                 0    Capomulin Female           1          24\n",
      "    m957          0           45.000000                 0    Capomulin Female           3          19\n",
      "    f966          0           45.000000                 0    Capomulin   Male          16          17\n",
      "    m601          0           45.000000                 0    Capomulin   Male          22          17\n",
      "    a275          5           46.795257                 0     Ceftamin Female          20          28\n",
      "    w575          5           48.913860                 1    Zoniferol Female          16          28\n",
      "    x822          5           45.671104                 1     Ceftamin   Male           3          29\n",
      "    l509          5           45.851193                 0    Capomulin   Male          17          21\n",
      "    n304          5           46.431216                 0     Naftisol   Male           9          26\n",
      "    d164          5           46.617671                 0    Zoniferol   Male          21          28\n",
      "    l897          5           45.462243                 0    Capomulin   Male          17          19\n",
      "    l558          5           45.809089                 0     Ceftamin Female          13          30\n",
      "    g296          5           46.593233                 0    Zoniferol Female          14          29\n",
      "    c458          5           45.722279                 0     Ramicane Female          23          20\n",
      "    a401          5           46.111986                 0    Zoniferol Female           8          25\n",
      "    l700          5           45.918372                 0     Naftisol Female          18          27\n",
      "    f234          5           47.313491                 0     Stelasyn   Male          14          28\n",
      "    x613          5           46.097041                 0    Zoniferol Female           2          29\n",
      "    u149          5           45.792068                 0     Ceftamin   Male          24          29\n",
      "    k210          5           47.918998                 0     Ceftamin   Male          15          28\n",
      "    x402          5           46.327570                 1     Stelasyn   Male          21          28\n",
      "    q610          5           45.629494                 0     Ramicane Female          18          21\n",
      "    x581          5           47.196927                 0     Ceftamin Female          19          28\n",
      "    a492          5           46.409143                 0     Stelasyn   Male          20          25\n",
      "    m133          5           46.621301                 0     Naftisol Female           2          26\n",
      "    l725          5           48.736319                 1     Naftisol Female           8          26\n",
      "    q633          5           47.183802                 0    Zoniferol   Male          12          25\n",
      "    f129          5           47.000594                 0    Zoniferol Female          11          29\n",
      "    q483          5           46.776816                 1     Ceftamin   Male           6          26\n",
      "    a444          5           44.005975                 0     Ramicane Female          10          25\n",
      "    v835          5           47.156011                 0     Naftisol   Male           7          29\n",
      "    r604          5           47.067744                 1     Naftisol   Male           7          30\n",
      "    f394          5           47.033100                 0    Zoniferol   Male          19          30\n",
      "    y865          5           46.735006                 1     Ceftamin   Male          23          26\n",
      "    d251          5           41.746355                 1     Ramicane Female           8          19\n",
      "    b313          5           47.154433                 0    Zoniferol   Male          12          27\n",
      "    y769          5           46.422652                 1     Ceftamin Female           6          27\n",
      "    z234          5           46.129357                 1     Naftisol Female          19          27\n",
      "    b559          5           47.409897                 0     Naftisol   Male          20          26\n",
      "    f993          5           46.395760                 0     Naftisol   Male          21          28\n",
      "    q119          5           47.864440                 0     Ketapril   Male          17          30\n",
      "    j989          5           45.620718                 1     Ramicane   Male           8          19\n",
      "    w150          5           39.202129                 0    Capomulin   Male          23          23\n",
      "    n923          5           45.824881                 0     Ketapril   Male          19          30\n",
      "    y449          5           45.877545                 0     Ramicane   Male          19          24\n",
      "    l661          5           46.268799                 0     Ceftamin   Male          18          26\n",
      "    c302          5           47.690680                 1    Zoniferol Female          10          29\n",
      "    c264          5           45.791704                 0    Zoniferol Female          11          27\n",
      "    l471          5           46.251872                 0     Ceftamin Female           7          28\n",
      "    x930          5           46.078234                 0     Naftisol   Male          13          26\n",
      "    k754          5           45.727760                 0    Zoniferol Female           8          26\n",
      "    f436          5           46.370798                 1     Ceftamin Female           3          25\n",
      "    v295          5           46.111818                 1     Naftisol Female           2          27\n",
      "    j913          5           44.014900                 0     Ramicane Female           4          17\n",
      "    s710          5           43.180977                 0    Capomulin Female           1          23\n",
      "    z969          5           49.332999                 0     Naftisol   Male           9          30\n",
      "    k894          5           47.645687                 0    Zoniferol Female          13          29\n",
      "    l490          5           45.612539                 1     Ceftamin   Male          24          26\n",
      "    b759          5           48.009190                 0     Ceftamin Female          12          25\n",
      "    a411          5           45.466677                 0     Ramicane   Male           3          22\n",
      "    f545          5           46.565813                 0    Zoniferol Female          20          26\n",
      "    o725          5           46.889821                 0     Naftisol   Male           4          26\n",
      "    y601          5           48.475003                 1     Naftisol Female          23          25\n",
      "    w914          5           45.893720                 0    Capomulin   Male          24          21\n",
      "    n967          5           46.077192                 1    Zoniferol   Male          11          27\n",
      "    l733          5           46.174226                 0     Ceftamin Female           4          30\n",
      "    m601          5           41.408591                 1    Capomulin   Male          22          17\n",
      "    b487          5           46.213977                 0     Ceftamin Female           6          28\n",
      "    o287          5           45.586804                 0     Ceftamin   Male           2          28\n",
      "    p310          5           46.558532                 1     Propriva   Male           6          26\n",
      "    r107          5           48.513420                 0     Propriva Female           2          28\n",
      "    s565          5           48.242552                 0     Stelasyn Female           3          29\n",
      "    w350          5           48.232113                 0     Propriva   Male           7          26\n",
      "    s187          5           47.576718                 1     Propriva   Male          22          25\n",
      "    j984          5           48.410721                 1     Stelasyn Female           2          30\n",
      "    w697          5           48.301823                 1     Stelasyn Female          14          30\n",
      "    j755          5           47.242844                 0     Naftisol   Male          23          27\n",
      "    g570          5           47.656424                 1     Propriva   Male          16          29\n",
      "    u364          5           45.760886                 1    Capomulin   Male          18          17\n",
      "    x209          5           46.754269                 0     Propriva Female           7          29\n",
      "    c402          5           49.342630                 1     Stelasyn Female           1          27\n",
      "    b742          5           41.534097                 0    Capomulin   Male           7          21\n",
      "    n630          5           46.099100                 0     Propriva Female          15          29\n",
      "    g989          5           48.786801                 0     Propriva Female          21          26\n",
      "    e213          5           45.699250                 1     Naftisol   Male           8          27\n",
      "    a366          5           48.951368                 0     Stelasyn Female          16          29\n",
      "    w746          5           49.453270                 0     Propriva   Male           1          26\n",
      "    s141          5           45.831134                 0     Propriva   Male           8          25\n",
      "    i901          5           46.493024                 0     Stelasyn   Male          23          29\n",
      "    t198          5           47.461261                 0     Propriva   Male          22          26\n",
      "    b879          5           49.156156                 1     Stelasyn Female           4          26\n",
      "    k603          5           46.042116                 0     Propriva   Male           2          27\n",
      "    o523          5           45.544700                 0     Propriva Female           6          25\n",
      "    v923          5           45.704434                 0    Capomulin Female          19          21\n",
      "    f966          5           38.796474                 0    Capomulin   Male          16          17\n",
      "    p387          5           48.667631                 0     Stelasyn   Male           3          30\n",
      "    g867          5           46.880749                 0     Stelasyn Female           9          25\n",
      "    i635          5           47.235937                 0     Propriva   Male          21          26\n",
      "    s619          5           46.602269                 0     Stelasyn   Male          22          30\n",
      "    a699          5           46.553090                 0     Propriva Female           5          28\n",
      "    q132          5           46.716398                 1    Infubinol Female           1          30\n",
      "    k862          5           49.203058                 0     Stelasyn Female          13          25\n",
      "    h333          5           45.751727                 0     Stelasyn   Male          21          27\n",
      "    x401          5           45.473753                 0    Capomulin Female          16          15\n",
      "    o926          5           46.761164                 0    Zoniferol   Male          15          29\n",
      "    c927          5           46.351842                 0     Propriva Female           4          26\n",
      "    c559          5           46.562638                 0    Zoniferol Female          19          28\n",
      "    r701          5           46.886971                 0     Naftisol   Male          21          25\n",
      "    j119          5           45.838998                 0    Capomulin Female           7          23\n",
      "    p438          5           46.827934                 0     Ceftamin Female          11          26\n",
      "    m269          5           49.011180                 0     Stelasyn Female          22          28\n",
      "    a963          5           46.233506                 0     Stelasyn Female          23          27\n",
      "    p136          5           49.273971                 0    Zoniferol Female           5          28\n",
      "    t724          5           46.359258                 0     Naftisol Female           2          25\n",
      "    g989          5           47.570392                 0     Propriva Female          21          26\n",
      "    z314          5           45.934712                 0     Stelasyn Female          21          28\n",
      "    a818          5           45.696709                 0     Naftisol Female          12          28\n",
      "    v764          5           47.054185                 0     Stelasyn Female           5          30\n",
      "    j365          5           46.711261                 0    Zoniferol   Male          24          28\n",
      "    i557          5           42.261665                 0    Capomulin Female           1          24\n",
      "    x264          5           47.038415                 0     Naftisol Female          21          27\n",
      "    v991          5           49.214328                 1     Propriva Female          10          30\n",
      "    a788          5           47.006580                 0    Zoniferol   Male           5          30\n",
      "    x111          5           46.941015                 1     Propriva Female          24          27\n",
      "    k510          5           46.608467                 0     Stelasyn Female           8          27\n",
      "    z435          5           47.115980                 0     Propriva Female          12          26\n",
      "    e584          5           45.656979                 0     Naftisol   Male           9          27\n",
      "    m331          5           45.523014                 1    Zoniferol Female          19          26\n",
      "    n678          5           47.554284                 0     Propriva   Male           5          29\n",
      "    p981          5           47.000627                 0     Stelasyn   Male          20          29\n",
      "    g558          5           46.188742                 0     Propriva   Male           8          29\n",
      "    e291          5           46.142505                 0     Naftisol Female          14          29\n",
      "    q511          5           45.832654                 0    Zoniferol Female           2          28\n",
      "    u946          5           45.991808                 1     Propriva   Male           5          30\n",
      "    z795          5           46.833475                 0     Naftisol Female          13          29\n",
      "    t451          5           48.047139                 0     Stelasyn   Male           8          29\n",
      "    s337          5           46.849852                 0    Zoniferol   Male          14          27\n",
      "    o562          5           46.514950                 1     Propriva Female           4          25\n",
      "    w540          5           45.885370                 1     Stelasyn Female           8          26\n",
      "    w140          5           47.717952                 0    Zoniferol Female          19          30\n",
      "    l215          5           49.481949                 1     Propriva   Male          10          29\n",
      "    y793          5           41.019913                 0    Capomulin   Male          17          17\n",
      "    n763          5           46.085981                 0      Placebo Female          16          25\n",
      "    a203          5           48.508468                 0    Infubinol Female          20          23\n",
      "    w584          5           46.051931                 0    Infubinol   Male           3          29\n",
      "    y163          5           48.284970                 0    Infubinol Female          17          27\n",
      "    o973          5           46.717877                 0     Ketapril Female          11          29\n",
      "    o795          5           46.760927                 1      Placebo Female          20          26\n",
      "    w422          5           48.457459                 0     Ketapril Female          18          26\n",
      "    e662          5           45.816283                 0     Ramicane   Male           8          24\n",
      "    g791          5           45.851531                 0     Ramicane   Male          11          16\n",
      "    c580          5           46.628455                 0     Ketapril   Male          22          25\n",
      "    e476          5           47.111801                 0    Infubinol   Male          23          26\n",
      "    k483          5           46.611056                 0    Infubinol Female          20          30\n",
      "    y478          5           48.641078                 1      Placebo Female           3          25\n",
      "    i669          5           46.764668                 1      Placebo Female          18          27\n",
      "    d474          5           45.918352                 0     Ketapril   Male          18          27\n",
      "    w193          5           45.493858                 0    Infubinol   Male          22          30\n",
      "    q582          5           45.955399                 1      Placebo   Male           5          30\n",
      "    s166          5           47.186788                 0      Placebo   Male          19          27\n",
      "    o331          5           47.059664                 1     Ketapril   Male          24          30\n",
      "    k382          5           46.274997                 1     Ketapril   Male          22          29\n",
      "    k804          5           48.266204                 0    Infubinol Female          23          29\n",
      "    r850          5           46.862912                 0      Placebo   Male           5          30\n",
      "    g316          5           44.022752                 0    Capomulin Female          22          22\n",
      "    v766          5           48.151251                 1    Infubinol   Male          16          27\n",
      "    g497          5           48.782069                 0     Ketapril   Male          19          28\n",
      "    a520          5           38.723707                 0     Ramicane   Male          13          21\n",
      "    x773          5           45.850831                 1      Placebo Female          21          30\n",
      "    m550          5           49.054097                 1     Ketapril   Male          18          28\n",
      "    t994          5           47.891487                 0      Placebo   Male          14          30\n",
      "    n364          5           45.521875                 0     Ramicane   Male           4          17\n",
      "    l264          5           46.668766                 0     Ketapril Female          15          30\n",
      "    e227          5           47.238011                 0      Placebo   Male           1          30\n",
      "    c326          5           36.321346                 0    Infubinol Female          18          25\n",
      "    r157          5           45.597064                 0    Capomulin   Male          22          25\n",
      "    c766          5           47.313055                 0      Placebo Female          13          26\n",
      "    v719          5           47.188363                 0    Infubinol Female          17          30\n",
      "    w678          5           43.166373                 0     Ramicane Female           5          24\n",
      "    c139          5           48.753112                 0    Infubinol   Male          11          28\n",
      "    m546          5           42.998876                 0     Ramicane   Male          18          16\n",
      "    v339          5           46.250112                 0    Infubinol   Male          20          26\n",
      "    s152          5           47.459053                 1      Placebo Female           4          30\n",
      "    m650          5           48.562495                 1     Ketapril   Male          15          27\n",
      "    c282          5           45.725690                 0      Placebo   Male          12          27\n",
      "    v989          5           48.858135                 0      Placebo   Male           4          25\n",
      "    r944          5           45.737145                 0    Capomulin   Male          12          25\n",
      "    r554          5           45.781746                 1    Capomulin Female           8          17\n",
      "    c895          5           45.477544                 0    Infubinol Female           7          29\n",
      "    v409          5           46.220796                 0      Placebo Female          16          25\n",
      "    u196          5           45.557464                 1     Ramicane   Male          18          25\n",
      "    c832          5           48.685461                 1     Ketapril   Male          18          29\n",
      "    v289          5           46.204460                 0     Ketapril Female           3          26\n",
      "    a897          5           45.691124                 1      Placebo   Male           7          28\n",
      "    f345          5           45.591147                 0    Infubinol   Male          23          26\n",
      "    s508          5           38.711872                 0     Ramicane   Male           1          17\n",
      "    a577          5           46.197720                 1    Infubinol Female           6          25\n",
      "    z578          5           42.188787                 0     Ramicane   Male          11          16\n",
      "    i177          5           44.065398                 0     Ramicane   Male          10          18\n",
      "    a644          5           45.550158                 0     Ramicane Female           7          17\n",
      "    c757          5           47.783280                 0      Placebo   Male           9          27\n",
      "    s185          5           43.878496                 0    Capomulin Female           3          17\n",
      "    i738          5           45.595685                 0    Capomulin Female          23          20\n",
      "    m756          5           47.010364                 1    Infubinol   Male          19          30\n",
      "    o813          5           45.699331                 0    Infubinol   Male          24          28\n",
      "    j246          5           45.641438                 0    Capomulin Female          21          21\n",
      "    a685          5           46.870483                 0    Infubinol   Male           8          30\n",
      "    r811          5           45.625802                 0     Ramicane   Male           9          19\n",
      "    h246          5           49.470417                 0     Ketapril   Male          13          30\n",
      "    q597          5           45.766111                 0     Ramicane   Male          20          25\n",
      "    a251          5           46.982127                 0    Infubinol Female          21          25\n",
      "    q787          5           47.116616                 0      Placebo   Male          17          27\n",
      "    c758          5           45.578678                 0     Ramicane   Male           9          17\n",
      "    u327          5           45.694188                 0     Ketapril   Male          17          25\n",
      "    t565          5           45.895647                 0    Capomulin Female          20          17\n",
      "    c819          5           45.769249                 1     Ketapril   Male          21          25\n",
      "    o302          5           48.937012                 0      Placebo Female           2          29\n",
      "    h531          5           47.784682                 0     Ceftamin   Male           5          27\n",
      "    i477          5           46.657385                 0      Placebo Female           3          30\n",
      "    w151          5           45.546076                 1     Ceftamin   Male          24          25\n",
      "    y260          5           46.799839                 0     Ketapril Female           7          25\n",
      "    r921          5           45.568211                 0     Ramicane Female           5          25\n",
      "    a457          5           47.462891                 0     Ketapril Female          11          30\n",
      "    j296          5           46.799256                 1     Ceftamin Female          24          30\n",
      "    w167          5           48.786272                 0      Placebo Female           6          28\n",
      "    a262          5           48.717568                 1      Placebo Female          17          29\n",
      "    b128          5           45.651331                 0    Capomulin Female           9          22\n",
      "    n671          5           47.353889                 0    Infubinol   Male          18          25\n",
      "    g288          5           45.839400                 0    Capomulin   Male           3          19\n",
      "    v603          5           46.016006                 0     Ketapril Female          22          30\n",
      "    i334          5           41.020518                 0     Ramicane Female           8          20\n",
      "    k403          5           38.825898                 0     Ramicane   Male          21          16\n",
      "    p189          5           49.048707                 1     Ketapril   Male           8          28\n",
      "    o809          5           46.877243                 0    Infubinol   Male           3          25\n",
      "    g107          5           48.791665                 0     Ketapril Female           2          29\n",
      "    t718          5           45.921253                 1      Placebo Female          10          30\n",
      "    i386          5           46.853697                 1    Infubinol Female          23          29\n",
      "    s121          5           45.635662                 1    Infubinol   Male          23          26\n",
      "    z581          5           49.273092                 1    Infubinol Female          24          25\n",
      "    f278          5           48.194578                 0     Ketapril   Male          12          30\n",
      "    j235          5           46.588820                 0      Placebo   Male           6          30\n",
      "    m957          5           45.622381                 1    Capomulin Female           3          19\n",
      "    e291         10           48.529741                 1     Naftisol Female          14          29\n",
      "    u946         10           46.730506                 1     Propriva   Male           5          30\n",
      "    g558         10           50.094754                 0     Propriva   Male           8          29\n",
      "    i386         10           49.861547                 2    Infubinol Female          23          29\n",
      "    e584         10           47.250641                 0     Naftisol   Male           9          27\n",
      "    o523         10           47.081086                 1     Propriva Female           6          25\n",
      "    i635         10           48.685756                 1     Propriva   Male          21          26\n",
      "    b879         10           50.338946                 1     Stelasyn Female           4          26\n",
      "    u327         10           49.235259                 0     Ketapril   Male          17          25\n",
      "    n678         10           49.145709                 1     Propriva   Male           5          29\n",
      "    r554         10           39.005494                 2    Capomulin Female           8          17\n",
      "    z435         10           48.710661                 0     Propriva Female          12          26\n",
      "    s565         10           52.777527                 0     Stelasyn Female           3          29\n",
      "    g497         10           49.647087                 0     Ketapril   Male          19          28\n",
      "    s187         10           48.146351                 1     Propriva   Male          22          25\n",
      "    o809         10           48.670732                 0    Infubinol   Male           3          25\n",
      "    z581         10           50.478750                 2    Infubinol Female          24          25\n",
      "    r107         10           49.186011                 0     Propriva Female           2          28\n",
      "    k804         10           49.471244                 0    Infubinol Female          23          29\n",
      "    a366         10           53.523990                 0     Stelasyn Female          16          29\n",
      "    j755         10           48.167061                 0     Naftisol   Male          23          27\n",
      "    g570         10           49.188232                 1     Propriva   Male          16          29\n",
      "    d474         10           46.974963                 0     Ketapril   Male          18          27\n",
      "    c832         10           49.811413                 1     Ketapril   Male          18          29\n",
      "    x209         10           48.929895                 0     Propriva Female           7          29\n",
      "    u364         10           46.568417                 2    Capomulin   Male          18          17\n",
      "    k483         10           50.296041                 1    Infubinol Female          20          30\n",
      "    o973         10           48.245790                 0     Ketapril Female          11          29\n",
      "    y163         10           49.112399                 1    Infubinol Female          17          27\n",
      "    e213         10           47.391571                 2     Naftisol   Male           8          27\n",
      "    a251         10           48.591179                 1    Infubinol Female          21          25\n",
      "    p387         10           53.362963                 0     Stelasyn   Male           3          30\n",
      "    v923         10           39.848223                 0    Capomulin Female          19          21\n",
      "    x111         10           49.122969                 1     Propriva Female          24          27\n",
      "    a577         10           49.509639                 1    Infubinol Female           6          25\n",
      "    g288         10           46.304003                 1    Capomulin   Male           3          19\n",
      "    v603         10           47.830557                 0     Ketapril Female          22          30\n",
      "    c139         10           49.992954                 0    Infubinol   Male          11          28\n",
      "    j296         10           48.529978                 2     Ceftamin Female          24          30\n",
      "    o331         10           50.128455                 1     Ketapril   Male          24          30\n",
      "    b759         10           49.133355                 0     Ceftamin Female          12          25\n",
      "    l490         10           47.259606                 1     Ceftamin   Male          24          26\n",
      "    z969         10           52.656081                 1     Naftisol   Male           9          30\n",
      "    n671         10           51.039357                 0    Infubinol   Male          18          25\n",
      "    g107         10           53.435987                 0     Ketapril Female           2          29\n",
      "    v835         10           48.965918                 0     Naftisol   Male           7          29\n",
      "    s710         10           43.688026                 0    Capomulin Female           1          23\n",
      "    s121         10           49.048835                 1    Infubinol   Male          23          26\n",
      "    f436         10           48.146978                 2     Ceftamin Female           3          25\n",
      "    r604         10           48.786560                 1     Naftisol   Male           7          30\n",
      "    l733         10           48.354952                 0     Ceftamin Female           4          30\n",
      "    l509         10           46.759074                 0    Capomulin   Male          17          21\n",
      "    y260         10           48.081807                 1     Ketapril Female           7          25\n",
      "    v766         10           50.363110                 1    Infubinol   Male          16          27\n",
      "    n304         10           47.201251                 0     Naftisol   Male           9          26\n",
      "    a457         10           49.783419                 0     Ketapril Female          11          30\n",
      "    l558         10           46.784535                 0     Ceftamin Female          13          30\n",
      "    o725         10           48.199452                 0     Naftisol   Male           4          26\n",
      "    c819         10           46.658395                 1     Ketapril   Male          21          25\n",
      "    i738         10           43.421014                 0    Capomulin Female          23          20\n",
      "    n923         10           48.791950                 1     Ketapril   Male          19          30\n",
      "    p189         10           51.582162                 2     Ketapril   Male           8          28\n",
      "    q119         10           51.236606                 0     Ketapril   Male          17          30\n",
      "    l661         10           49.683620                 0     Ceftamin   Male          18          26\n",
      "    f993         10           48.185373                 0     Naftisol   Male          21          28\n",
      "    m957         10           46.414518                 1    Capomulin Female           3          19\n",
      "    h246         10           51.368862                 1     Ketapril   Male          13          30\n",
      "    w151         10           46.501476                 1     Ceftamin   Male          24          25\n",
      "    y769         10           48.015163                 1     Ceftamin Female           6          27\n",
      "    y865         10           49.522740                 1     Ceftamin   Male          23          26\n",
      "    b559         10           48.036432                 0     Naftisol   Male          20          26\n",
      "    s141         10           47.235692                 0     Propriva   Male           8          25\n",
      "    l471         10           48.182063                 0     Ceftamin Female           7          28\n",
      "    x930         10           50.260694                 0     Naftisol   Male          13          26\n",
      "    a685         10           47.664753                 0    Infubinol   Male           8          30\n",
      "    w193         10           48.346550                 0    Infubinol   Male          22          30\n",
      "    x822         10           48.983717                 1     Ceftamin   Male           3          29\n",
      "    k382         10           50.180968                 1     Ketapril   Male          22          29\n",
      "    v289         10           48.133482                 0     Ketapril Female           3          26\n",
      "    b487         10           47.664387                 0     Ceftamin Female           6          28\n",
      "    c895         10           49.779015                 0    Infubinol Female           7          29\n",
      "    t724         10           50.703900                 0     Naftisol Female           2          25\n",
      "    j119         10           46.425366                 0    Capomulin Female           7          23\n",
      "    p438         10           50.517498                 0     Ceftamin Female          11          26\n",
      "    r701         10           49.654596                 0     Naftisol   Male          21          25\n",
      "    m650         10           50.968998                 1     Ketapril   Male          15          27\n",
      "    i557         10           42.992077                 0    Capomulin Female           1          24\n",
      "    v719         10           51.497054                 1    Infubinol Female          17          30\n",
      "    c927         10           50.965298                 1     Propriva Female           4          26\n",
      "    x264         10           47.887128                 1     Naftisol Female          21          27\n",
      "    v991         10           52.644906                 1     Propriva Female          10          30\n",
      "    l264         10           50.659581                 0     Ketapril Female          15          30\n",
      "    o562         10           47.147670                 1     Propriva Female           4          25\n",
      "    f345         10           47.222446                 0    Infubinol   Male          23          26\n",
      "    a818         10           49.790919                 0     Naftisol Female          12          28\n",
      "    o287         10           47.360201                 1     Ceftamin   Male           2          28\n",
      "    m550         10           50.548035                 2     Ketapril   Male          18          28\n",
      "    l700         10           47.013567                 1     Naftisol Female          18          27\n",
      "    g316         10           44.502042                 0    Capomulin Female          22          22\n",
      "    u149         10           47.404834                 0     Ceftamin   Male          24          29\n",
      "    e476         10           49.431685                 0    Infubinol   Male          23          26\n",
      "    k210         10           49.379932                 0     Ceftamin   Male          15          28\n",
      "    l725         10           50.823912                 2     Naftisol Female           8          26\n",
      "    a275         10           47.371343                 0     Ceftamin Female          20          28\n",
      "    z795         10           48.030804                 0     Naftisol Female          13          29\n",
      "    c580         10           47.570174                 1     Ketapril   Male          22          25\n",
      "    m133         10           47.503338                 0     Naftisol Female           2          26\n",
      "    w422         10           49.935970                 0     Ketapril Female          18          26\n",
      "    x581         10           49.067028                 1     Ceftamin Female          19          28\n",
      "    v295         10           47.539462                 2     Naftisol Female           2          27\n",
      "    a203         10           51.852437                 1    Infubinol Female          20          23\n",
      "    y793         10           41.630010                 1    Capomulin   Male          17          17\n",
      "    q483         10           47.839101                 1     Ceftamin   Male           6          26\n",
      "    w584         10           47.298508                 0    Infubinol   Male           3          29\n",
      "    f966         10           35.624403                 0    Capomulin   Male          16          17\n",
      "    q132         10           47.953844                 2    Infubinol Female           1          30\n",
      "    m269         10           50.860130                 0     Stelasyn Female          22          28\n",
      "    w167         10           51.826410                 0      Placebo Female           6          28\n",
      "    m601         10           36.825367                 1    Capomulin   Male          22          17\n",
      "    a492         10           48.432197                 0     Stelasyn   Male          20          25\n",
      "    x773         10           47.189206                 2      Placebo Female          21          30\n",
      "    a401         10           47.725937                 1    Zoniferol Female           8          25\n",
      "    i177         10           41.020929                 0     Ramicane   Male          10          18\n",
      "    s166         10           49.000125                 0      Placebo   Male          19          27\n",
      "    q582         10           47.013575                 1      Placebo   Male           5          30\n",
      "    w540         10           47.459067                 1     Stelasyn Female           8          26\n",
      "    j365         10           48.349320                 0    Zoniferol   Male          24          28\n",
      "    v764         10           48.189001                 1     Stelasyn Female           5          30\n",
      "    g791         10           40.170558                 0     Ramicane   Male          11          16\n",
      "    y478         10           52.288934                 1      Placebo Female           3          25\n",
      "    l897         10           46.154737                 0    Capomulin   Male          17          19\n",
      "    o795         10           51.123704                 1      Placebo Female          20          26\n",
      "    g989         10           51.745156                 0     Propriva Female          21          26\n",
      "    p136         10           50.907890                 0    Zoniferol Female           5          28\n",
      "    t451         10           48.957919                 0     Stelasyn   Male           8          29\n",
      "    c282         10           48.179506                 0      Placebo   Male          12          27\n",
      "    s337         10           47.894441                 0    Zoniferol   Male          14          27\n",
      "    m546         10           43.748224                 0     Ramicane   Male          18          16\n",
      "    v989         10           52.614689                 1      Placebo   Male           4          25\n",
      "    a788         10           50.159721                 1    Zoniferol   Male           5          30\n",
      "    a644         10           46.380713                 0     Ramicane Female           7          17\n",
      "    v409         10           50.649038                 1      Placebo Female          16          25\n",
      "    r944         10           46.544292                 0    Capomulin   Male          12          25\n",
      "    a963         10           47.150522                 0     Stelasyn Female          23          27\n",
      "    t994         10           52.614163                 1      Placebo   Male          14          30\n",
      "    c559         10           47.293260                 0    Zoniferol Female          19          28\n",
      "    a520         10           36.429388                 0     Ramicane   Male          13          21\n",
      "    a444         10           44.512560                 0     Ramicane Female          10          25\n",
      "    u196         10           46.422943                 1     Ramicane   Male          18          25\n",
      "    e227         10           51.349757                 1      Placebo   Male           1          30\n",
      "    f129         10           48.179719                 1    Zoniferol Female          11          29\n",
      "    t718         10           46.392688                 1      Placebo Female          10          30\n",
      "    n967         10           47.471723                 1    Zoniferol   Male          11          27\n",
      "    d251         10           42.432258                 1     Ramicane Female           8          19\n",
      "    b313         10           48.319372                 1    Zoniferol   Male          12          27\n",
      "    f545         10           51.072512                 0    Zoniferol Female          20          26\n",
      "    a411         10           40.759788                 1     Ramicane   Male           3          22\n",
      "    w914         10           43.231963                 0    Capomulin   Male          24          21\n",
      "    c302         10           48.533567                 1    Zoniferol Female          10          29\n",
      "    j989         10           46.343832                 1     Ramicane   Male           8          19\n",
      "    k894         10           49.272870                 1    Zoniferol Female          13          29\n",
      "    y449         10           46.378092                 0     Ramicane   Male          19          24\n",
      "    w150         10           39.952347                 0    Capomulin   Male          23          23\n",
      "    j913         10           44.497162                 0     Ramicane Female           4          17\n",
      "    a897         10           47.972927                 1      Placebo   Male           7          28\n",
      "    k754         10           49.746117                 0    Zoniferol Female           8          26\n",
      "    k403         10           35.014271                 1     Ramicane   Male          21          16\n",
      "    c757         10           49.219317                 0      Placebo   Male           9          27\n",
      "    g296         10           48.269509                 0    Zoniferol Female          14          29\n",
      "    r921         10           42.711927                 0     Ramicane Female           5          25\n",
      "    q633         10           49.001866                 0    Zoniferol   Male          12          25\n",
      "    t565         10           46.749006                 0    Capomulin Female          20          17\n",
      "    r811         10           39.453903                 0     Ramicane   Male           9          19\n",
      "    f234         10           47.904324                 0     Stelasyn   Male          14          28\n",
      "    x613         10           46.818176                 0    Zoniferol Female           2          29\n",
      "    x402         10           46.886962                 1     Stelasyn   Male          21          28\n",
      "    o302         10           49.701450                 0      Placebo Female           2          29\n",
      "    w575         10           50.135955                 1    Zoniferol Female          16          28\n",
      "    c458         10           44.454378                 1     Ramicane Female          23          20\n",
      "    i477         10           47.520632                 0      Placebo Female           3          30\n",
      "    c758         10           46.287992                 0     Ramicane   Male           9          17\n",
      "    d164         10           47.474645                 1    Zoniferol   Male          21          28\n",
      "    q610         10           44.991485                 0     Ramicane Female          18          21\n",
      "    s185         10           37.614948                 0    Capomulin Female           3          17\n",
      "    q511         10           50.311647                 0    Zoniferol Female           2          28\n",
      "    c264         10           49.026592                 0    Zoniferol Female          11          27\n",
      "    k862         10           50.523550                 1     Stelasyn Female          13          25\n",
      "    n763         10           46.817315                 1      Placebo Female          16          25\n",
      "    h333         10           46.233844                 1     Stelasyn   Male          21          27\n",
      "    c402         10           50.566894                 1     Stelasyn Female           1          27\n",
      "    q787         10           48.593862                 1      Placebo   Male          17          27\n",
      "    b128         10           43.270852                 0    Capomulin Female           9          22\n",
      "    g867         10           48.183402                 0     Stelasyn Female           9          25\n",
      "    g989         10           49.880528                 0     Propriva Female          21          26\n",
      "    b742         10           41.999228                 0    Capomulin   Male           7          21\n",
      "    e662         10           46.409084                 0     Ramicane   Male           8          24\n",
      "    i669         10           48.281633                 1      Placebo Female          18          27\n",
      "    a699         10           47.867376                 0     Propriva Female           5          28\n",
      "    q597         10           42.537986                 0     Ramicane   Male          20          25\n",
      "    j984         10           50.141084                 1     Stelasyn Female           2          30\n",
      "    a262         10           49.595181                 1      Placebo Female          17          29\n",
      "    w350         10           48.899552                 0     Propriva   Male           7          26\n",
      "    n364         10           40.375138                 0     Ramicane   Male           4          17\n",
      "    z578         10           42.952118                 0     Ramicane   Male          11          16\n",
      "    w697         10           48.925056                 2     Stelasyn Female          14          30\n",
      "    p310         10           48.665607                 1     Propriva   Male           6          26\n",
      "    k603         10           46.606947                 0     Propriva   Male           2          27\n",
      "    k510         10           47.658250                 1     Stelasyn Female           8          27\n",
      "    r850         10           48.515091                 1      Placebo   Male           5          30\n",
      "    j235         10           48.018788                 1      Placebo   Male           6          30\n",
      "    i901         10           50.421250                 0     Stelasyn   Male          23          29\n",
      "    s152         10           52.181644                 2      Placebo Female           4          30\n",
      "    o926         10           47.565674                 1    Zoniferol   Male          15          29\n",
      "    m331         10           47.646877                 1    Zoniferol Female          19          26\n",
      "    x401         10           39.113891                 0    Capomulin Female          16          15\n",
      "    l215         10           53.653970                 1     Propriva   Male          10          29\n",
      "    j246         10           46.408361                 0    Capomulin Female          21          21\n",
      "    s508         10           34.850998                 0     Ramicane   Male           1          17\n",
      "    p981         10           47.545846                 0     Stelasyn   Male          20          29\n",
      "    i334         10           41.631247                 0     Ramicane Female           8          20\n",
      "    r157         10           46.059608                 0    Capomulin   Male          22          25\n",
      "    t198         10           49.000810                 1     Propriva   Male          22          26\n",
      "    c766         10           49.500271                 1      Placebo Female          13          26\n",
      "    q597         15           41.395660                 0     Ramicane   Male          20          25\n",
      "    l661         15           50.947545                 1     Ceftamin   Male          18          26\n",
      "    y769         15           52.761021                 2     Ceftamin Female           6          27\n",
      "    s185         15           38.177232                 0    Capomulin Female           3          17\n",
      "    d251         15           39.472787                 1     Ramicane Female           8          19\n",
      "    y865         15           50.806519                 1     Ceftamin   Male          23          26\n",
      "    a685         15           48.951474                 0    Infubinol   Male           8          30\n",
      "    a262         15           53.827974                 2      Placebo Female          17          29\n",
      "    b128         15           43.784893                 0    Capomulin Female           9          22\n",
      "    r811         15           40.022292                 0     Ramicane   Male           9          19\n",
      "    z581         15           51.196304                 2    Infubinol Female          24          25\n",
      "    c819         15           48.370999                 1     Ketapril   Male          21          25\n",
      "    r850         15           50.218605                 1      Placebo   Male           5          30\n",
      "    b559         15           51.378862                 0     Naftisol   Male          20          26\n",
      "    c264         15           53.664942                 1    Zoniferol Female          11          27\n",
      "    o302         15           51.381489                 0      Placebo Female           2          29\n",
      "    g288         15           42.172301                 1    Capomulin   Male           3          19\n",
      "    h246         15           56.184327                 1     Ketapril   Male          13          30\n",
      "    a251         15           50.534456                 1    Infubinol Female          21          25\n",
      "    c757         15           51.532603                 0      Placebo   Male           9          27\n",
      "    j989         15           41.128354                 1     Ramicane   Male           8          19\n",
      "    i334         15           39.158001                 0     Ramicane Female           8          20\n",
      "    f993         15           49.106975                 1     Naftisol   Male          21          28\n",
      "    y449         15           44.183451                 0     Ramicane   Male          19          24\n",
      "    i738         15           37.978778                 0    Capomulin Female          23          20\n",
      "    i386         15           51.736561                 2    Infubinol Female          23          29\n",
      "    u327         15           50.659964                 0     Ketapril   Male          17          25\n",
      "    q787         15           49.217732                 2      Placebo   Male          17          27\n",
      "    n923         15           51.738706                 1     Ketapril   Male          19          30\n",
      "    c758         15           46.940945                 1     Ramicane   Male           9          17\n",
      "    c302         15           52.716635                 2    Zoniferol Female          10          29\n",
      "    q132         15           49.159749                 3    Infubinol Female           1          30\n",
      "    n671         15           54.216064                 0    Infubinol   Male          18          25\n",
      "    a897         15           52.343085                 2      Placebo   Male           7          28\n",
      "    k403         15           34.223992                 1     Ramicane   Male          21          16\n",
      "    b313         15           49.188387                 1    Zoniferol   Male          12          27\n",
      "    p189         15           53.675542                 2     Ketapril   Male           8          28\n",
      "    m957         15           39.804453                 1    Capomulin Female           3          19\n",
      "    w151         15           47.242929                 1     Ceftamin   Male          24          25\n",
      "    v603         15           52.102947                 0     Ketapril Female          22          30\n",
      "    j296         15           50.701280                 2     Ceftamin Female          24          30\n",
      "    o331         15           54.789768                 1     Ketapril   Male          24          30\n",
      "    a644         15           46.910892                 0     Ramicane Female           7          17\n",
      "    o809         15           49.683445                 1    Infubinol   Male           3          25\n",
      "    n763         15           47.798100                 1      Placebo Female          16          25\n",
      "    w422         15           52.246310                 0     Ketapril Female          18          26\n",
      "    o795         15           55.886338                 2      Placebo Female          20          26\n",
      "    a203         15           52.777870                 1    Infubinol Female          20          23\n",
      "    a520         15           35.590254                 0     Ramicane   Male          13          21\n",
      "    y163         15           51.523068                 1    Infubinol Female          17          27\n",
      "    r944         15           47.373423                 0    Capomulin   Male          12          25\n",
      "    m550         15           51.166065                 3     Ketapril   Male          18          28\n",
      "    f345         15           48.352239                 0    Infubinol   Male          23          26\n",
      "    s152         15           57.224981                 2      Placebo Female           4          30\n",
      "    t994         15           53.458639                 1      Placebo   Male          14          30\n",
      "    c895         15           52.949465                 1    Infubinol Female           7          29\n",
      "    y793         15           42.283665                 1    Capomulin   Male          17          17\n",
      "    u196         15           47.227171                 1     Ramicane   Male          18          25\n",
      "    c832         15           52.864534                 1     Ketapril   Male          18          29\n",
      "    s508         15           35.276906                 0     Ramicane   Male           1          17\n",
      "    m546         15           39.897435                 0     Ramicane   Male          18          16\n",
      "    a577         15           50.915007                 2    Infubinol Female           6          25\n",
      "    m650         15           53.149559                 1     Ketapril   Male          15          27\n",
      "    v719         15           52.609108                 1    Infubinol Female          17          30\n",
      "    c766         15           50.596633                 2      Placebo Female          13          26\n",
      "    c282         15           49.266079                 0      Placebo   Male          12          27\n",
      "    j235         15           51.161138                 1      Placebo   Male           6          30\n",
      "    e227         15           52.833942                 1      Placebo   Male           1          30\n",
      "    c139         15           51.833225                 0    Infubinol   Male          11          28\n",
      "    n364         15           36.940274                 0     Ramicane   Male           4          17\n",
      "    v289         15           52.602166                 0     Ketapril Female           3          26\n",
      "    r921         15           43.527261                 0     Ramicane Female           5          25\n",
      "    y478         15           53.610406                 1      Placebo Female           3          25\n",
      "    c580         15           51.991708                 1     Ketapril   Male          22          25\n",
      "    t565         15           44.440949                 0    Capomulin Female          20          17\n",
      "    g497         15           53.646168                 1     Ketapril   Male          19          28\n",
      "    t718         15           48.085126                 1      Placebo Female          10          30\n",
      "    g107         15           58.135545                 0     Ketapril Female           2          29\n",
      "    s121         15           50.824560                 2    Infubinol   Male          23          26\n",
      "    z578         15           38.688516                 0     Ramicane   Male          11          16\n",
      "    j246         15           43.312654                 0    Capomulin Female          21          21\n",
      "    k804         15           50.477618                 0    Infubinol Female          23          29\n",
      "    w167         15           53.900489                 0      Placebo Female           6          28\n",
      "    d474         15           47.777936                 0     Ketapril   Male          18          27\n",
      "    y260         15           50.196152                 2     Ketapril Female           7          25\n",
      "    v766         15           51.542431                 1    Infubinol   Male          16          27\n",
      "    w584         15           51.265440                 0    Infubinol   Male           3          29\n",
      "    x773         15           47.671236                 3      Placebo Female          21          30\n",
      "    i669         15           48.857601                 1      Placebo Female          18          27\n",
      "    i177         15           40.330935                 0     Ramicane   Male          10          18\n",
      "    r157         15           46.539206                 0    Capomulin   Male          22          25\n",
      "    k382         15           54.429168                 1     Ketapril   Male          22          29\n",
      "    k483         15           53.244458                 1    Infubinol Female          20          30\n",
      "    q582         15           48.322640                 2      Placebo   Male           5          30\n",
      "    e476         15           54.046213                 0    Infubinol   Male          23          26\n",
      "    g791         15           40.678129                 0     Ramicane   Male          11          16\n",
      "    g316         15           45.216743                 0    Capomulin Female          22          22\n",
      "    r554         15           35.463758                 2    Capomulin Female           8          17\n",
      "    o973         15           49.871936                 0     Ketapril Female          11          29\n",
      "    e662         15           43.553773                 0     Ramicane   Male           8          24\n",
      "    w193         15           49.385574                 0    Infubinol   Male          22          30\n",
      "    s141         15           49.232345                 1     Propriva   Male           8          25\n",
      "    n967         15           49.825004                 1    Zoniferol   Male          11          27\n",
      "    p438         15           52.198368                 0     Ceftamin Female          11          26\n",
      "    g989         15           51.325852                 1     Propriva Female          21          26\n",
      "    b487         15           51.683256                 0     Ceftamin Female           6          28\n",
      "    g570         15           52.682695                 1     Propriva   Male          16          29\n",
      "    j119         15           47.322984                 0    Capomulin Female           7          23\n",
      "    j755         15           51.453974                 0     Naftisol   Male          23          27\n",
      "    v764         15           49.412624                 2     Stelasyn Female           5          30\n",
      "    a818         15           51.227566                 0     Naftisol Female          12          28\n",
      "    o287         15           48.679453                 1     Ceftamin   Male           2          28\n",
      "    w540         15           48.250146                 2     Stelasyn Female           8          26\n",
      "    w350         15           50.854632                 1     Propriva   Male           7          26\n",
      "    q483         15           48.468483                 1     Ceftamin   Male           6          26\n",
      "    j365         15           49.588263                 0    Zoniferol   Male          24          28\n",
      "    j984         15           51.166757                 1     Stelasyn Female           2          30\n",
      "    v295         15           50.666054                 2     Naftisol Female           2          27\n",
      "    s187         15           52.081632                 1     Propriva   Male          22          25\n",
      "    a401         15           49.934725                 1    Zoniferol Female           8          25\n",
      "    x581         15           49.746427                 2     Ceftamin Female          19          28\n",
      "    a492         15           51.985263                 0     Stelasyn   Male          20          25\n",
      "    e291         15           49.348426                 1     Naftisol Female          14          29\n",
      "    a275         15           49.734404                 0     Ceftamin Female          20          28\n",
      "    f129         15           49.988302                 1    Zoniferol Female          11          29\n",
      "    s565         15           54.328317                 1     Stelasyn Female           3          29\n",
      "    x402         15           49.119948                 1     Stelasyn   Male          21          28\n",
      "    l725         15           54.244563                 2     Naftisol Female           8          26\n",
      "    b742         15           39.524843                 0    Capomulin   Male           7          21\n",
      "    t724         15           55.584617                 0     Naftisol Female           2          25\n",
      "    k210         15           51.073558                 0     Ceftamin   Male          15          28\n",
      "    p136         15           51.991416                 1    Zoniferol Female           5          28\n",
      "    m269         15           55.905344                 0     Stelasyn Female          22          28\n",
      "    q511         15           52.133081                 0    Zoniferol Female           2          28\n",
      "    u946         15           47.673029                 1     Propriva   Male           5          30\n",
      "    x401         15           39.776250                 0    Capomulin Female          16          15\n",
      "    g558         15           51.007258                 0     Propriva   Male           8          29\n",
      "    t451         15           49.652788                 0     Stelasyn   Male           8          29\n",
      "    z795         15           49.368132                 1     Naftisol Female          13          29\n",
      "    o562         15           51.505086                 1     Propriva Female           4          25\n",
      "    s337         15           48.571516                 0    Zoniferol   Male          14          27\n",
      "    v991         15           54.588591                 1     Propriva Female          10          30\n",
      "    a788         15           52.539949                 1    Zoniferol   Male           5          30\n",
      "    a963         15           47.836852                 0     Stelasyn Female          23          27\n",
      "    x264         15           50.002314                 1     Naftisol Female          21          27\n",
      "    e584         15           48.430411                 1     Naftisol   Male           9          27\n",
      "    c927         15           53.266431                 1     Propriva Female           4          26\n",
      "    p981         15           49.657710                 0     Stelasyn   Male          20          29\n",
      "    o926         15           48.254248                 1    Zoniferol   Male          15          29\n",
      "    i557         15           43.529876                 0    Capomulin Female           1          24\n",
      "    c559         15           51.414904                 1    Zoniferol Female          19          28\n",
      "    u364         15           47.212200                 2    Capomulin   Male          18          17\n",
      "    r701         15           52.484804                 0     Naftisol   Male          21          25\n",
      "    l897         15           44.061521                 0    Capomulin   Male          17          19\n",
      "    k510         15           49.687052                 1     Stelasyn Female           8          27\n",
      "    e213         15           51.791695                 2     Naftisol   Male           8          27\n",
      "    h333         15           50.692604                 2     Stelasyn   Male          21          27\n",
      "    c402         15           52.230719                 1     Stelasyn Female           1          27\n",
      "    g989         15           53.442020                 0     Propriva Female          21          26\n",
      "    m601         15           35.464612                 1    Capomulin   Male          22          17\n",
      "    m133         15           48.665207                 1     Naftisol Female           2          26\n",
      "    m331         15           52.110088                 1    Zoniferol Female          19          26\n",
      "    w914         15           43.688449                 0    Capomulin   Male          24          21\n",
      "    s710         15           41.845235                 0    Capomulin Female           1          23\n",
      "    a699         15           49.530401                 0     Propriva Female           5          28\n",
      "    g296         15           49.653244                 1    Zoniferol Female          14          29\n",
      "    a411         15           41.484169                 1     Ramicane   Male           3          22\n",
      "    b879         15           51.618387                 1     Stelasyn Female           4          26\n",
      "    p387         15           55.251380                 0     Stelasyn   Male           3          30\n",
      "    r604         15           51.074521                 1     Naftisol   Male           7          30\n",
      "    l509         15           47.488599                 1    Capomulin   Male          17          21\n",
      "    f436         15           48.722078                 2     Ceftamin Female           3          25\n",
      "    u149         15           48.522373                 0     Ceftamin   Male          24          29\n",
      "    b759         15           51.587799                 0     Ceftamin Female          12          25\n",
      "    g867         15           51.060419                 1     Stelasyn Female           9          25\n",
      "    k603         15           48.775286                 0     Propriva   Male           2          27\n",
      "    i635         15           49.536898                 1     Propriva   Male          21          26\n",
      "    k862         15           54.474534                 1     Stelasyn Female          13          25\n",
      "    k754         15           51.323570                 0    Zoniferol Female           8          26\n",
      "    j913         15           45.252534                 0     Ramicane Female           4          17\n",
      "    v835         15           50.545206                 1     Naftisol   Male           7          29\n",
      "    l490         15           50.524813                 1     Ceftamin   Male          24          26\n",
      "    k894         15           49.987766                 1    Zoniferol Female          13          29\n",
      "    l733         15           49.285195                 0     Ceftamin Female           4          30\n",
      "    f966         15           32.623003                 0    Capomulin   Male          16          17\n",
      "    f545         15           53.945544                 1    Zoniferol Female          20          26\n",
      "    o725         15           50.015079                 1     Naftisol   Male           4          26\n",
      "    p310         15           49.770741                 1     Propriva   Male           6          26\n",
      "    r107         15           53.090335                 0     Propriva Female           2          28\n",
      "    q633         15           50.583557                 1    Zoniferol   Male          12          25\n",
      "    x930         15           51.973769                 0     Naftisol   Male          13          26\n",
      "    f234         15           48.735197                 1     Stelasyn   Male          14          28\n",
      "    l700         15           49.040225                 1     Naftisol Female          18          27\n",
      "    a444         15           43.001280                 0     Ramicane Female          10          25\n",
      "    a366         15           55.265582                 0     Stelasyn Female          16          29\n",
      "    x822         15           49.694665                 1     Ceftamin   Male           3          29\n",
      "    x613         15           48.077646                 0    Zoniferol Female           2          29\n",
      "    l471         15           49.406879                 0     Ceftamin Female           7          28\n",
      "    z969         15           54.713005                 2     Naftisol   Male           9          30\n",
      "    c458         15           45.107423                 2     Ramicane Female          23          20\n",
      "    q610         15           45.889028                 0     Ramicane Female          18          21\n",
      "    w697         15           52.657265                 2     Stelasyn Female          14          30\n",
      "    v923         15           40.457989                 0    Capomulin Female          19          21\n",
      "    w575         15           50.867452                 1    Zoniferol Female          16          28\n",
      "    t198         15           49.781181                 2     Propriva   Male          22          26\n",
      "    n304         15           48.477979                 0     Naftisol   Male           9          26\n",
      "    i901         15           51.419642                 0     Stelasyn   Male          23          29\n",
      "    u364         20           40.343948                 2    Capomulin   Male          18          17\n",
      "    o926         20           51.826638                 2    Zoniferol   Male          15          29\n",
      "    q132         20           51.909025                 4    Infubinol Female           1          30\n",
      "    a577         20           52.365185                 2    Infubinol Female           6          25\n",
      "    i386         20           55.087724                 2    Infubinol Female          23          29\n",
      "    t198         20           51.490740                 3     Propriva   Male          22          26\n",
      "    g558         20           55.090097                 1     Propriva   Male           8          29\n",
      "    c766         20           53.006865                 3      Placebo Female          13          26\n",
      "    u946         20           49.110050                 1     Propriva   Male           5          30\n",
      "    p310         20           54.205181                 1     Propriva   Male           6          26\n",
      "    s152         20           62.351609                 2      Placebo Female           4          30\n",
      "    z581         20           51.807944                 2    Infubinol Female          24          25\n",
      "    f966         20           30.485985                 0    Capomulin   Male          16          17\n",
      "    o809         20           50.336553                 1    Infubinol   Male           3          25\n",
      "    s187         20           53.744734                 1     Propriva   Male          22          25\n",
      "    b128         20           42.731552                 0    Capomulin Female           9          22\n",
      "    i669         20           50.873690                 1      Placebo Female          18          27\n",
      "    b742         20           37.950355                 0    Capomulin   Male           7          21\n",
      "    k804         20           54.484519                 0    Infubinol Female          23          29\n",
      "    a699         20           50.712423                 0     Propriva Female           5          28\n",
      "    i635         20           51.877062                 1     Propriva   Male          21          26\n",
      "    r107         20           55.263858                 0     Propriva Female           2          28\n",
      "    r554         20           36.015589                 2    Capomulin Female           8          17\n",
      "    w350         20           52.132321                 1     Propriva   Male           7          26\n",
      "    k603         20           50.180109                 0     Propriva   Male           2          27\n",
      "    a251         20           54.462594                 1    Infubinol Female          21          25\n",
      "    k483         20           54.778961                 1    Infubinol Female          20          30\n",
      "    a262         20           57.013313                 2      Placebo Female          17          29\n",
      "    n763         20           49.258126                 1      Placebo Female          16          25\n",
      "    q787         20           50.229934                 2      Placebo   Male          17          27\n",
      "    y163         20           54.571076                 1    Infubinol Female          17          27\n",
      "    g570         20           54.643295                 1     Propriva   Male          16          29\n",
      "    g989         20           55.326122                 1     Propriva Female          21          26\n",
      "    s141         20           51.621646                 1     Propriva   Male           8          25\n",
      "    q511         20           52.672712                 0    Zoniferol Female           2          28\n",
      "    s121         20           52.005066                 2    Infubinol   Male          23          26\n",
      "    t718         20           52.636700                 2      Placebo Female          10          30\n",
      "    k210         20           51.997619                 0     Ceftamin   Male          15          28\n",
      "    u149         20           50.378058                 0     Ceftamin   Male          24          29\n",
      "    n671         20           54.822521                 0    Infubinol   Male          18          25\n",
      "    o302         20           56.177611                 0      Placebo Female           2          29\n",
      "    q633         20           53.287287                 1    Zoniferol   Male          12          25\n",
      "    x822         20           51.914910                 2     Ceftamin   Male           3          29\n",
      "    a685         20           49.490559                 0    Infubinol   Male           8          30\n",
      "    m957         20           38.909349                 1    Capomulin Female           3          19\n",
      "    w575         20           55.591816                 1    Zoniferol Female          16          28\n",
      "    l733         20           53.244312                 1     Ceftamin Female           4          30\n",
      "    c757         20           52.818634                 1      Placebo   Male           9          27\n",
      "    w151         20           49.554263                 2     Ceftamin   Male          24          25\n",
      "    g296         20           51.447118                 2    Zoniferol Female          14          29\n",
      "    s185         20           36.866876                 0    Capomulin Female           3          17\n",
      "    a897         20           54.595705                 3      Placebo   Male           7          28\n",
      "    c264         20           54.568196                 1    Zoniferol Female          11          27\n",
      "    f545         20           58.841189                 1    Zoniferol Female          20          26\n",
      "    y769         20           55.025724                 2     Ceftamin Female           6          27\n",
      "    l471         20           52.228327                 0     Ceftamin Female           7          28\n",
      "    l661         20           52.617490                 1     Ceftamin   Male          18          26\n",
      "    b313         20           53.979680                 1    Zoniferol   Male          12          27\n",
      "    a401         20           52.204511                 2    Zoniferol Female           8          25\n",
      "    b759         20           54.443035                 0     Ceftamin Female          12          25\n",
      "    k754         20           52.693423                 1    Zoniferol Female           8          26\n",
      "    c302         20           54.080908                 3    Zoniferol Female          10          29\n",
      "    j296         20           54.005342                 3     Ceftamin Female          24          30\n",
      "    l490         20           51.905447                 1     Ceftamin   Male          24          26\n",
      "    l509         20           48.070452                 2    Capomulin   Male          17          21\n",
      "    w914         20           41.108092                 0    Capomulin   Male          24          21\n",
      "    k894         20           50.981639                 1    Zoniferol Female          13          29\n",
      "    e227         20           56.607552                 1      Placebo   Male           1          30\n",
      "    a275         20           50.513437                 1     Ceftamin Female          20          28\n",
      "    x581         20           51.207969                 3     Ceftamin Female          19          28\n",
      "    o562         20           53.616863                 1     Propriva Female           4          25\n",
      "    c139         20           56.742007                 0    Infubinol   Male          11          28\n",
      "    c282         20           51.950574                 0      Placebo   Male          12          27\n",
      "    v719         20           54.048608                 1    Infubinol Female          17          30\n",
      "    v991         20           57.740695                 2     Propriva Female          10          30\n",
      "    s337         20           49.202054                 1    Zoniferol   Male          14          27\n",
      "    c927         20           55.481689                 1     Propriva Female           4          26\n",
      "    t994         20           56.527952                 1      Placebo   Male          14          30\n",
      "    a788         20           54.060983                 1    Zoniferol   Male           5          30\n",
      "    c895         20           53.676840                 2    Infubinol Female           7          29\n",
      "    l897         20           44.813093                 0    Capomulin   Male          17          19\n",
      "    f345         20           49.613383                 0    Infubinol   Male          23          26\n",
      "    c559         20           52.604367                 2    Zoniferol Female          19          28\n",
      "    r944         20           43.225671                 1    Capomulin   Male          12          25\n",
      "    p438         20           52.905299                 0     Ceftamin Female          11          26\n",
      "    o795         20           60.610059                 3      Placebo Female          20          26\n",
      "    y865         20           52.361982                 1     Ceftamin   Male          23          26\n",
      "    x773         20           49.739713                 3      Placebo Female          21          30\n",
      "    w193         20           50.005138                 0    Infubinol   Male          22          30\n",
      "    j365         20           50.939353                 1    Zoniferol   Male          24          28\n",
      "    q483         20           50.239856                 1     Ceftamin   Male           6          26\n",
      "    j119         20           48.158209                 1    Capomulin Female           7          23\n",
      "    e476         20           55.249273                 0    Infubinol   Male          23          26\n",
      "    w167         20           57.548157                 0      Placebo Female           6          28\n",
      "    q582         20           51.185976                 2      Placebo   Male           5          30\n",
      "    p136         20           54.913799                 1    Zoniferol Female           5          28\n",
      "    w584         20           53.323507                 1    Infubinol   Male           3          29\n",
      "    b487         20           53.427663                 0     Ceftamin Female           6          28\n",
      "    y478         20           56.848850                 1      Placebo Female           3          25\n",
      "    g316         20           45.933322                 1    Capomulin Female          22          22\n",
      "    a203         20           55.173336                 1    Infubinol Female          20          23\n",
      "    o287         20           50.856141                 2     Ceftamin   Male           2          28\n",
      "    j246         20           44.020370                 0    Capomulin Female          21          21\n",
      "    j235         20           52.942902                 1      Placebo   Male           6          30\n",
      "    m550         20           53.757945                 3     Ketapril   Male          18          28\n",
      "    a818         20           54.834624                 0     Naftisol Female          12          28\n",
      "    i901         20           55.974405                 0     Stelasyn   Male          23          29\n",
      "    v923         20           39.648296                 0    Capomulin Female          19          21\n",
      "    c758         20           43.126311                 1     Ramicane   Male           9          17\n",
      "    v295         20           55.731375                 3     Naftisol Female           2          27\n",
      "    k862         20           57.057848                 1     Stelasyn Female          13          25\n",
      "    z578         20           36.890016                 0     Ramicane   Male          11          16\n",
      "    o331         20           58.965720                 1     Ketapril   Male          24          30\n",
      "    g791         20           41.211897                 0     Ramicane   Male          11          16\n",
      "    w697         20           54.228091                 3     Stelasyn Female          14          30\n",
      "    c819         20           49.762415                 1     Ketapril   Male          21          25\n",
      "    k403         20           32.997729                 1     Ramicane   Male          21          16\n",
      "    m133         20           52.636882                 1     Naftisol Female           2          26\n",
      "    j984         20           54.372516                 1     Stelasyn Female           2          30\n",
      "    c832         20           56.710234                 1     Ketapril   Male          18          29\n",
      "    q597         20           41.925587                 0     Ramicane   Male          20          25\n",
      "    t565         20           39.070214                 0    Capomulin Female          20          17\n",
      "    c402         20           54.883320                 2     Stelasyn Female           1          27\n",
      "    h333         20           51.997806                 2     Stelasyn   Male          21          27\n",
      "    k510         20           52.105574                 1     Stelasyn Female           8          27\n",
      "    o973         20           51.956993                 1     Ketapril Female          11          29\n",
      "    l700         20           50.734768                 1     Naftisol Female          18          27\n",
      "    p981         20           50.358069                 0     Stelasyn   Male          20          29\n",
      "    m650         20           56.777939                 2     Ketapril   Male          15          27\n",
      "    j989         20           41.635344                 1     Ramicane   Male           8          19\n",
      "    b879         20           53.983436                 1     Stelasyn Female           4          26\n",
      "    g107         20           62.706031                 0     Ketapril Female           2          29\n",
      "    a644         20           45.865065                 0     Ramicane Female           7          17\n",
      "    y793         20           40.716428                 2    Capomulin   Male          17          17\n",
      "    i557         20           43.967895                 0    Capomulin Female           1          24\n",
      "    e291         20           52.533765                 1     Naftisol Female          14          29\n",
      "    c580         20           55.575322                 2     Ketapril   Male          22          25\n",
      "    k382         20           57.824351                 2     Ketapril   Male          22          29\n",
      "    w422         20           53.676243                 1     Ketapril Female          18          26\n",
      "    s508         20           35.928651                 0     Ramicane   Male           1          17\n",
      "    e584         20           50.344921                 2     Naftisol   Male           9          27\n",
      "    x264         20           53.074270                 1     Naftisol Female          21          27\n",
      "    e213         20           52.613763                 2     Naftisol   Male           8          27\n",
      "    r921         20           44.136316                 0     Ramicane Female           5          25\n",
      "    j755         20           55.496608                 1     Naftisol   Male          23          27\n",
      "    e662         20           44.001296                 0     Ramicane   Male           8          24\n",
      "    r701         20           54.114137                 0     Naftisol   Male          21          25\n",
      "    y260         20           50.729582                 3     Ketapril Female           7          25\n",
      "    i177         20           35.345361                 0     Ramicane   Male          10          18\n",
      "    r811         20           40.772803                 0     Ramicane   Male           9          19\n",
      "    s565         20           57.046189                 1     Stelasyn Female           3          29\n",
      "    m546         20           36.712295                 0     Ramicane   Male          18          16\n",
      "    a366         20           57.285987                 0     Stelasyn Female          16          29\n",
      "    t724         20           57.229409                 0     Naftisol Female           2          25\n",
      "    p387         20           56.587617                 0     Stelasyn   Male           3          30\n",
      "    v289         20           54.250054                 0     Ketapril Female           3          26\n",
      "    h246         20           57.935912                 1     Ketapril   Male          13          30\n",
      "    l725         20           59.615155                 2     Naftisol Female           8          26\n",
      "    z969         20           57.898778                 2     Naftisol   Male           9          30\n",
      "    w540         20           50.672727                 2     Stelasyn Female           8          26\n",
      "    i334         20           39.687832                 0     Ramicane Female           8          20\n",
      "    v835         20           51.296543                 2     Naftisol   Male           7          29\n",
      "    a444         20           41.714619                 0     Ramicane Female          10          25\n",
      "    t451         20           51.063678                 0     Stelasyn   Male           8          29\n",
      "    a492         20           53.677193                 0     Stelasyn   Male          20          25\n",
      "    g288         20           42.957120                 1    Capomulin   Male           3          19\n",
      "    x402         20           50.414750                 2     Stelasyn   Male          21          28\n",
      "    n923         20           52.599206                 1     Ketapril   Male          19          30\n",
      "    i738         20           38.531136                 0    Capomulin Female          23          20\n",
      "    n364         20           37.478868                 0     Ramicane   Male           4          17\n",
      "    f234         20           51.112713                 2     Stelasyn   Male          14          28\n",
      "    m601         20           34.255732                 1    Capomulin   Male          22          17\n",
      "    f993         20           52.079510                 1     Naftisol   Male          21          28\n",
      "    c458         20           39.505135                 2     Ramicane Female          23          20\n",
      "    u196         20           46.105363                 1     Ramicane   Male          18          25\n",
      "    a411         20           38.087373                 1     Ramicane   Male           3          22\n",
      "    x930         20           52.556066                 0     Naftisol   Male          13          26\n",
      "    u327         20           53.189879                 0     Ketapril   Male          17          25\n",
      "    q610         20           46.585433                 0     Ramicane Female          18          21\n",
      "    b559         20           55.654456                 1     Naftisol   Male          20          26\n",
      "    j913         20           42.168341                 0     Ramicane Female           4          17\n",
      "    v603         20           53.721242                 0     Ketapril Female          22          30\n",
      "    g497         20           55.096994                 1     Ketapril   Male          19          28\n",
      "    z795         20           53.280657                 1     Naftisol Female          13          29\n",
      "    a520         20           35.947745                 0     Ramicane   Male          13          21\n",
      "    d474         20           51.731494                 0     Ketapril   Male          18          27\n",
      "    d251         20           37.652091                 1     Ramicane Female           8          19\n",
      "    s710         20           42.629963                 1    Capomulin Female           1          23\n",
      "    r604         20           51.902753                 1     Naftisol   Male           7          30\n",
      "    x401         20           36.065835                 0    Capomulin Female          16          15\n",
      "    m269         20           61.145866                 0     Stelasyn Female          22          28\n",
      "    a963         20           51.463734                 0     Stelasyn Female          23          27\n",
      "    p189         20           56.530204                 3     Ketapril   Male           8          28\n",
      "    g989         20           54.657650                 1     Propriva Female          21          26\n",
      "    n304         20           49.253309                 1     Naftisol   Male           9          26\n",
      "    u149         25           52.925348                 0     Ceftamin   Male          24          29\n",
      "    x264         25           56.891053                 2     Naftisol Female          21          27\n",
      "    l725         25           65.008829                 2     Naftisol Female           8          26\n",
      "    i177         25           34.082180                 1     Ramicane   Male          10          18\n",
      "    l471         25           52.847559                 1     Ceftamin Female           7          28\n",
      "    r944         25           41.086991                 1    Capomulin   Male          12          25\n",
      "    v295         25           57.691859                 3     Naftisol Female           2          27\n",
      "    x930         25           53.726101                 0     Naftisol   Male          13          26\n",
      "    c927         25           56.545519                 2     Propriva Female           4          26\n",
      "    a520         25           36.558581                 1     Ramicane   Male          13          21\n",
      "    y865         25           57.173538                 2     Ceftamin   Male          23          26\n",
      "    b559         25           57.043669                 1     Naftisol   Male          20          26\n",
      "    m546         25           37.444445                 0     Ramicane   Male          18          16\n",
      "    v991         25           60.016747                 2     Propriva Female          10          30\n",
      "    l700         25           54.234502                 1     Naftisol Female          18          27\n",
      "    w167         25           61.868577                 0      Placebo Female           6          28\n",
      "    s710         25           43.060409                 1    Capomulin Female           1          23\n",
      "    n304         25           53.970859                 2     Naftisol   Male           9          26\n",
      "    k210         25           54.613973                 0     Ceftamin   Male          15          28\n",
      "    p438         25           54.510575                 0     Ceftamin Female          11          26\n",
      "    x581         25           51.935283                 3     Ceftamin Female          19          28\n",
      "    q582         25           51.968211                 2      Placebo   Male           5          30\n",
      "    r604         25           52.936858                 1     Naftisol   Male           7          30\n",
      "    j119         25           42.417166                 1    Capomulin Female           7          23\n",
      "    l490         25           55.810034                 2     Ceftamin   Male          24          26\n",
      "    q483         25           52.430066                 1     Ceftamin   Male           6          26\n",
      "    a275         25           53.576064                 1     Ceftamin Female          20          28\n",
      "    a818         25           56.966273                 0     Naftisol Female          12          28\n",
      "    l733         25           54.951668                 1     Ceftamin Female           4          30\n",
      "    o287         25           52.068486                 3     Ceftamin   Male           2          28\n",
      "    z969         25           63.145652                 2     Naftisol   Male           9          30\n",
      "    m133         25           54.082437                 2     Naftisol Female           2          26\n",
      "    t565         25           37.342210                 0    Capomulin Female          20          17\n",
      "    l509         25           44.006257                 2    Capomulin   Male          17          21\n",
      "    o795         25           65.741777                 4      Placebo Female          20          26\n",
      "    t724         25           59.826068                 1     Naftisol Female           2          25\n",
      "    b759         25           55.083632                 0     Ceftamin Female          12          25\n",
      "    b487         25           56.057749                 1     Ceftamin Female           6          28\n",
      "    u196         25           46.705325                 1     Ramicane   Male          18          25\n",
      "    r701         25           57.898490                 1     Naftisol   Male          21          25\n",
      "    y478         25           57.826976                 1      Placebo Female           3          25\n",
      "    x773         25           51.104421                 3      Placebo Female          21          30\n",
      "    x822         25           54.041333                 2     Ceftamin   Male           3          29\n",
      "    o809         25           52.318174                 1    Infubinol   Male           3          25\n",
      "    i557         25           44.596219                 0    Capomulin Female           1          24\n",
      "    p136         25           56.281477                 1    Zoniferol Female           5          28\n",
      "    c559         25           54.555442                 2    Zoniferol Female          19          28\n",
      "    m269         25           64.893020                 0     Stelasyn Female          22          28\n",
      "    a788         25           56.770280                 1    Zoniferol   Male           5          30\n",
      "    x401         25           36.617120                 0    Capomulin Female          16          15\n",
      "    a963         25           52.129804                 0     Stelasyn Female          23          27\n",
      "    l897         25           45.354679                 0    Capomulin   Male          17          19\n",
      "    s337         25           50.970689                 2    Zoniferol   Male          14          27\n",
      "    b313         25           55.745146                 1    Zoniferol   Male          12          27\n",
      "    j989         25           39.934112                 1     Ramicane   Male           8          19\n",
      "    q511         25           57.257583                 0    Zoniferol Female           2          28\n",
      "    t451         25           55.527553                 0     Stelasyn   Male           8          29\n",
      "    c302         25           55.076229                 3    Zoniferol Female          10          29\n",
      "    o926         25           54.763339                 3    Zoniferol   Male          15          29\n",
      "    p981         25           52.544705                 1     Stelasyn   Male          20          29\n",
      "    c264         25           56.966769                 2    Zoniferol Female          11          27\n",
      "    d251         25           38.097513                 1     Ramicane Female           8          19\n",
      "    w540         25           52.600270                 2     Stelasyn Female           8          26\n",
      "    j365         25           51.810320                 1    Zoniferol   Male          24          28\n",
      "    j913         25           37.860669                 0     Ramicane Female           4          17\n",
      "    a411         25           38.701438                 1     Ramicane   Male           3          22\n",
      "    k894         25           52.325838                 2    Zoniferol Female          13          29\n",
      "    g296         25           55.670107                 3    Zoniferol Female          14          29\n",
      "    w914         25           40.291917                 0    Capomulin   Male          24          21\n",
      "    q610         25           40.146450                 0     Ramicane Female          18          21\n",
      "    w575         25           58.587322                 1    Zoniferol Female          16          28\n",
      "    h333         25           53.730914                 2     Stelasyn   Male          21          27\n",
      "    m601         25           33.118756                 1    Capomulin   Male          22          17\n",
      "    q633         25           55.683102                 1    Zoniferol   Male          12          25\n",
      "    f234         25           52.178602                 2     Stelasyn   Male          14          28\n",
      "    f545         25           60.253481                 1    Zoniferol Female          20          26\n",
      "    x402         25           52.431737                 2     Stelasyn   Male          21          28\n",
      "    a401         25           54.209836                 3    Zoniferol Female           8          25\n",
      "    a492         25           54.701229                 1     Stelasyn   Male          20          25\n",
      "    a444         25           42.291394                 0     Ramicane Female          10          25\n",
      "    c458         25           37.753150                 2     Ramicane Female          23          20\n",
      "    z795         25           57.947100                 2     Naftisol Female          13          29\n",
      "    g989         25           56.045564                 1     Propriva Female          21          26\n",
      "    s185         25           33.949940                 0    Capomulin Female           3          17\n",
      "    a366         25           59.011728                 0     Stelasyn Female          16          29\n",
      "    s187         25           56.485220                 1     Propriva   Male          22          25\n",
      "    s565         25           58.553611                 1     Stelasyn Female           3          29\n",
      "    r921         25           42.655341                 1     Ramicane Female           5          25\n",
      "    o302         25           60.517103                 0      Placebo Female           2          29\n",
      "    g570         25           56.849406                 1     Propriva   Male          16          29\n",
      "    j755         25           58.055818                 1     Naftisol   Male          23          27\n",
      "    e213         25           55.224476                 2     Naftisol   Male           8          27\n",
      "    t718         25           55.876588                 3      Placebo Female          10          30\n",
      "    u364         25           35.503616                 2    Capomulin   Male          18          17\n",
      "    g558         25           55.754083                 2     Propriva   Male           8          29\n",
      "    e584         25           51.386419                 2     Naftisol   Male           9          27\n",
      "    e291         25           55.138953                 2     Naftisol Female          14          29\n",
      "    a644         25           41.481224                 0     Ramicane Female           7          17\n",
      "    o562         25           54.742733                 1     Propriva Female           4          25\n",
      "    r811         25           37.614011                 0     Ramicane   Male           9          19\n",
      "    r107         25           57.706667                 1     Propriva Female           2          28\n",
      "    p387         25           58.098489                 0     Stelasyn   Male           3          30\n",
      "    i635         25           52.928823                 1     Propriva   Male          21          26\n",
      "    w350         25           52.805915                 1     Propriva   Male           7          26\n",
      "    k403         25           33.464577                 1     Ramicane   Male          21          16\n",
      "    j984         25           57.064355                 1     Stelasyn Female           2          30\n",
      "    p310         25           55.341834                 2     Propriva   Male           6          26\n",
      "    a897         25           56.413320                 3      Placebo   Male           7          28\n",
      "    a699         25           51.846381                 0     Propriva Female           5          28\n",
      "    w697         25           57.610394                 3     Stelasyn Female          14          30\n",
      "    c402         25           58.269889                 2     Stelasyn Female           1          27\n",
      "    b742         25           38.617684                 0    Capomulin   Male           7          21\n",
      "    k862         25           58.719297                 2     Stelasyn Female          13          25\n",
      "    t198         25           56.184664                 3     Propriva   Male          22          26\n",
      "    c758         25           43.602267                 1     Ramicane   Male           9          17\n",
      "    c757         25           57.106418                 2      Placebo   Male           9          27\n",
      "    s141         25           53.804370                 1     Propriva   Male           8          25\n",
      "    i901         25           56.575195                 0     Stelasyn   Male          23          29\n",
      "    b879         25           56.469987                 2     Stelasyn Female           4          26\n",
      "    v923         25           40.156413                 1    Capomulin Female          19          21\n",
      "    y769         25           58.335959                 3     Ceftamin Female           6          27\n",
      "    g791         25           35.569399                 1     Ramicane   Male          11          16\n",
      "    c282         25           56.292200                 1      Placebo   Male          12          27\n",
      "    s121         25           55.650681                 2    Infubinol   Male          23          26\n",
      "    g107         25           64.663626                 0     Ketapril Female           2          29\n",
      "    k804         25           55.674808                 1    Infubinol Female          23          29\n",
      "    w151         25           51.869059                 2     Ceftamin   Male          24          25\n",
      "    d474         25           54.279325                 0     Ketapril   Male          18          27\n",
      "    e227         25           60.600292                 1      Placebo   Male           1          30\n",
      "    m550         25           57.620682                 4     Ketapril   Male          18          28\n",
      "    r554         25           33.893345                 3    Capomulin Female           8          17\n",
      "    f345         25           53.078894                 0    Infubinol   Male          23          26\n",
      "    c139         25           61.461970                 0    Infubinol   Male          11          28\n",
      "    g288         25           42.368692                 1    Capomulin   Male           3          19\n",
      "    p189         25           62.108960                 3     Ketapril   Male           8          28\n",
      "    g497         25           57.524446                 2     Ketapril   Male          19          28\n",
      "    g316         25           46.809225                 1    Capomulin Female          22          22\n",
      "    y260         25           54.437562                 4     Ketapril Female           7          25\n",
      "    c895         25           57.534193                 2    Infubinol Female           7          29\n",
      "    i334         25           38.248817                 1     Ramicane Female           8          20\n",
      "    h246         25           59.548854                 1     Ketapril   Male          13          30\n",
      "    k483         25           57.432007                 2    Infubinol Female          20          30\n",
      "    z578         25           37.414114                 0     Ramicane   Male          11          16\n",
      "    c766         25           58.214624                 3      Placebo Female          13          26\n",
      "    a577         25           54.380932                 2    Infubinol Female           6          25\n",
      "    c819         25           51.828357                 1     Ketapril   Male          21          25\n",
      "    q597         25           42.575707                 1     Ramicane   Male          20          25\n",
      "    c832         25           58.891816                 2     Ketapril   Male          18          29\n",
      "    i669         25           53.303185                 2      Placebo Female          18          27\n",
      "    a685         25           51.939951                 0    Infubinol   Male           8          30\n",
      "    a262         25           60.131862                 2      Placebo Female          17          29\n",
      "    m650         25           62.253597                 2     Ketapril   Male          15          27\n",
      "    y163         25           56.176385                 1    Infubinol Female          17          27\n",
      "    n671         25           56.174458                 0    Infubinol   Male          18          25\n",
      "    v289         25           56.720095                 0     Ketapril Female           3          26\n",
      "    b128         25           43.262145                 1    Capomulin Female           9          22\n",
      "    m957         25           37.695432                 1    Capomulin Female           3          19\n",
      "    o973         25           53.179815                 1     Ketapril Female          11          29\n",
      "    n763         25           53.405871                 2      Placebo Female          16          25\n",
      "    o331         25           61.102306                 1     Ketapril   Male          24          30\n",
      "    j296         25           55.767148                 3     Ceftamin Female          24          30\n",
      "    q132         25           52.780489                 4    Infubinol Female           1          30\n",
      "    w584         25           55.650838                 1    Infubinol   Male           3          29\n",
      "    j246         25           44.555226                 0    Capomulin Female          21          21\n",
      "    e476         25           57.408638                 0    Infubinol   Male          23          26\n",
      "    c580         25           56.289062                 2     Ketapril   Male          22          25\n",
      "    u327         25           56.059634                 0     Ketapril   Male          17          25\n",
      "    i386         25           56.687864                 3    Infubinol Female          23          29\n",
      "    s152         25           64.119142                 2      Placebo Female           4          30\n",
      "    w422         25           56.957917                 2     Ketapril Female          18          26\n",
      "    v603         25           56.075230                 1     Ketapril Female          22          30\n",
      "    a251         25           57.414646                 1    Infubinol Female          21          25\n",
      "    l661         25           53.180657                 2     Ceftamin   Male          18          26\n",
      "    k382         25           59.503904                 3     Ketapril   Male          22          29\n",
      "    i738         25           34.973438                 0    Capomulin Female          23          20\n",
      "    n923         25           56.855465                 2     Ketapril   Male          19          30\n",
      "    e662         25           44.664594                 1     Ramicane   Male           8          24\n",
      "    n364         25           33.205008                 0     Ramicane   Male           4          17\n",
      "    q787         25           52.713188                 2      Placebo   Male          17          27\n",
      "    y793         25           38.992734                 2    Capomulin   Male          17          17\n",
      "    z581         25           54.316407                 2    Infubinol Female          24          25\n",
      "    s508         25           36.338569                 0     Ramicane   Male           1          17\n",
      "    a203         25           56.793208                 1    Infubinol Female          20          23\n",
      "    m650         30           64.901888                 3     Ketapril   Male          15          27\n",
      "    n763         30           55.413660                 3      Placebo Female          16          25\n",
      "    z578         30           37.815935                 0     Ramicane   Male          11          16\n",
      "    c758         30           44.118270                 1     Ramicane   Male           9          17\n",
      "    v923         30           40.752216                 2    Capomulin Female          19          21\n",
      "    k862         30           60.605440                 3     Stelasyn Female          13          25\n",
      "    g570         30           60.328717                 1     Propriva   Male          16          29\n",
      "    e584         30           54.984408                 3     Naftisol   Male           9          27\n",
      "    t198         30           56.924974                 3     Propriva   Male          22          26\n",
      "    s141         30           55.841410                 1     Propriva   Male           8          25\n",
      "    c139         30           64.149871                 1    Infubinol   Male          11          28\n",
      "    w422         30           60.096635                 3     Ketapril Female          18          26\n",
      "    b742         30           39.167949                 0    Capomulin   Male           7          21\n",
      "    i557         30           45.261384                 0    Capomulin Female           1          24\n",
      "    u364         30           35.978334                 2    Capomulin   Male          18          17\n",
      "    g316         30           44.221480                 2    Capomulin Female          22          22\n",
      "    r921         30           43.419381                 1     Ramicane Female           5          25\n",
      "    m550         30           60.856543                 4     Ketapril   Male          18          28\n",
      "    e213         30           56.458729                 3     Naftisol   Male           8          27\n",
      "    a203         30           59.523197                 1    Infubinol Female          20          23\n",
      "    a644         30           37.211121                 0     Ramicane Female           7          17\n",
      "    j755         30           60.007210                 1     Naftisol   Male          23          27\n",
      "    r107         30           58.406473                 1     Propriva Female           2          28\n",
      "    p387         30           63.269246                 0     Stelasyn   Male           3          30\n",
      "    c895         30           60.969711                 2    Infubinol Female           7          29\n",
      "    r811         30           38.242066                 0     Ramicane   Male           9          19\n",
      "    c580         30           58.046569                 3     Ketapril   Male          22          25\n",
      "    f345         30           54.363797                 1    Infubinol   Male          23          26\n",
      "    o302         30           62.030594                 1      Placebo Female           2          29\n",
      "    e662         30           45.350232                 1     Ramicane   Male           8          24\n",
      "    b879         30           60.907615                 2     Stelasyn Female           4          26\n",
      "    s565         30           63.668967                 1     Stelasyn Female           3          29\n",
      "    t718         30           57.704114                 3      Placebo Female          10          30\n",
      "    g558         30           58.952829                 3     Propriva   Male           8          29\n",
      "    c757         30           60.098572                 2      Placebo   Male           9          27\n",
      "    i901         30           60.591858                 0     Stelasyn   Male          23          29\n",
      "    i635         30           53.597038                 2     Propriva   Male          21          26\n",
      "    s187         30           60.008783                 2     Propriva   Male          22          25\n",
      "    c402         30           63.743194                 2     Stelasyn Female           1          27\n",
      "    a699         30           54.379345                 0     Propriva Female           5          28\n",
      "    c264         30           57.823916                 2    Zoniferol Female          11          27\n",
      "    p136         30           57.052805                 1    Zoniferol Female           5          28\n",
      "    g497         30           61.108186                 2     Ketapril   Male          19          28\n",
      "    d251         30           38.718256                 2     Ramicane Female           8          19\n",
      "    r554         30           32.680655                 3    Capomulin Female           8          17\n",
      "    j365         30           54.404882                 1    Zoniferol   Male          24          28\n",
      "    z581         30           56.286750                 2    Infubinol Female          24          25\n",
      "    a492         30           56.201041                 1     Stelasyn   Male          20          25\n",
      "    a444         30           42.786278                 0     Ramicane Female          10          25\n",
      "    q787         30           55.036206                 2      Placebo   Male          17          27\n",
      "    a401         30           55.910162                 3    Zoniferol Female           8          25\n",
      "    f545         30           65.893986                 1    Zoniferol Female          20          26\n",
      "    x402         30           54.351585                 3     Stelasyn   Male          21          28\n",
      "    f234         30           56.873817                 2     Stelasyn   Male          14          28\n",
      "    a251         30           59.861241                 1    Infubinol Female          21          25\n",
      "    q633         30           58.057253                 1    Zoniferol   Male          12          25\n",
      "    c458         30           38.342008                 2     Ramicane Female          23          20\n",
      "    v603         30           57.990554                 1     Ketapril Female          22          30\n",
      "    j246         30           38.044082                 1    Capomulin Female          21          21\n",
      "    w575         30           60.153065                 1    Zoniferol Female          16          28\n",
      "    w914         30           40.993110                 0    Capomulin   Male          24          21\n",
      "    q610         30           40.668343                 1     Ramicane Female          18          21\n",
      "    i386         30           59.133640                 3    Infubinol Female          23          29\n",
      "    m601         30           31.758275                 1    Capomulin   Male          22          17\n",
      "    k894         30           54.400123                 3    Zoniferol Female          13          29\n",
      "    u327         30           57.314072                 0     Ketapril   Male          17          25\n",
      "    g296         30           57.997706                 3    Zoniferol Female          14          29\n",
      "    j913         30           34.757240                 0     Ramicane Female           4          17\n",
      "    q132         30           54.656549                 4    Infubinol Female           1          30\n",
      "    i334         30           39.005554                 1     Ramicane Female           8          20\n",
      "    x401         30           32.915292                 0    Capomulin Female          16          15\n",
      "    o809         30           54.832629                 1    Infubinol   Male           3          25\n",
      "    c559         30           57.146144                 2    Zoniferol Female          19          28\n",
      "    o331         30           66.330663                 1     Ketapril   Male          24          30\n",
      "    a897         30           59.916934                 3      Placebo   Male           7          28\n",
      "    a577         30           57.031862                 2    Infubinol Female           6          25\n",
      "    j984         30           61.240506                 1     Stelasyn Female           2          30\n",
      "    q597         30           43.339161                 1     Ramicane   Male          20          25\n",
      "    k403         30           31.099498                 1     Ramicane   Male          21          16\n",
      "    w350         30           55.879909                 1     Propriva   Male           7          26\n",
      "    c832         30           60.496376                 2     Ketapril   Male          18          29\n",
      "    s185         30           32.959671                 1    Capomulin Female           3          17\n",
      "    w584         30           58.268442                 1    Infubinol   Male           3          29\n",
      "    y163         30           59.412537                 2    Infubinol Female          17          27\n",
      "    g989         30           59.082294                 1     Propriva Female          21          26\n",
      "    h333         30           55.455290                 2     Stelasyn   Male          21          27\n",
      "    a262         30           64.958092                 3      Placebo Female          17          29\n",
      "    w697         30           60.720636                 3     Stelasyn Female          14          30\n",
      "    p981         30           56.339104                 1     Stelasyn   Male          20          29\n",
      "    c302         30           57.419744                 3    Zoniferol Female          10          29\n",
      "    t451         30           59.275823                 0     Stelasyn   Male           8          29\n",
      "    k483         30           59.747077                 2    Infubinol Female          20          30\n",
      "    q511         30           59.364353                 1    Zoniferol Female           2          28\n",
      "    o973         30           57.769960                 1     Ketapril Female          11          29\n",
      "    l897         30           39.352792                 1    Capomulin   Male          17          19\n",
      "    j989         30           34.671781                 1     Ramicane   Male           8          19\n",
      "    g288         30           42.874461                 1    Capomulin   Male           3          19\n",
      "    s337         30           52.747718                 3    Zoniferol   Male          14          27\n",
      "    a963         30           53.401667                 1     Stelasyn Female          23          27\n",
      "    k804         30           59.240615                 2    Infubinol Female          23          29\n",
      "    d474         30           55.341342                 0     Ketapril   Male          18          27\n",
      "    a788         30           60.413709                 1    Zoniferol   Male           5          30\n",
      "    m269         30           67.712510                 1     Stelasyn Female          22          28\n",
      "    o926         30           56.917398                 3    Zoniferol   Male          15          29\n",
      "    b128         30           40.605335                 1    Capomulin Female           9          22\n",
      "    a366         30           63.440686                 1     Stelasyn Female          16          29\n",
      "    r701         30           60.341819                 1     Naftisol   Male          21          25\n",
      "    m957         30           38.212479                 1    Capomulin Female           3          19\n",
      "    v295         30           59.333772                 3     Naftisol Female           2          27\n",
      "    b759         30           55.742829                 1     Ceftamin Female          12          25\n",
      "    n364         30           33.817758                 0     Ramicane   Male           4          17\n",
      "    z969         30           65.841013                 3     Naftisol   Male           9          30\n",
      "    w151         30           56.767158                 2     Ceftamin   Male          24          25\n",
      "    l700         30           56.653215                 1     Naftisol Female          18          27\n",
      "    o287         30           54.503001                 3     Ceftamin   Male           2          28\n",
      "    t724         30           64.234595                 2     Naftisol Female           2          25\n",
      "    r944         30           41.680791                 1    Capomulin   Male          12          25\n",
      "    x773         30           52.813115                 4      Placebo Female          21          30\n",
      "    l509         30           44.708055                 2    Capomulin   Male          17          21\n",
      "    a275         30           54.444713                 2     Ceftamin Female          20          28\n",
      "    g107         30           69.160520                 0     Ketapril Female           2          29\n",
      "    s508         30           35.474022                 0     Ramicane   Male           1          17\n",
      "    l471         30           58.093604                 1     Ceftamin Female           7          28\n",
      "    u196         30           47.622816                 2     Ramicane   Male          18          25\n",
      "    p438         30           56.406422                 0     Ceftamin Female          11          26\n",
      "    j296         30           56.803061                 3     Ceftamin Female          24          30\n",
      "    n923         30           59.632561                 3     Ketapril   Male          19          30\n",
      "    a411         30           39.130737                 1     Ramicane   Male           3          22\n",
      "    l733         30           56.319065                 1     Ceftamin Female           4          30\n",
      "    p189         30           67.104537                 4     Ketapril   Male           8          28\n",
      "    n304         30           55.039020                 3     Naftisol   Male           9          26\n",
      "    q582         30           52.648893                 2      Placebo   Male           5          30\n",
      "    g791         30           34.952583                 1     Ramicane   Male          11          16\n",
      "    n671         30           60.165180                 0    Infubinol   Male          18          25\n",
      "    e227         30           62.464385                 2      Placebo   Male           1          30\n",
      "    o795         30           68.217070                 4      Placebo Female          20          26\n",
      "    r604         30           54.688215                 2     Naftisol   Male           7          30\n",
      "    x581         30           55.492826                 3     Ceftamin Female          19          28\n",
      "    c819         30           56.098998                 1     Ketapril   Male          21          25\n",
      "    l490         30           57.918381                 3     Ceftamin   Male          24          26\n",
      "    a818         30           60.072372                 0     Naftisol Female          12          28\n",
      "    c766         30           60.255924                 3      Placebo Female          13          26\n",
      "    l725         30           66.599545                 3     Naftisol Female           8          26\n",
      "    q483         30           54.952226                 1     Ceftamin   Male           6          26\n",
      "    t565         30           32.868916                 0    Capomulin Female          20          17\n",
      "    j119         30           43.013681                 1    Capomulin Female           7          23\n",
      "    l661         30           55.329099                 2     Ceftamin   Male          18          26\n",
      "    m546         30           37.969934                 0     Ramicane   Male          18          16\n",
      "    x822         30           55.445155                 2     Ceftamin   Male           3          29\n",
      "    k210         30           59.989510                 1     Ceftamin   Male          15          28\n",
      "    w167         30           67.197872                 0      Placebo Female           6          28\n",
      "    h246         30           63.599610                 1     Ketapril   Male          13          30\n",
      "    s710         30           43.571703                 1    Capomulin Female           1          23\n",
      "    v991         30           62.743643                 3     Propriva Female          10          30\n",
      "    b559         30           61.190387                 1     Naftisol   Male          20          26\n",
      "    i738         30           35.578780                 1    Capomulin Female          23          20\n",
      "    z795         30           59.789636                 2     Naftisol Female          13          29\n",
      "    c282         30           59.005902                 1      Placebo   Male          12          27\n",
      "    e476         30           57.992797                 1    Infubinol   Male          23          26\n",
      "    k382         30           63.469442                 4     Ketapril   Male          22          29\n",
      "    y769         30           61.071949                 3     Ceftamin Female           6          27\n",
      "    o562         30           59.653525                 1     Propriva Female           4          25\n",
      "    i177         30           34.711473                 1     Ramicane   Male          10          18\n",
      "    y478         30           59.374615                 1      Placebo Female           3          25\n",
      "    y865         30           59.033275                 3     Ceftamin   Male          23          26\n",
      "    a520         30           36.947710                 1     Ramicane   Male          13          21\n",
      "    x264         30           58.158694                 3     Naftisol Female          21          27\n",
      "    a685         30           55.453855                 1    Infubinol   Male           8          30\n",
      "    y793         30           35.726023                 2    Capomulin   Male          17          17\n",
      "    y260         30           58.582676                 4     Ketapril Female           7          25\n",
      "    c927         30           60.753925                 2     Propriva Female           4          26\n",
      "    i334         35           39.769552                 2     Ramicane Female           8          20\n",
      "    l897         35           37.682767                 1    Capomulin   Male          17          19\n",
      "    o809         35           55.629428                 1    Infubinol   Male           3          25\n",
      "    a520         35           37.624710                 1     Ramicane   Male          13          21\n",
      "    p189         35           67.873777                 4     Ketapril   Male           8          28\n",
      "    k483         35           60.541562                 2    Infubinol Female          20          30\n",
      "    x822         35           56.796567                 2     Ceftamin   Male           3          29\n",
      "    a963         35           56.813976                 1     Stelasyn Female          23          27\n",
      "    l725         35           69.125702                 3     Naftisol Female           8          26\n",
      "    l733         35           57.600798                 1     Ceftamin Female           4          30\n",
      "    m269         35           68.689917                 1     Stelasyn Female          22          28\n",
      "    y478         35           61.888027                 1      Placebo Female           3          25\n",
      "    s185         35           28.328531                 1    Capomulin Female           3          17\n",
      "    s337         35           54.810813                 3    Zoniferol   Male          14          27\n",
      "    o973         35           60.242219                 1     Ketapril Female          11          29\n",
      "    d474         35           56.479113                 0     Ketapril   Male          18          27\n",
      "    h246         35           67.211270                 2     Ketapril   Male          13          30\n",
      "    j989         35           35.115590                 1     Ramicane   Male           8          19\n",
      "    k804         35           62.117279                 2    Infubinol Female          23          29\n",
      "    e227         35           66.949121                 3      Placebo   Male           1          30\n",
      "    w151         35           58.339141                 2     Ceftamin   Male          24          25\n",
      "    q511         35           60.838661                 1    Zoniferol Female           2          28\n",
      "    l700         35           61.462604                 1     Naftisol Female          18          27\n",
      "    t451         35           63.756990                 0     Stelasyn   Male           8          29\n",
      "    e662         35           43.220276                 1     Ramicane   Male           8          24\n",
      "    z581         35           58.628399                 3    Infubinol Female          24          25\n",
      "    c264         35           61.074795                 2    Zoniferol Female          11          27\n",
      "    w914         35           41.664916                 1    Capomulin   Male          24          21\n",
      "    l661         35           56.474129                 2     Ceftamin   Male          18          26\n",
      "    v603         35           63.189432                 1     Ketapril Female          22          30\n",
      "    j246         35           38.753265                 1    Capomulin Female          21          21\n",
      "    q610         35           36.561652                 2     Ramicane Female          18          21\n",
      "    l509         35           40.207288                 2    Capomulin   Male          17          21\n",
      "    m546         35           38.627536                 1     Ramicane   Male          18          16\n",
      "    w575         35           63.686445                 2    Zoniferol Female          16          28\n",
      "    i386         35           64.925420                 3    Infubinol Female          23          29\n",
      "    y865         35           61.153140                 3     Ceftamin   Male          23          26\n",
      "    n364         35           34.487522                 1     Ramicane   Male           4          17\n",
      "    i738         35           36.175953                 1    Capomulin Female          23          20\n",
      "    k894         35           55.362662                 4    Zoniferol Female          13          29\n",
      "    c282         35           59.887655                 1      Placebo   Male          12          27\n",
      "    g296         35           60.384520                 4    Zoniferol Female          14          29\n",
      "    u327         35           58.089028                 1     Ketapril   Male          17          25\n",
      "    j913         35           35.170148                 0     Ramicane Female           4          17\n",
      "    y769         35           63.430632                 3     Ceftamin Female           6          27\n",
      "    m601         35           30.834357                 1    Capomulin   Male          22          17\n",
      "    a444         35           41.735951                 0     Ramicane Female          10          25\n",
      "    q633         35           63.125659                 1    Zoniferol   Male          12          25\n",
      "    l471         35           61.405999                 1     Ceftamin Female           7          28\n",
      "    a251         35           60.903885                 1    Infubinol Female          21          25\n",
      "    x401         35           30.206825                 0    Capomulin Female          16          15\n",
      "    n304         35           57.122419                 4     Naftisol   Male           9          26\n",
      "    o795         35           69.085094                 4      Placebo Female          20          26\n",
      "    p136         35           57.630782                 1    Zoniferol Female           5          28\n",
      "    n923         35           60.356294                 3     Ketapril   Male          19          30\n",
      "    r604         35           59.217000                 2     Naftisol   Male           7          30\n",
      "    t565         35           33.515671                 0    Capomulin Female          20          17\n",
      "    d251         35           37.708529                 2     Ramicane Female           8          19\n",
      "    j365         35           56.961200                 2    Zoniferol   Male          24          28\n",
      "    c559         35           59.455041                 2    Zoniferol Female          19          28\n",
      "    a492         35           57.308554                 1     Stelasyn   Male          20          25\n",
      "    g497         35           64.094889                 2     Ketapril   Male          19          28\n",
      "    z969         35           69.176246                 4     Naftisol   Male           9          30\n",
      "    a401         35           60.347145                 3    Zoniferol Female           8          25\n",
      "    f545         35           66.742924                 1    Zoniferol Female          20          26\n",
      "    u196         35           47.001465                 2     Ramicane   Male          18          25\n",
      "    x402         35           55.240962                 3     Stelasyn   Male          21          28\n",
      "    r554         35           33.069337                 3    Capomulin Female           8          17\n",
      "    q787         35           60.333852                 3      Placebo   Male          17          27\n",
      "    f234         35           57.748758                 2     Stelasyn   Male          14          28\n",
      "    j296         35           58.714483                 3     Ceftamin Female          24          30\n",
      "    c302         35           62.236572                 3    Zoniferol Female          10          29\n",
      "    c832         35           61.124487                 2     Ketapril   Male          18          29\n",
      "    g288         35           38.954115                 1    Capomulin   Male           3          19\n",
      "    f345         35           56.523327                 1    Infubinol   Male          23          26\n",
      "    g107         35           71.905117                 0     Ketapril Female           2          29\n",
      "    b559         35           65.705763                 1     Naftisol   Male          20          26\n",
      "    r701         35           64.730010                 1     Naftisol   Male          21          25\n",
      "    m550         35           62.539154                 4     Ketapril   Male          18          28\n",
      "    x773         35           55.192736                 4      Placebo Female          21          30\n",
      "    b128         35           37.967644                 1    Capomulin Female           9          22\n",
      "    p387         35           66.492204                 1     Stelasyn   Male           3          30\n",
      "    t724         35           67.744328                 2     Naftisol Female           2          25\n",
      "    s565         35           64.776579                 2     Stelasyn Female           3          29\n",
      "    r811         35           36.003020                 1     Ramicane   Male           9          19\n",
      "    i635         35           55.679997                 2     Propriva   Male          21          26\n",
      "    o287         35           55.118290                 4     Ceftamin   Male           2          28\n",
      "    c766         35           65.952368                 4      Placebo Female          13          26\n",
      "    o926         35           58.593993                 3    Zoniferol   Male          15          29\n",
      "    r944         35           40.401765                 2    Capomulin   Male          12          25\n",
      "    i901         35           62.127336                 0     Stelasyn   Male          23          29\n",
      "    g316         35           44.702833                 2    Capomulin Female          22          22\n",
      "    a818         35           63.298546                 0     Naftisol Female          12          28\n",
      "    m650         35           69.265747                 4     Ketapril   Male          15          27\n",
      "    b879         35           64.260886                 2     Stelasyn Female           4          26\n",
      "    z578         35           38.504824                 0     Ramicane   Male          11          16\n",
      "    n763         35           57.382413                 3      Placebo Female          16          25\n",
      "    y793         35           36.327870                 2    Capomulin   Male          17          17\n",
      "    u364         35           35.459490                 2    Capomulin   Male          18          17\n",
      "    k382         35           66.079185                 4     Ketapril   Male          22          29\n",
      "    t718         35           60.463899                 3      Placebo Female          10          30\n",
      "    e584         35           58.086560                 3     Naftisol   Male           9          27\n",
      "    e476         35           60.064340                 1    Infubinol   Male          23          26\n",
      "    v991         35           63.895313                 4     Propriva Female          10          30\n",
      "    g558         35           60.862159                 4     Propriva   Male           8          29\n",
      "    z795         35           60.435654                 2     Naftisol Female          13          29\n",
      "    i557         35           45.941949                 0    Capomulin Female           1          24\n",
      "    p438         35           57.538555                 1     Ceftamin Female          11          26\n",
      "    w167         35           68.134288                 0      Placebo Female           6          28\n",
      "    i177         35           35.152166                 1     Ramicane   Male          10          18\n",
      "    a203         35           61.931650                 2    Infubinol Female          20          23\n",
      "    a644         35           35.128631                 0     Ramicane Female           7          17\n",
      "    c927         35           61.872274                 3     Propriva Female           4          26\n",
      "    j755         35           62.732858                 1     Naftisol   Male          23          27\n",
      "    y260         35           59.603558                 4     Ketapril Female           7          25\n",
      "    w422         35           61.409620                 4     Ketapril Female          18          26\n",
      "    x264         35           61.299608                 4     Naftisol Female          21          27\n",
      "    g570         35           62.330420                 2     Propriva   Male          16          29\n",
      "    e213         35           58.245854                 3     Naftisol   Male           8          27\n",
      "    q483         35           59.253484                 1     Ceftamin   Male           6          26\n",
      "    c757         35           64.291164                 2      Placebo   Male           9          27\n",
      "    a411         35           39.717236                 1     Ramicane   Male           3          22\n",
      "    o562         35           65.360767                 1     Propriva Female           4          25\n",
      "    a685         35           58.092629                 1    Infubinol   Male           8          30\n",
      "    a897         35           64.052873                 3      Placebo   Male           7          28\n",
      "    g989         35           62.570880                 2     Propriva Female          21          26\n",
      "    o331         35           70.126238                 2     Ketapril   Male          24          30\n",
      "    q597         35           43.807201                 1     Ramicane   Male          20          25\n",
      "    j984         35           64.055399                 1     Stelasyn Female           2          30\n",
      "    v295         35           61.893153                 3     Naftisol Female           2          27\n",
      "    q582         35           53.713158                 2      Placebo   Male           5          30\n",
      "    k862         35           66.580722                 3     Stelasyn Female          13          25\n",
      "    j119         35           43.765705                 1    Capomulin Female           7          23\n",
      "    k210         35           63.329330                 1     Ceftamin   Male          15          28\n",
      "    y163         35           61.730196                 2    Infubinol Female          17          27\n",
      "    a275         35           56.353538                 2     Ceftamin Female          20          28\n",
      "    w350         35           56.683558                 1     Propriva   Male           7          26\n",
      "    s508         35           35.846141                 0     Ramicane   Male           1          17\n",
      "    k403         35           26.546993                 1     Ramicane   Male          21          16\n",
      "    a699         35           56.510682                 1     Propriva Female           5          28\n",
      "    s710         35           44.160519                 1    Capomulin Female           1          23\n",
      "    c402         35           65.807963                 2     Stelasyn Female           1          27\n",
      "    c819         35           57.729535                 1     Ketapril   Male          21          25\n",
      "    x581         35           58.077583                 3     Ceftamin Female          19          28\n",
      "    c139         35           67.821420                 1    Infubinol   Male          11          28\n",
      "    a262         35           66.561963                 4      Placebo Female          17          29\n",
      "    m957         35           32.562839                 1    Capomulin Female           3          19\n",
      "    b742         35           39.847576                 0    Capomulin   Male           7          21\n",
      "    c758         35           37.802385                 1     Ramicane   Male           9          17\n",
      "    v923         35           41.439242                 2    Capomulin Female          19          21\n",
      "    w697         35           63.689042                 3     Stelasyn Female          14          30\n",
      "    p981         35           59.131023                 1     Stelasyn   Male          20          29\n",
      "    t198         35           57.735941                 3     Propriva   Male          22          26\n",
      "    g791         35           30.960392                 1     Ramicane   Male          11          16\n",
      "    a262         40           69.592732                 4      Placebo Female          17          29\n",
      "    a644         40           35.779451                 0     Ramicane Female           7          17\n",
      "    i334         40           40.442370                 2     Ramicane Female           8          20\n",
      "    a520         40           38.259725                 1     Ramicane   Male          13          21\n",
      "    k894         40           58.647056                 4    Zoniferol Female          13          29\n",
      "    e662         40           44.006724                 2     Ramicane   Male           8          24\n",
      "    n364         40           34.954733                 1     Ramicane   Male           4          17\n",
      "    k403         40           24.365505                 1     Ramicane   Male          21          16\n",
      "    b128         40           38.379726                 2    Capomulin Female           9          22\n",
      "    i177         40           35.557933                 2     Ramicane   Male          10          18\n",
      "    c302         40           63.281071                 4    Zoniferol Female          10          29\n",
      "    s508         40           32.798171                 0     Ramicane   Male           1          17\n",
      "    y478         40           65.971120                 1      Placebo Female           3          25\n",
      "    t718         40           61.530399                 3      Placebo Female          10          30\n",
      "    c282         40           65.021799                 2      Placebo   Male          12          27\n",
      "    o795         40           70.266479                 4      Placebo Female          20          26\n",
      "    m546         40           35.114575                 1     Ramicane   Male          18          16\n",
      "    z578         40           34.022093                 0     Ramicane   Male          11          16\n",
      "    g791         40           31.369406                 1     Ramicane   Male          11          16\n",
      "    c758         40           32.833189                 1     Ramicane   Male           9          17\n",
      "    d251         40           38.265404                 2     Ramicane Female           8          19\n",
      "    c264         40           65.708323                 2    Zoniferol Female          11          27\n",
      "    u196         40           43.453687                 2     Ramicane   Male          18          25\n",
      "    c757         40           66.604368                 2      Placebo   Male           9          27\n",
      "    r811         40           36.520033                 1     Ramicane   Male           9          19\n",
      "    c766         40           67.685295                 4      Placebo Female          13          26\n",
      "    e227         40           70.715218                 3      Placebo   Male           1          30\n",
      "    n763         40           58.011146                 4      Placebo Female          16          25\n",
      "    f545         40           71.108118                 1    Zoniferol Female          20          26\n",
      "    r944         40           41.042045                 2    Capomulin   Male          12          25\n",
      "    x773         40           55.987676                 4      Placebo Female          21          30\n",
      "    s185         40           25.472143                 1    Capomulin Female           3          17\n",
      "    a897         40           67.211743                 4      Placebo   Male           7          28\n",
      "    q787         40           62.034127                 3      Placebo   Male          17          27\n",
      "    a444         40           42.504926                 0     Ramicane Female          10          25\n",
      "    m601         40           31.378045                 1    Capomulin   Male          22          17\n",
      "    t565         40           33.949341                 0    Capomulin Female          20          17\n",
      "    q597         40           44.471821                 2     Ramicane   Male          20          25\n",
      "    j989         40           35.501190                 1     Ramicane   Male           8          19\n",
      "    u327         40           60.466545                 1     Ketapril   Male          17          25\n",
      "    b879         40           67.189127                 2     Stelasyn Female           4          26\n",
      "    j755         40           67.207710                 1     Naftisol   Male          23          27\n",
      "    y260         40           60.914176                 4     Ketapril Female           7          25\n",
      "    g570         40           68.525856                 2     Propriva   Male          16          29\n",
      "    a275         40           60.921539                 3     Ceftamin Female          20          28\n",
      "    s710         40           40.171920                 1    Capomulin Female           1          23\n",
      "    s565         40           67.221007                 2     Stelasyn Female           3          29\n",
      "    p387         40           69.038876                 1     Stelasyn   Male           3          30\n",
      "    l471         40           63.844858                 1     Ceftamin Female           7          28\n",
      "    i635         40           56.842435                 3     Propriva   Male          21          26\n",
      "    e476         40           61.525276                 1    Infubinol   Male          23          26\n",
      "    k382         40           67.420955                 4     Ketapril   Male          22          29\n",
      "    j119         40           44.585090                 1    Capomulin Female           7          23\n",
      "    i901         40           64.303455                 0     Stelasyn   Male          23          29\n",
      "    a203         40           63.593490                 2    Infubinol Female          20          23\n",
      "    b742         40           38.255627                 0    Capomulin   Male           7          21\n",
      "    w422         40           63.072585                 4     Ketapril Female          18          26\n",
      "    k862         40           67.571341                 4     Stelasyn Female          13          25\n",
      "    t198         40           59.129960                 4     Propriva   Male          22          26\n",
      "    k210         40           66.622836                 2     Ceftamin   Male          15          28\n",
      "    a699         40           58.605448                 1     Propriva Female           5          28\n",
      "    f345         40           58.315593                 1    Infubinol   Male          23          26\n",
      "    v923         40           42.151015                 2    Capomulin Female          19          21\n",
      "    m550         40           68.210720                 4     Ketapril   Male          18          28\n",
      "    l661         40           59.205669                 3     Ceftamin   Male          18          26\n",
      "    o287         40           57.197193                 4     Ceftamin   Male           2          28\n",
      "    v295         40           65.466074                 3     Naftisol Female           2          27\n",
      "    e213         40           60.236548                 3     Naftisol   Male           8          27\n",
      "    w151         40           62.187950                 2     Ceftamin   Male          24          25\n",
      "    p189         40           74.106091                 4     Ketapril   Male           8          28\n",
      "    t724         40           69.728326                 2     Naftisol Female           2          25\n",
      "    q483         40           64.192341                 1     Ceftamin   Male           6          26\n",
      "    r701         40           66.640722                 1     Naftisol   Male          21          25\n",
      "    p438         40           59.305288                 1     Ceftamin Female          11          26\n",
      "    a818         40           69.273814                 1     Naftisol Female          12          28\n",
      "    x264         40           63.283288                 4     Naftisol Female          21          27\n",
      "    c927         40           64.183229                 4     Propriva Female           4          26\n",
      "    a411         40           40.258818                 1     Ramicane   Male           3          22\n",
      "    j296         40           60.072688                 3     Ceftamin Female          24          30\n",
      "    a685         40           60.567904                 2    Infubinol   Male           8          30\n",
      "    z795         40           62.376639                 3     Naftisol Female          13          29\n",
      "    v991         40           64.851129                 4     Propriva Female          10          30\n",
      "    h246         40           71.150835                 2     Ketapril   Male          13          30\n",
      "    u364         40           36.024138                 2    Capomulin   Male          18          17\n",
      "    o562         40           71.172463                 1     Propriva Female           4          25\n",
      "    m957         40           32.947615                 1    Capomulin Female           3          19\n",
      "    c819         40           62.175705                 1     Ketapril   Male          21          25\n",
      "    x581         40           60.280405                 3     Ceftamin Female          19          28\n",
      "    e584         40           62.816871                 4     Naftisol   Male           9          27\n",
      "    g558         40           61.774963                 4     Propriva   Male           8          29\n",
      "    y793         40           31.475411                 2    Capomulin   Male          17          17\n",
      "    i557         40           46.821070                 1    Capomulin Female           1          24\n",
      "    j984         40           67.777080                 1     Stelasyn Female           2          30\n",
      "    l725         40           73.693494                 3     Naftisol Female           8          26\n",
      "    g316         40           45.565821                 2    Capomulin Female          22          22\n",
      "    p136         40           61.380249                 1    Zoniferol Female           5          28\n",
      "    r604         40           60.186115                 2     Naftisol   Male           7          30\n",
      "    a492         40           57.928499                 1     Stelasyn   Male          20          25\n",
      "    k483         40           64.138725                 3    Infubinol Female          20          30\n",
      "    o973         40           64.487812                 2     Ketapril Female          11          29\n",
      "    j365         40           62.327171                 2    Zoniferol   Male          24          28\n",
      "    d474         40           60.233733                 1     Ketapril   Male          18          27\n",
      "    l509         40           40.770813                 2    Capomulin   Male          17          21\n",
      "    z581         40           60.053740                 3    Infubinol Female          24          25\n",
      "    a401         40           61.768605                 4    Zoniferol Female           8          25\n",
      "    g497         40           67.742814                 2     Ketapril   Male          19          28\n",
      "    x402         40           56.691723                 3     Stelasyn   Male          21          28\n",
      "    y865         40           63.469549                 3     Ceftamin   Male          23          26\n",
      "    q633         40           68.498639                 2    Zoniferol   Male          12          25\n",
      "    z969         40           70.314904                 4     Naftisol   Male           9          30\n",
      "    a251         40           63.095076                 1    Infubinol Female          21          25\n",
      "    w914         40           35.611309                 2    Capomulin   Male          24          21\n",
      "    w575         40           64.938406                 3    Zoniferol Female          16          28\n",
      "    r554         40           31.804841                 3    Capomulin Female           8          17\n",
      "    i386         40           67.289621                 4    Infubinol Female          23          29\n",
      "    j913         40           31.001861                 1     Ramicane Female           4          17\n",
      "    g296         40           62.221915                 4    Zoniferol Female          14          29\n",
      "    i738         40           36.843898                 2    Capomulin Female          23          20\n",
      "    c832         40           62.572318                 2     Ketapril   Male          18          29\n",
      "    c559         40           60.861844                 3    Zoniferol Female          19          28\n",
      "    x401         40           28.167397                 0    Capomulin Female          16          15\n",
      "    n304         40           59.830507                 4     Naftisol   Male           9          26\n",
      "    w350         40           62.324348                 2     Propriva   Male           7          26\n",
      "    m650         40           70.797068                 4     Ketapril   Male          15          27\n",
      "    c402         40           70.222297                 2     Stelasyn Female           1          27\n",
      "    b559         40           69.969616                 1     Naftisol   Male          20          26\n",
      "    o926         40           59.903044                 3    Zoniferol   Male          15          29\n",
      "    c139         40           69.428141                 2    Infubinol   Male          11          28\n",
      "    l897         40           38.343902                 1    Capomulin   Male          17          19\n",
      "    x822         40           59.555685                 2     Ceftamin   Male           3          29\n",
      "    l700         40           62.986678                 1     Naftisol Female          18          27\n",
      "    t451         40           67.654796                 1     Stelasyn   Male           8          29\n",
      "    y163         40           63.620680                 2    Infubinol Female          17          27\n",
      "    q511         40           63.194428                 2    Zoniferol Female           2          28\n",
      "    l733         40           59.443506                 1     Ceftamin Female           4          30\n",
      "    m269         40           70.214644                 1     Stelasyn Female          22          28\n",
      "    y769         40           64.251028                 4     Ceftamin Female           6          27\n",
      "    g288         40           36.356851                 1    Capomulin   Male           3          19\n",
      "    n923         40           66.229606                 3     Ketapril   Male          19          30\n",
      "    a963         40           58.463787                 1     Stelasyn Female          23          27\n",
      "    o331         40           71.447743                 3     Ketapril   Male          24          30\n",
      "    s337         40           56.994816                 4    Zoniferol   Male          14          27\n",
      "    n364         45           31.095335                 1     Ramicane   Male           4          17\n",
      "    b128         45           38.982878                 2    Capomulin Female           9          22\n",
      "    l661         45           59.851956                 3     Ceftamin   Male          18          26\n",
      "    y865         45           64.729837                 3     Ceftamin   Male          23          26\n",
      "    y769         45           68.594745                 4     Ceftamin Female           6          27\n",
      "    b559         45           73.051363                 1     Naftisol   Male          20          26\n",
      "    t565         45           34.455298                 0    Capomulin Female          20          17\n",
      "    c282         45           65.815165                 2      Placebo   Male          12          27\n",
      "    l509         45           41.483008                 3    Capomulin   Male          17          21\n",
      "    j296         45           61.849023                 3     Ceftamin Female          24          30\n",
      "    a411         45           38.407618                 1     Ramicane   Male           3          22\n",
      "    p189         45           75.294936                 4     Ketapril   Male           8          28\n",
      "    m650         45           73.901399                 4     Ketapril   Male          15          27\n",
      "    q597         45           45.220869                 2     Ramicane   Male          20          25\n",
      "    g288         45           37.074024                 1    Capomulin   Male           3          19\n",
      "    o331         45           78.567014                 4     Ketapril   Male          24          30\n",
      "    y163         45           67.685569                 3    Infubinol Female          17          27\n",
      "    i334         45           36.374510                 2     Ramicane Female           8          20\n",
      "    c139         45           72.226731                 2    Infubinol   Male          11          28\n",
      "    c832         45           65.415955                 3     Ketapril   Male          18          29\n",
      "    a262         45           70.717621                 4      Placebo Female          17          29\n",
      "    z581         45           62.754451                 3    Infubinol Female          24          25\n",
      "    g497         45           69.872251                 2     Ketapril   Male          19          28\n",
      "    a251         45           65.525743                 1    Infubinol Female          21          25\n",
      "    q787         45           66.096475                 3      Placebo   Male          17          27\n",
      "    r554         45           32.377357                 3    Capomulin Female           8          17\n",
      "    k483         45           66.196912                 3    Infubinol Female          20          30\n",
      "    w151         45           67.527482                 3     Ceftamin   Male          24          25\n",
      "    g316         45           40.159220                 2    Capomulin Female          22          22\n",
      "    m550         45           69.253503                 4     Ketapril   Male          18          28\n",
      "    e227         45           73.212939                 3      Placebo   Male           1          30\n",
      "    a685         45           66.083066                 3    Infubinol   Male           8          30\n",
      "    s508         45           30.276232                 0     Ramicane   Male           1          17\n",
      "    h246         45           74.104086                 2     Ketapril   Male          13          30\n",
      "    y793         45           31.896238                 2    Capomulin   Male          17          17\n",
      "    c766         45           69.823146                 4      Placebo Female          13          26\n",
      "    z578         45           30.638696                 0     Ramicane   Male          11          16\n",
      "    m957         45           33.329098                 1    Capomulin Female           3          19\n",
      "    e662         45           40.659006                 2     Ramicane   Male           8          24\n",
      "    e476         45           62.435404                 1    Infubinol   Male          23          26\n",
      "    k382         45           73.715619                 4     Ketapril   Male          22          29\n",
      "    a203         45           67.973419                 2    Infubinol Female          20          23\n",
      "    w422         45           67.989530                 4     Ketapril Female          18          26\n",
      "    f345         45           60.918767                 1    Infubinol   Male          23          26\n",
      "    y260         45           62.909441                 4     Ketapril Female           7          25\n",
      "    m546         45           30.564625                 1     Ramicane   Male          18          16\n",
      "    a818         45           74.997764                 2     Naftisol Female          12          28\n",
      "    l471         45           67.748662                 1     Ceftamin Female           7          28\n",
      "    s337         45           62.109651                 4    Zoniferol   Male          14          27\n",
      "    a963         45           62.765093                 1     Stelasyn Female          23          27\n",
      "    q511         45           68.611061                 3    Zoniferol Female           2          28\n",
      "    k403         45           22.050126                 1     Ramicane   Male          21          16\n",
      "    t451         45           68.711630                 1     Stelasyn   Male           8          29\n",
      "    o926         45           62.327966                 4    Zoniferol   Male          15          29\n",
      "    l897         45           38.846876                 1    Capomulin   Male          17          19\n",
      "    c302         45           64.575222                 4    Zoniferol Female          10          29\n",
      "    w350         45           64.957562                 2     Propriva   Male           7          26\n",
      "    c402         45           74.040390                 3     Stelasyn Female           1          27\n",
      "    v923         45           40.658124                 2    Capomulin Female          19          21\n",
      "    c758         45           33.397653                 1     Ramicane   Male           9          17\n",
      "    j984         45           70.653832                 1     Stelasyn Female           2          30\n",
      "    a699         45           62.191414                 1     Propriva Female           5          28\n",
      "    a897         45           72.255963                 4      Placebo   Male           7          28\n",
      "    t198         45           64.911363                 4     Propriva   Male          22          26\n",
      "    k862         45           69.299149                 4     Stelasyn Female          13          25\n",
      "    j989         45           36.134852                 1     Ramicane   Male           8          19\n",
      "    b742         45           38.939633                 0    Capomulin   Male           7          21\n",
      "    m269         45           75.123690                 1     Stelasyn Female          22          28\n",
      "    c264         45           67.942121                 2    Zoniferol Female          11          27\n",
      "    g296         45           68.163195                 4    Zoniferol Female          14          29\n",
      "    j913         45           31.560470                 1     Ramicane Female           4          17\n",
      "    w575         45           68.401286                 3    Zoniferol Female          16          28\n",
      "    k894         45           60.752704                 4    Zoniferol Female          13          29\n",
      "    a444         45           43.047543                 0     Ramicane Female          10          25\n",
      "    q633         45           70.827796                 2    Zoniferol   Male          12          25\n",
      "    w914         45           36.041047                 2    Capomulin   Male          24          21\n",
      "    a401         45           66.794156                 4    Zoniferol Female           8          25\n",
      "    f545         45           73.324432                 1    Zoniferol Female          20          26\n",
      "    x402         45           61.619606                 3     Stelasyn   Male          21          28\n",
      "    j365         45           64.294085                 2    Zoniferol   Male          24          28\n",
      "    m601         45           28.430964                 1    Capomulin   Male          22          17\n",
      "    d251         45           37.311236                 2     Ramicane Female           8          19\n",
      "    a492         45           60.122011                 1     Stelasyn   Male          20          25\n",
      "    x401         45           28.484033                 0    Capomulin Female          16          15\n",
      "    p136         45           63.488697                 2    Zoniferol Female           5          28\n",
      "    c559         45           61.840058                 4    Zoniferol Female          19          28\n",
      "    s185         45           23.343598                 1    Capomulin Female           3          17\n",
      "    i738         45           37.311846                 2    Capomulin Female          23          20\n",
      "    i901         45           65.341811                 0     Stelasyn   Male          23          29\n",
      "    c757         45           69.042841                 3      Placebo   Male           9          27\n",
      "    t724         45           75.113288                 2     Naftisol Female           2          25\n",
      "    s710         45           40.728578                 1    Capomulin Female           1          23\n",
      "    x581         45           64.634949                 3     Ceftamin Female          19          28\n",
      "    a275         45           62.999356                 3     Ceftamin Female          20          28\n",
      "    a520         45           38.810366                 1     Ramicane   Male          13          21\n",
      "    k210         45           68.923185                 3     Ceftamin   Male          15          28\n",
      "    j119         45           38.125164                 1    Capomulin Female           7          23\n",
      "    y478         45           66.842635                 1      Placebo Female           3          25\n",
      "    l725         45           76.668817                 3     Naftisol Female           8          26\n",
      "    x822         45           61.386660                 3     Ceftamin   Male           3          29\n",
      "    l700         45           63.946640                 1     Naftisol Female          18          27\n",
      "    l733         45           64.299830                 1     Ceftamin Female           4          30\n",
      "    n304         45           63.586395                 4     Naftisol   Male           9          26\n",
      "    o795         45           73.059454                 4      Placebo Female          20          26\n",
      "    u196         45           40.667713                 3     Ramicane   Male          18          25\n",
      "    r604         45           62.670759                 3     Naftisol   Male           7          30\n",
      "    z969         45           73.867845                 4     Naftisol   Male           9          30\n",
      "    g791         45           29.128472                 1     Ramicane   Male          11          16\n",
      "    i635         45           58.633404                 3     Propriva   Male          21          26\n",
      "    o287         45           59.741901                 4     Ceftamin   Male           2          28\n",
      "    r701         45           69.778544                 1     Naftisol   Male          21          25\n",
      "    r811         45           37.225650                 1     Ramicane   Male           9          19\n",
      "    u327         45           66.268801                 2     Ketapril   Male          17          25\n",
      "    s565         45           72.588964                 2     Stelasyn Female           3          29\n",
      "    g570         45           70.492788                 2     Propriva   Male          16          29\n",
      "    i557         45           47.685963                 1    Capomulin Female           1          24\n",
      "    a644         45           32.978522                 1     Ramicane Female           7          17\n",
      "    j755         45           69.563621                 1     Naftisol   Male          23          27\n",
      "    e213         45           63.105696                 4     Naftisol   Male           8          27\n",
      "    e584         45           68.359777                 4     Naftisol   Male           9          27\n",
      "    t718         45           63.423695                 4      Placebo Female          10          30\n",
      "    o562         45           72.455421                 2     Propriva Female           4          25\n",
      "    i177         45           33.562402                 3     Ramicane   Male          10          18\n",
      "    v991         45           70.167749                 4     Propriva Female          10          30\n",
      "    z795         45           65.741070                 3     Naftisol Female          13          29\n",
      "    r944         45           41.581521                 2    Capomulin   Male          12          25\n",
      "    u364         45           31.023923                 3    Capomulin   Male          18          17\n",
      "    p438         45           61.433892                 1     Ceftamin Female          11          26\n",
      "    x773         45           58.634971                 4      Placebo Female          21          30\n",
      "    b879         45           72.555239                 2     Stelasyn Female           4          26\n"
     ]
    }
   ],
   "source": [
    "# Dependencies and Setup\n",
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "import scipy.stats as st\n",
    "import seaborn as sns\n",
    "\n",
    "# data files\n",
    "mouse_metadata_path = \"data/Mouse_metadata.csv\"\n",
    "study_results_path = \"data/Study_results.csv\"\n",
    "\n",
    "# Read results\n",
    "mouse_metadata = pd.read_csv(mouse_metadata_path)\n",
    "study_results = pd.read_csv(study_results_path)\n",
    "\n",
    "# Combine the data into single DataFrame\n",
    "combined_data = pd.merge(study_results, mouse_metadata, how='left', on='Mouse ID')\n",
    "\n",
    "# Display the data\n",
    "print(\"Combined Data:\")\n",
    "print(combined_data.to_string(index=False))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of mice in the combined dataset is: 249\n"
     ]
    }
   ],
   "source": [
    "# Check number of mice\n",
    "num_mice = combined_data['Mouse ID'].nunique()\n",
    "print(f'The number of mice in the combined dataset is: {num_mice}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Duplicate Mice:\n",
      "['g989']\n"
     ]
    }
   ],
   "source": [
    "# duplicate mice by ID\n",
    "duplicate_mice_ids = combined_data[combined_data.duplicated(subset=['Mouse ID', 'Timepoint'], keep=False)]['Mouse ID'].unique()\n",
    "\n",
    "print(\"Duplicate Mice:\")\n",
    "print(duplicate_mice_ids)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All data for the duplicate Mouse ID 'g989':\n",
      "     Mouse ID  Timepoint  Tumor Volume (mm3)  Metastatic Sites Drug Regimen     Sex  Age_months  Weight (g)\n",
      "107      g989          0           45.000000                 0     Propriva  Female          21          26\n",
      "137      g989          0           45.000000                 0     Propriva  Female          21          26\n",
      "329      g989          5           48.786801                 0     Propriva  Female          21          26\n",
      "360      g989          5           47.570392                 0     Propriva  Female          21          26\n",
      "620      g989         10           51.745156                 0     Propriva  Female          21          26\n",
      "681      g989         10           49.880528                 0     Propriva  Female          21          26\n",
      "815      g989         15           51.325852                 1     Propriva  Female          21          26\n",
      "869      g989         15           53.442020                 0     Propriva  Female          21          26\n",
      "950      g989         20           55.326122                 1     Propriva  Female          21          26\n",
      "1111     g989         20           54.657650                 1     Propriva  Female          21          26\n",
      "1195     g989         25           56.045564                 1     Propriva  Female          21          26\n",
      "1380     g989         30           59.082294                 1     Propriva  Female          21          26\n",
      "1592     g989         35           62.570880                 2     Propriva  Female          21          26\n"
     ]
    }
   ],
   "source": [
    "# Optional: Get all the data for the duplicate mouse ID\n",
    "# Set display options\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.expand_frame_repr', False)\n",
    "\n",
    "# Optional: Get all the data for the duplicate mouse ID\n",
    "duplicate_mouse_id = 'g989'\n",
    "all_data_duplicate_mouse = combined_data[combined_data['Mouse ID'] == duplicate_mouse_id]\n",
    "print(f\"All data for the duplicate Mouse ID '{duplicate_mouse_id}':\")\n",
    "print(all_data_duplicate_mouse)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "     Mouse ID  Timepoint  Tumor Volume (mm3)  Metastatic Sites Drug Regimen     Sex  Age_months  Weight (g)\n",
      "0        b128          0           45.000000                 0    Capomulin  Female           9          22\n",
      "1        f932          0           45.000000                 0     Ketapril    Male          15          29\n",
      "2        g107          0           45.000000                 0     Ketapril  Female           2          29\n",
      "3        a457          0           45.000000                 0     Ketapril  Female          11          30\n",
      "4        c819          0           45.000000                 0     Ketapril    Male          21          25\n",
      "...       ...        ...                 ...               ...          ...     ...         ...         ...\n",
      "1888     r944         45           41.581521                 2    Capomulin    Male          12          25\n",
      "1889     u364         45           31.023923                 3    Capomulin    Male          18          17\n",
      "1890     p438         45           61.433892                 1     Ceftamin  Female          11          26\n",
      "1891     x773         45           58.634971                 4      Placebo  Female          21          30\n",
      "1892     b879         45           72.555239                 2     Stelasyn  Female           4          26\n",
      "\n",
      "[1880 rows x 8 columns]\n"
     ]
    }
   ],
   "source": [
    "# Create a clean DataFrame by dropping the duplicate mouse by its ID.\n",
    "# Set display options\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.expand_frame_repr', False)\n",
    "\n",
    "# Create a clean DataFrame by dropping the duplicate mouse by its ID\n",
    "cleaned_data = combined_data[combined_data['Mouse ID'] != 'g989']\n",
    "\n",
    "# Display the cleaned data for preview\n",
    "print(cleaned_data)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The number of mice in the cleaned dataset is: 248\n"
     ]
    }
   ],
   "source": [
    "# Check number of mice in the clean DataFrame\n",
    "num_mice_cleaned = cleaned_data['Mouse ID'].nunique()\n",
    "print(f'The number of mice in the cleaned dataset is: {num_mice_cleaned}')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Summary Statistics"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Summary Statistics DataFrame of Tumor Volume for Each Drug Regimen:\n",
      "                   mean     median   variance   std_dev       sem\n",
      "Drug Regimen                                                     \n",
      "Capomulin     40.675741  41.557809  24.947764  4.994774  0.329346\n",
      "Ceftamin      52.591172  51.776157  39.290177  6.268188  0.469821\n",
      "Infubinol     52.884795  51.820584  43.128684  6.567243  0.492236\n",
      "Ketapril      55.235638  53.698743  68.553577  8.279709  0.603860\n",
      "Naftisol      54.331565  52.509285  66.173479  8.134708  0.596466\n",
      "Placebo       54.033581  52.288934  61.168083  7.821003  0.581331\n",
      "Propriva      52.320930  50.446266  43.852013  6.622085  0.544332\n",
      "Ramicane      40.216745  40.673236  23.486704  4.846308  0.320955\n",
      "Stelasyn      54.233149  52.431737  59.450562  7.710419  0.573111\n",
      "Zoniferol     53.236507  51.818479  48.533355  6.966589  0.516398\n"
     ]
    }
   ],
   "source": [
    "# Group by 'Drug Regimen' and calculate mean, median, variance, standard deviation, and SEM of the tumor volume\n",
    "summary_stats = cleaned_data.groupby('Drug Regimen').agg(\n",
    "    mean=('Tumor Volume (mm3)', 'mean'),\n",
    "    median=('Tumor Volume (mm3)', 'median'),\n",
    "    variance=('Tumor Volume (mm3)', 'var'),\n",
    "    std_dev=('Tumor Volume (mm3)', 'std'),\n",
    "    sem=('Tumor Volume (mm3)', 'sem')\n",
    ")\n",
    "\n",
    "# Display the summary statistics DataFrame\n",
    "print(\"Summary Statistics DataFrame of Tumor Volume for Each Drug Regimen:\")\n",
    "print(summary_stats)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Summary Statistics Table of Tumor Volume for Each Drug Regimen (Single Line):\n",
      "                   Mean     Median   Variance  Std_Deviation       SEM\n",
      "Drug Regimen                                                          \n",
      "Capomulin     40.675741  41.557809  24.947764       4.994774  0.329346\n",
      "Ceftamin      52.591172  51.776157  39.290177       6.268188  0.469821\n",
      "Infubinol     52.884795  51.820584  43.128684       6.567243  0.492236\n",
      "Ketapril      55.235638  53.698743  68.553577       8.279709  0.603860\n",
      "Naftisol      54.331565  52.509285  66.173479       8.134708  0.596466\n",
      "Placebo       54.033581  52.288934  61.168083       7.821003  0.581331\n",
      "Propriva      52.320930  50.446266  43.852013       6.622085  0.544332\n",
      "Ramicane      40.216745  40.673236  23.486704       4.846308  0.320955\n",
      "Stelasyn      54.233149  52.431737  59.450562       7.710419  0.573111\n",
      "Zoniferol     53.236507  51.818479  48.533355       6.966589  0.516398\n"
     ]
    }
   ],
   "source": [
    "# A more advanced method to generate a summary statistics table of mean, median, variance, standard deviation,\n",
    "\n",
    "summary_stats_single_line = cleaned_data.groupby('Drug Regimen')['Tumor Volume (mm3)'].agg(\n",
    "    Mean='mean',\n",
    "    Median='median',\n",
    "    Variance='var',\n",
    "    Std_Deviation='std',\n",
    "    SEM='sem'\n",
    ")\n",
    "\n",
    "# Display the summary statistics table\n",
    "print(\"Summary Statistics Table of Tumor Volume for Each Drug Regimen (Single Line):\")\n",
    "print(summary_stats_single_line)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Bar and Pie Charts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAjsAAAIDCAYAAADi/9+bAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8g+/7EAAAACXBIWXMAAA9hAAAPYQGoP6dpAABubElEQVR4nO3dd1QU598F8LsU6UWQIooIaFQUNWqwRUVFsRt7QcWusZfYYqyxNyzxpzExgsYWTWKJHeyIPYpdwV5AFAEBQYF5//Awrysgu7Dr7E7u55w9h3122PkuW7g78xSFIAgCiIiIiGTKQOoCiIiIiLSJYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hhyRz9OhRKBQKHD16VOpSCiz7MWzfvl3qUlQSGxuLjh07wt7eHgqFAkuXLpW6JK06d+4c6tSpAwsLCygUCly6dEnqkjTO19cXlSpVkrqM/xQ5fHb91zDs/McoFAqVLqq8iefMmYMdO3Zovebg4GAoFAqYmpriyZMnOW7nh73qRo8ejQMHDmDSpEnYsGEDmjVrlue2H78mrK2t0aBBA+zZs+czVlxw7969Q6dOnRAfH4+goCBs2LABbm5uWttf9j/AvC5btmzR2r4Lo3Tp0mKNBgYGsLW1hbe3NwYOHIgzZ85IXV6ePqxboVDAwsICPj4+WL9+vdSlkQ4ykroA+rw2bNigdH39+vU4dOhQjvYKFSrke19z5sxBx44d8c0332iyxDylp6dj3rx5WLFixWfZnxwdPnwYbdu2xXfffafS9k2aNEGvXr0gCAIePHiAVatWoXXr1ti3bx/8/f21XG3hREdH48GDB/jll1/Qv3//z7bfESNG4KuvvsrRXrt27c9Wg7qqVq2KsWPHAgBev36NGzduYNu2bfjll18wevRoLFmyROIKc/dh3c+ePcOvv/6KwMBApKenY8CAAVrbb/369fHmzRsUKVJEa/sgzWLY+Y/p0aOH0vXTp0/j0KFDOdp1UdWqVfHLL79g0qRJcHFxkbqczyolJQUWFhaFvp/nz5/D1tZW5e2/+OILpddGhw4d4OXlhWXLlul82Hn+/DkAqPV486PK81CvXj107NhRY/v8HEqUKJHjM2D+/Pno3r07goKCULZsWXz77bd5/n5GRgaysrI++z//j+vu3bs3PDw8EBQUpNWwY2BgAFNTU63dP2keT2NRDikpKRg7dixcXV1hYmKCcuXKYdGiRRAEQdxGoVAgJSUFISEh4mHk3r17AwAePHiAIUOGoFy5cjAzM4O9vT06deqE+/fvF6qu77//HpmZmZg3b94nt7t//z4UCgWCg4Nz3KZQKDB9+nTx+vTp06FQKHD79m306NEDNjY2cHBwwJQpUyAIAh49eoS2bdvC2toazs7OWLx4ca77zMzMxPfffw9nZ2dYWFigTZs2ePToUY7tzpw5g2bNmsHGxgbm5uZo0KABwsPDlbbJrun69evo3r07ihYtiq+//vqTj/nu3bvo1KkT7OzsYG5ujlq1aimdbso+FSgIAlauXCk+Z+qqUKECihUrhujoaKX258+fo1+/fnBycoKpqSmqVKmCkJAQpW2qVauG9u3bK7V5e3tDoVAgMjJSbNu6dSsUCgVu3LgB4P2RhlGjRqF06dIwMTGBo6MjmjRpgosXL+ZZZ+/evdGgQQMAQKdOnaBQKODr6yvefvjwYdSrVw8WFhawtbVF27Ztxf1lK8jzoKp169ahUaNGcHR0hImJCby8vLBq1apct923bx8aNGgAKysrWFtb46uvvsKmTZtybHf9+nU0bNgQ5ubmKFGiBBYsWFCoGs3MzLBhwwbY2dlh9uzZ4vs/+/21aNEiLF26FJ6enjAxMcH169fF19nH7/W8+risXLkSHh4eMDMzg4+PD06cOAFfX1+l50odDg4OKF++fI7XZ1ZWFpYuXYqKFSvC1NQUTk5OGDRoEF69epVju+nTp8PFxQXm5uZo2LAhrl+/jtKlS4ufb3k9nuzT6ZGRkWjQoAHMzc1RpkwZsT/fsWPHULNmTZiZmaFcuXIIDQ3NUf+TJ0/Qt29fODk5wcTEBBUrVsRvv/2mtE32vv/44w/Mnj0bJUuWhKmpKRo3boyoqKgC/d3+C3hkh5QIgoA2bdrgyJEj6NevH6pWrYoDBw5g3LhxePLkCYKCggC8Px3Wv39/+Pj4YODAgQAAT09PAO87hZ46dQpdu3ZFyZIlcf/+faxatQq+vr64fv06zM3NC1Sbu7s7evXqhV9++QUTJ07U6NGdLl26oEKFCpg3bx727NmDWbNmwc7ODj///DMaNWqE+fPnY+PGjfjuu+/w1VdfoX79+kq/P3v2bCgUCkyYMAHPnz/H0qVL4efnh0uXLsHMzAzA+3+wzZs3R/Xq1TFt2jQYGBiI//ROnDgBHx8fpfvs1KkTypYtizlz5igFzY/FxsaiTp06SE1NxYgRI2Bvb4+QkBC0adMG27dvR7t27VC/fn1s2LABPXv2FE9NFURiYiJevXolPtcA8ObNG/j6+iIqKgrDhg2Du7s7tm3bht69eyMhIQEjR44E8P6Ix+bNm8Xfi4+Px7Vr12BgYIATJ06gcuXKAIATJ07AwcFBPJU6ePBgbN++HcOGDYOXlxdevnyJkydP4saNG6hWrVqudQ4aNAglSpTAnDlzxNNKTk5OAIDQ0FA0b94cHh4emD59Ot68eYMVK1agbt26uHjxIkqXLq10X6o+D9lev36NFy9e5GjP7hQOAKtWrULFihXRpk0bGBkZYffu3RgyZAiysrIwdOhQ8XeCg4PRt29fVKxYEZMmTYKtrS3+/fdf7N+/H927dxe3e/XqFZo1a4b27dujc+fO2L59OyZMmABvb280b94835rzYmlpiXbt2mHt2rW4fv06KlasKN62bt06pKWlYeDAgTAxMYGdnZ1a971q1SoMGzYM9erVw+jRo3H//n188803KFq0KEqWLFmgejMyMvD48WMULVpUqX3QoEEIDg5Gnz59MGLECNy7dw8//fQT/v33X4SHh8PY2BgAMGnSJCxYsACtW7eGv78/Ll++DH9/f6Slpam0/1evXqFVq1bo2rUrOnXqhFWrVqFr167YuHEjRo0ahcGDB6N79+5YuHAhOnbsiEePHsHKygrA+/dxrVq1oFAoMGzYMDg4OGDfvn3o168fkpKSMGrUKKV9zZs3DwYGBvjuu++QmJiIBQsWICAgQKf7WUlKoP+0oUOHCh++DHbs2CEAEGbNmqW0XceOHQWFQiFERUWJbRYWFkJgYGCO+0xNTc3RFhERIQAQ1q9fL7YdOXJEACAcOXLkkzWuW7dOACCcO3dOiI6OFoyMjIQRI0aItzdo0ECoWLGieP3evXsCAGHdunU57guAMG3aNPH6tGnTBADCwIEDxbaMjAyhZMmSgkKhEObNmye2v3r1SjAzM1N6zNmPoUSJEkJSUpLY/scffwgAhGXLlgmCIAhZWVlC2bJlBX9/fyErK0vpb+Xu7i40adIkR03dunX75N8l26hRowQAwokTJ8S2169fC+7u7kLp0qWFzMxMpcc/dOhQle4XgNCvXz8hLi5OeP78uXD+/HmhWbNmAgBh4cKF4nZLly4VAAi///672Pb27Vuhdu3agqWlpfh32bZtmwBAuH79uiAIgrBr1y7BxMREaNOmjdClSxfxdytXriy0a9dOvG5jY6NyzR/Kfm62bdum1F61alXB0dFRePnypdh2+fJlwcDAQOjVq5fYpu7zkL2/vC7Pnj0Tt83tPeLv7y94eHiI1xMSEgQrKyuhZs2awps3b5S2/fA11KBBgxzvrfT0dMHZ2Vno0KFDvnW7ubkJLVu2zPP2oKAgAYCwc+dOQRD+//1lbW0tPH/+XGnb7PfqvXv3lNo/fq+np6cL9vb2wldffSW8e/dO3C44OFgAIDRo0EClups2bSrExcUJcXFxwpUrV4SePXvmeI2fOHFCACBs3LhR6ff379+v1B4TEyMYGRkJ33zzjdJ206dPFwDk+r7/8LMr+3nYtGmT2Hbz5k0BgGBgYCCcPn1abD9w4ECOz6h+/foJxYsXF168eKG0/65duwo2NjbiayZ73xUqVBDS09PF7ZYtWyYAEK5cuZLv3+6/iKexSMnevXthaGiIESNGKLWPHTsWgiBg3759+d5H9pEM4P2ImJcvX6JMmTKwtbX95KkHVXh4eKBnz55Ys2YNnj17Vqj7+tCHHVgNDQ1Ro0YNCIKAfv36ie22trYoV64c7t69m+P3e/XqJX5DA4COHTuiePHi2Lt3LwDg0qVLuHPnDrp3746XL1/ixYsXePHiBVJSUtC4cWMcP34cWVlZSvc5ePBglWrfu3cvfHx8lE6xWFpaYuDAgbh//z6uX7+u2h8hF2vXroWDgwMcHR1Ro0YNhIWFYfz48RgzZozS/p2dndGtWzexzdjYGCNGjEBycjKOHTsG4P2RHQA4fvw4gPdHcL766is0adIEJ06cAAAkJCTg6tWr4rbA+7/7mTNn8PTp0wI/jmzPnj3DpUuX0Lt3b6UjEZUrV0aTJk3E5+tDqj4P2aZOnYpDhw7luHy4vw/fI4mJiXjx4gUaNGiAu3fvIjExEQBw6NAhvH79GhMnTszRP+TjU5CWlpZKfVeKFCkCHx+fXF+r6rK0tATw/ojVhzp06AAHB4cC3ef58+fx8uVLDBgwAEZG/3+CISAgIMdRmU85ePAgHBwc4ODgAG9vb2zYsAF9+vTBwoULxW22bdsGGxsbNGnSRHzfvXjxAtWrV4elpSWOHDkCAAgLC0NGRgaGDBmitI/hw4erXI+lpSW6du0qXi9XrhxsbW1RoUIF1KxZU2zP/jn7+REEAX/++Sdat24NQRCU6vT390diYmKOz84+ffoo9ZHKfs9o4jmXI4YdUvLgwQO4uLgo/eMG/n901oMHD/K9jzdv3mDq1Klin59ixYrBwcEBCQkJ4gd5Yfzwww/IyMjIt++OOkqVKqV03cbGBqampihWrFiO9o/P8wNA2bJlla4rFAqUKVNG7Ltw584dAEBgYKD44Zx9+fXXX5Genp7jb+Pu7q5S7Q8ePEC5cuVytKvznOWlbdu2OHToEPbs2SP2YUlNTYWBwf9/dDx48ABly5ZVastt/05OTihbtqwYbE6cOIF69eqhfv36ePr0Ke7evYvw8HBkZWUphZ0FCxbg6tWrcHV1hY+PD6ZPn17gD/TsWvL6e2UH0A+p+jxk8/b2hp+fX47Lh/+YwsPD4efnJ/YZcnBwwPfffw8A4usgu9+JKtMqlCxZMkcAKlq0aK6vVXUlJycDQI7PBHX/Lh/Kfh7KlCmj1G5kZJTjNOKn1KxZE4cOHcL+/fuxaNEi2Nra4tWrV0p/6zt37iAxMRGOjo453nvJycliR/a8arKzs1M5gOX2PNjY2MDV1TVHGwDx+YmLi0NCQgLWrFmTo8Y+ffoA+P8O99k+/szKrlETz7kcsc8Oadzw4cOxbt06jBo1CrVr14aNjQ0UCgW6du2a4+hFQXh4eKBHjx5Ys2YNJk6cmOP2vDreZmZm5nmfhoaGKrUBUKnfxseyH/fChQtRtWrVXLfJ/gad7cNv/1IpWbIk/Pz8AAAtWrRAsWLFMGzYMDRs2DBHZ2NVfP311wgLC8ObN29w4cIFTJ06FZUqVYKtrS1OnDiBGzduwNLSEl9++aX4O507d0a9evXw999/4+DBg1i4cCHmz5+Pv/76q1D9UVSl6echOjoajRs3Rvny5bFkyRK4urqiSJEi2Lt3L4KCggr0HtHka/VjV69eBZAzBOT2dynIe68wihUrJr4+/f39Ub58ebRq1QrLli0Tjz5mZWXB0dERGzduzPU+Cnp0Kjd5PQ/5PT/Zz3mPHj0QGBiY67bZfdpUvU9SxrBDStzc3BAaGorXr18rfZO7efOmeHu2vD7Ytm/fjsDAQKWRS2lpaUhISNBYnT/88AN+//13zJ8/P8dt2d9wPt5fYY5w5Cf7yE02QRAQFRUlfkBld+i1trYWP5w1xc3NDbdu3crRnttzVliDBg1CUFAQfvjhB7Rr1w4KhQJubm6IjIxEVlaW0tGd3PZfr149rFu3Dlu2bEFmZibq1KkDAwMDfP3112LYqVOnTo4P8uLFi2PIkCEYMmQInj9/jmrVqmH27Nlqh53sWvL6exUrVkwjQ/w/Zffu3UhPT8euXbuUvp1nn07Jlv2auXr1ao6g8bkkJyfj77//hqurq0pzb6n63st+HqKiotCwYUOxPSMjA/fv38/xj11VLVu2RIMGDTBnzhwMGjQIFhYW8PT0RGhoKOrWrfvJ4PphTR8etXr58qXWj5Y4ODjAysoKmZmZGv98oPd4GouUtGjRApmZmfjpp5+U2oOCgqBQKJT+uVhYWOQaYAwNDXN8u1ixYoVGv915enqiR48e+PnnnxETE6N0m7W1NYoVKyb2Dcn2v//9T2P7/9j69euV+jRs374dz549E/9e1atXh6enJxYtWiSeFvhQXFxcgffdokULnD17FhEREWJbSkoK1qxZg9KlS8PLy6vA9/0xIyMjjB07Fjdu3MDOnTvF/cfExGDr1q3idhkZGVixYgUsLS3FIeDA//crmD9/PipXriwezq9Xrx7CwsJw/vx5pVNYmZmZOU7vOTo6wsXFBenp6WrXX7x4cVStWhUhISFKr92rV6/i4MGDaNGihdr3qa7sIPfheyQxMRHr1q1T2q5p06awsrLC3Llzc4wG+hzf3t+8eYOePXsiPj4ekydPVmmqguyA9uF7LzMzE2vWrFHarkaNGrC3t8cvv/yCjIwMsX3jxo2FDhYTJkzAy5cv8csvvwB4f2QwMzMTP/74Y45tMzIyxNdB48aNYWRklGMKgI8/C7XB0NAQHTp0wJ9//ikeSftQYT4f6D0e2SElrVu3RsOGDTF58mTcv38fVapUwcGDB7Fz506MGjVKachx9erVERoaiiVLlsDFxQXu7u6oWbMmWrVqhQ0bNsDGxgZeXl6IiIhAaGgo7O3tNVrr5MmTsWHDBty6dUtpSCzwvsPxvHnz0L9/f9SoUQPHjx/H7du3Nbr/D9nZ2eHrr79Gnz59EBsbi6VLl6JMmTLixGYGBgb49ddf0bx5c1SsWBF9+vRBiRIl8OTJExw5cgTW1tbYvXt3gfY9ceJEbN68Gc2bN8eIESNgZ2eHkJAQ3Lt3D3/++WeOvjSF1bt3b0ydOhXz58/HN998g4EDB+Lnn39G7969ceHCBZQuXRrbt29HeHg4li5dqnSEsEyZMnB2dsatW7eUOn7Wr18fEyZMAAClsPP69WuULFkSHTt2RJUqVWBpaYnQ0FCcO3cuzzmP8rNw4UI0b94ctWvXRr9+/cSh5zY2NkpzMBXUiRMnch2qXLlyZVSuXBlNmzZFkSJF0Lp1awwaNAjJycn45Zdf4OjoqNTp3traGkFBQejfvz+++uorca6fy5cvIzU1Ncc8RoXx5MkT/P777wDeH825fv06tm3bhpiYGIwdOxaDBg1S6X4qVqyIWrVqYdKkSYiPj4ednR22bNmiFGiA9x2op0+fjuHDh6NRo0bo3Lkz7t+/j+DgYHh6ehZoDqhszZs3R6VKlbBkyRIMHToUDRo0wKBBgzB37lxcunQJTZs2hbGxMe7cuYNt27Zh2bJl6NixI5ycnDBy5EgsXrwYbdq0QbNmzXD58mXs27cPxYoVK1RNqpg3bx6OHDmCmjVrYsCAAfDy8kJ8fDwuXryI0NBQxMfHa3X/sifNIDDSFR8PPReE98OWR48eLbi4uAjGxsZC2bJlhYULFyoNdxWE98Mq69evL5iZmSkNzXz16pXQp08foVixYoKlpaXg7+8v3Lx5U3Bzc8t3+GZuPhx6/rHAwEABgNLQc0F4P7S3X79+go2NjWBlZSV07txZeP78eZ5Dz+Pi4nLcr4WFRY79fTzMPfsxbN68WZg0aZLg6OgomJmZCS1bthQePHiQ4/f//fdfoX379oK9vb1gYmIiuLm5CZ07dxbCwsLyrelToqOjhY4dOwq2traCqamp4OPjI/zzzz85toOaQ8/z2jZ7OG72cxcbGys+50WKFBG8vb1zHfovCILQqVMnAYCwdetWse3t27eCubm5UKRIEaVh1unp6cK4ceOEKlWqCFZWVoKFhYVQpUoV4X//+1++9ec19FwQBCE0NFSoW7euYGZmJlhbWwutW7cWh8RnU/d5yG/o+Yevu127dgmVK1cWTE1NhdKlSwvz588Xfvvtt1yHbe/atUuoU6eOWKuPj4+wefNm8faPX5PZAgMDBTc3t3zrdnNzE2tUKBSCtbW1ULFiRWHAgAHCmTNncmyfPfT8w+kHPhQdHS34+fkJJiYmgpOTk/D9998Lhw4dyvW9vnz5csHNzU0wMTERfHx8hPDwcKF69epCs2bNVKo7ryHz2UPYP3wNrlmzRqhevbpgZmYmWFlZCd7e3sL48eOFp0+fittkZGQIU6ZMEZydnQUzMzOhUaNGwo0bNwR7e3th8ODB4nZ5DT3P7XnIq87c3l+xsbHC0KFDBVdXV8HY2FhwdnYWGjduLKxZsybHvj9+XX9qyg0SBIUgsDcTERFJLysrCw4ODmjfvr14GkpqCQkJKFq0KGbNmoXJkydLXQ4VEPvsEBHRZ5eWlpaj79H69esRHx9f4OUiCuvNmzc52pYuXQoAktVEmsEjO0RE9NkdPXoUo0ePRqdOnWBvb4+LFy9i7dq1qFChAi5cuCDJiuLBwcEIDg5GixYtYGlpiZMnT2Lz5s1o2rQpDhw48NnrIc1hB2UiIvrsSpcuDVdXVyxfvlzszNyrVy/MmzdPkqADvO9EbmRkhAULFiApKUnstDxr1ixJ6iHN4ZEdIiIikjX22SEiIiJZY9ghIiIiWWOfHbwf7vj06VNYWVlpfeIoIiIi0gxBEPD69Wu4uLh8cgJVhh0AT58+zbEqLREREemHR48eoWTJknnezrADiNPZP3r0CNbW1hJXQ0RERKpISkqCq6ur0rI0uWHYwf+v3m1tbc2wQ0REpGfy64LCDspEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQka1z1vIDi4uKQlJSk1X1YW1vDwcFBq/sgIiKSO4adAoiLi0PfgYPx+k2aVvdjZWaK39asZuAhIiIqBIadAkhKSsLrN2nw7fkt7IuX1Mo+Xj57jKMbViEpKYlhh4iIqBAYdgrBvnhJOLu5S11GoWj7dBxPxRERkdQYdv7DPsfpOJ6KIyIiqTHs/Idp+3QcT8UREZEuYNghWZyOIyIiygvn2SEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIllj2CEiIiJZY9ghIiIiWWPYISIiIlmTNOzMnTsXX331FaysrODo6IhvvvkGt27dUtomLS0NQ4cOhb29PSwtLdGhQwfExsYqbfPw4UO0bNkS5ubmcHR0xLhx45CRkfE5HwoRERHpKEnDzrFjxzB06FCcPn0ahw4dwrt379C0aVOkpKSI24wePRq7d+/Gtm3bcOzYMTx9+hTt27cXb8/MzETLli3x9u1bnDp1CiEhIQgODsbUqVOleEhERESkY4yk3Pn+/fuVrgcHB8PR0REXLlxA/fr1kZiYiLVr12LTpk1o1KgRAGDdunWoUKECTp8+jVq1auHgwYO4fv06QkND4eTkhKpVq+LHH3/EhAkTMH36dBQpUkSKh0ZEREQ6Qqf67CQmJgIA7OzsAAAXLlzAu3fv4OfnJ25Tvnx5lCpVChEREQCAiIgIeHt7w8nJSdzG398fSUlJuHbtWq77SU9PR1JSktKFiIiI5Elnwk5WVhZGjRqFunXrolKlSgCAmJgYFClSBLa2tkrbOjk5ISYmRtzmw6CTfXv2bbmZO3cubGxsxIurq6uGHw0RERHpCp0JO0OHDsXVq1exZcsWre9r0qRJSExMFC+PHj3S+j6JiIhIGpL22ck2bNgw/PPPPzh+/DhKliwptjs7O+Pt27dISEhQOroTGxsLZ2dncZuzZ88q3V/2aK3sbT5mYmICExMTDT8KIiIi0kWSHtkRBAHDhg3D33//jcOHD8Pd3V3p9urVq8PY2BhhYWFi261bt/Dw4UPUrl0bAFC7dm1cuXIFz58/F7c5dOgQrK2t4eXl9XkeCBEREeksSY/sDB06FJs2bcLOnTthZWUl9rGxsbGBmZkZbGxs0K9fP4wZMwZ2dnawtrbG8OHDUbt2bdSqVQsA0LRpU3h5eaFnz55YsGABYmJi8MMPP2Do0KE8ekNERETShp1Vq1YBAHx9fZXa161bh969ewMAgoKCYGBggA4dOiA9PR3+/v743//+J25raGiIf/75B99++y1q164NCwsLBAYGYubMmZ/rYRAREZEOkzTsCIKQ7zampqZYuXIlVq5cmec2bm5u2Lt3ryZLIyIiIpnQmdFYRERERNrAsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyxrBDREREssawQ0RERLLGsENERESyJunaWESaEBcXh6SkJK3uw9raGg4ODlrdBxERaQfDDum1uLg49B04GK/fpGl1P1ZmpvhtzWoGHiIiPcSwQ3otKSkJr9+kwbfnt7AvXlIr+3j57DGObliFpKQkhh0iIj3EsEOyYF+8JJzd3KUuo1B4Oo6ISDsYdoh0AE/HERFpD8MOkQ7g6TgiIu1h2CHSIXI4HUdEpGs4zw4RERHJGsMOERERyRpPYxGRxnBEGRHpIoYdItIIOY0ok0to0/bjYPAkfcGwQ0QaIZcRZXIJbZ/jcXAqA9IXDDtEpFH6PqJMLqFN24+DUxmQPmHYISLKhb6HtmxyeRxEhcHRWERERCRrPLJDREQ6i53FVccO43lj2CEiIp3EzuLqYYfxvDHsEBGRTmJncdWxw/inMewQEZFOk0sna7k8Dn3EDspEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGuFDjtJSUnYsWMHbty4oYl6iIiIiDRK7bDTuXNn/PTTTwCAN2/eoEaNGujcuTMqV66MP//8U+MFEhERERWG2mHn+PHjqFevHgDg77//hiAISEhIwPLlyzFr1iyNF0hERERUGGqHncTERNjZ2QEA9u/fjw4dOsDc3BwtW7bEnTt3NF4gERERUWGoHXZcXV0RERGBlJQU7N+/H02bNgUAvHr1CqamphovkIiIiKgwjNT9hVGjRiEgIACWlpZwc3ODr68vgPent7y9vTVdHxEREVGhqB12hgwZAh8fHzx69AhNmjSBgcH7g0MeHh7ss0NEREQ6R+3TWHfv3kWNGjXQrl07WFpaiu0tW7ZE3bp11bqv48ePo3Xr1nBxcYFCocCOHTuUbu/duzcUCoXSpVmzZkrbxMfHIyAgANbW1rC1tUW/fv2QnJys7sMiIiIimVI77JQpUwalSpVCz549sXbtWkRFRRV45ykpKahSpQpWrlyZ5zbNmjXDs2fPxMvmzZuVbg8ICMC1a9dw6NAh/PPPPzh+/DgGDhxY4JqIiIhIXtQ+jfXo0SMcPXoUx44dw4IFCzBgwAC4uLigQYMGaNiwIfr376/yfTVv3hzNmzf/5DYmJiZwdnbO9bYbN25g//79OHfuHGrUqAEAWLFiBVq0aIFFixbBxcVF9QdGREREsqT2kZ0SJUogICAAa9aswa1bt3Dr1i34+fnhjz/+wKBBgzRe4NGjR+Ho6Ihy5crh22+/xcuXL8XbIiIiYGtrKwYdAPDz84OBgQHOnDmT532mp6cjKSlJ6UJERETypPaRndTUVJw8eRJHjx7F0aNH8e+//6J8+fIYNmyYODJLU5o1a4b27dvD3d0d0dHR+P7779G8eXNERETA0NAQMTExcHR0VPodIyMj2NnZISYmJs/7nTt3LmbMmKHRWomIiEg3qR12bG1tUbRoUQQEBGDixImoV68eihYtqo3a0LVrV/Fnb29vVK5cGZ6enjh69CgaN25c4PudNGkSxowZI15PSkqCq6troWolIiIi3aR22GnRogVOnjyJLVu2ICYmBjExMfD19cUXX3yhjfqUeHh4oFixYoiKikLjxo3h7OyM58+fK22TkZGB+Pj4PPv5AO/7AZmYmGi7XCIiItmIi4vTercPa2trODg4aPx+1Q472cPDIyMjcezYMRw8eBBTpkyBkZERfH19sXHjRk3XKHr8+DFevnyJ4sWLAwBq166NhIQEXLhwAdWrVwcAHD58GFlZWahZs6bW6iAiIvoviYuLQ9+Bg/H6TZpW92NlZorf1qzWeOBRO+xk8/b2RkZGBt6+fYu0tDQcOHAAW7duVSvsJCcnKw1dv3fvHi5dugQ7OzvY2dlhxowZ6NChA5ydnREdHY3x48ejTJky8Pf3BwBUqFABzZo1w4ABA7B69Wq8e/cOw4YNQ9euXTkSi4iISEOSkpLw+k0afHt+C/viJbWyj5fPHuPohlVISkqSPuwsWbIER48excmTJ/H69WtUqVIF9evXx8CBA8XV0FV1/vx5NGzYULye3Y8mMDAQq1atQmRkJEJCQpCQkAAXFxc0bdoUP/74o9IpqI0bN2LYsGFo3LgxDAwM0KFDByxfvlzdh0VERET5sC9eEs5u7lKXoTa1w87mzZvRoEEDMdzY2NgUeOe+vr4QBCHP2w8cOJDvfdjZ2WHTpk0FroGIiIjkTe2wc+7cOW3UQURERKQVBeqzk5CQgLVr1+LGjRsAAC8vL/Tr169QR3mIiIiItEHtGZTPnz8PT09PBAUFIT4+HvHx8QgKCoKnpycuXryojRqJiIiICkztIzujR49GmzZt8Msvv8DI6P2vZ2RkoH///hg1ahSOHz+u8SKJiIiICkrtsHP+/HmloAO8X6Jh/PjxSmtUEREREekCtU9jWVtb4+HDhznaHz16BCsrK40URURERKQpaoedLl26oF+/fti6dSsePXqER48eYcuWLejfvz+6deumjRqJiIiICkzt01iLFi2CQqFAr169kJGRAQAwNjbGt99+i3nz5mm8QCIiIqLCUDvsFClSBMuWLcPcuXMRHR0NAPD09IS5uTnevHmj8QKJiIiICkPt01jZzM3N4e3tDW9vbxgaGmLJkiVwd9e/KaSJiIhI3lQOO+np6Zg0aRJq1KiBOnXqiKufr1u3Du7u7ggKCsLo0aO1VScRERFRgah8Gmvq1Kn4+eef4efnh1OnTqFTp07o06cPTp8+jSVLlqBTp04wNDTUZq1EREREalM57Gzbtg3r169HmzZtcPXqVVSuXBkZGRm4fPkyFAqFNmskIiIiKjCVT2M9fvwY1atXBwBUqlQJJiYmGD16NIMOERER6TSVw05mZiaKFCkiXjcyMoKlpaVWiiIiIiLSFJVPYwmCgN69e8PExAQAkJaWhsGDB8PCwkJpu7/++kuzFRIREREVgsphJzAwUOl6jx49NF4MERERkaapHHbWrVunzTqIiIiItKLAkwoSERER6QOGHSIiIpI1hh0iIiKSNYYdIiIikjWVwk61atXw6tUrAMDMmTORmpqq1aKIiIiINEWlsHPjxg2kpKQAAGbMmIHk5GStFkVERESkKSoNPa9atSr69OmDr7/+GoIgYNGiRXnOnjx16lSNFkhERERUGCqFneDgYEybNg3//PMPFAoF9u3bByOjnL+qUCgYdoiIiEinqBR2ypUrhy1btgAADAwMEBYWBkdHR60WRkRERKQJKs+gnC0rK0sbdRARERFphdphBwCio6OxdOlS3LhxAwDg5eWFkSNHwtPTU6PFERERERWW2vPsHDhwAF5eXjh79iwqV66MypUr48yZM6hYsSIOHTqkjRqJiIiICkztIzsTJ07E6NGjMW/evBztEyZMQJMmTTRWHBEREVFhqX1k58aNG+jXr1+O9r59++L69esaKYqIiIhIU9QOOw4ODrh06VKO9kuXLnGEFhEREekctU9jDRgwAAMHDsTdu3dRp04dAEB4eDjmz5+PMWPGaLxAIiIiosJQO+xMmTIFVlZWWLx4MSZNmgQAcHFxwfTp0zFixAiNF0hERERUGGqHHYVCgdGjR2P06NF4/fo1AMDKykrjhRERERFpQoHm2cnGkENERES6Tu0OykRERET6hGGHiIiIZI1hh4iIiGRNrbDz7t07NG7cGHfu3NFWPUREREQapVbYMTY2RmRkpLZqISIiItI4tU9j9ejRA2vXrtVGLUREREQap/bQ84yMDPz2228IDQ1F9erVYWFhoXT7kiVLNFYcERERUWGpHXauXr2KatWqAQBu376tdJtCodBMVUREREQaonbYOXLkiDbqICIiItKKAg89j4qKwoEDB/DmzRsAgCAIGiuKiIiISFPUDjsvX75E48aN8cUXX6BFixZ49uwZAKBfv34YO3asxgskIiIiKgy1w87o0aNhbGyMhw8fwtzcXGzv0qUL9u/fr9HiiIiIiApL7T47Bw8exIEDB1CyZEml9rJly+LBgwcaK4yIiIhIE9Q+spOSkqJ0RCdbfHw8TExMNFIUERERkaaoHXbq1auH9evXi9cVCgWysrKwYMECNGzYUKPFERERERWW2qexFixYgMaNG+P8+fN4+/Ytxo8fj2vXriE+Ph7h4eHaqJGIiIiowNQ+slOpUiXcvn0bX3/9Ndq2bYuUlBS0b98e//77Lzw9PbVRIxEREVGBqX1kBwBsbGwwefJkTddCREREpHEFCjuvXr3C2rVrcePGDQCAl5cX+vTpAzs7O40WR0RERFRYap/GOn78OEqXLo3ly5fj1atXePXqFZYvXw53d3ccP35cGzUSERERFZjaR3aGDh2KLl26YNWqVTA0NAQAZGZmYsiQIRg6dCiuXLmi8SKJiIiICkrtIztRUVEYO3asGHQAwNDQEGPGjEFUVJRGiyMiIiIqLLXDTrVq1cS+Oh+6ceMGqlSpopGiiIiIiDRFpdNYkZGR4s8jRozAyJEjERUVhVq1agEATp8+jZUrV2LevHnaqZKIiIiogFQKO1WrVoVCoYAgCGLb+PHjc2zXvXt3dOnSRXPVERERERWSSmHn3r172q6DiIiISCtUCjtubm7aroOIiIhIKwo0qeDTp09x8uRJPH/+HFlZWUq3jRgxQiOFEREREWmC2qOxgoOD4e7ujn79+mHRokUICgoSL0uXLlXrvo4fP47WrVvDxcUFCoUCO3bsULpdEARMnToVxYsXh5mZGfz8/HDnzh2lbeLj4xEQEABra2vY2tqiX79+SE5OVvdhERERkUypHXamTJmCqVOnIjExEffv38e9e/fEy927d9W6r5SUFFSpUgUrV67M9fYFCxZg+fLlWL16Nc6cOQMLCwv4+/sjLS1N3CYgIADXrl3DoUOH8M8//+D48eMYOHCgug+LiIiIZErt01ipqano2rUrDAzUzkk5NG/eHM2bN8/1NkEQsHTpUvzwww9o27YtAGD9+vVwcnLCjh070LVrV9y4cQP79+/HuXPnUKNGDQDAihUr0KJFCyxatAguLi6FrpGIiIj0m9qJpV+/fti2bZs2alFy7949xMTEwM/PT2yzsbFBzZo1ERERAQCIiIiAra2tGHQAwM/PDwYGBjhz5kye952eno6kpCSlCxEREcmT2kd25s6di1atWmH//v3w9vaGsbGx0u1LlizRSGExMTEAACcnJ6V2Jycn8baYmBg4Ojoq3W5kZAQ7Oztxm9zMnTsXM2bM0EidREREpNsKFHYOHDiAcuXKAQAUCoV424c/67JJkyZhzJgx4vWkpCS4urpKWBERERFpi9phZ/Hixfjtt9/Qu3dvLZTz/5ydnQEAsbGxKF68uNgeGxuLqlWrits8f/5c6fcyMjIQHx8v/n5uTExMYGJiovmiiYiISOeo3WfHxMQEdevW1UYtStzd3eHs7IywsDCxLSkpCWfOnEHt2rUBALVr10ZCQgIuXLggbnP48GFkZWWhZs2aWq+RiIiIdJ/aYWfkyJFYsWKFRnaenJyMS5cu4dKlSwDed0q+dOkSHj58CIVCgVGjRmHWrFnYtWsXrly5gl69esHFxQXffPMNAKBChQpo1qwZBgwYgLNnzyI8PBzDhg1D165dORKLiIiIABTgNNbZs2dx+PBh/PPPP6hYsWKODsp//fWXyvd1/vx5NGzYULye3Y8mMDAQwcHBGD9+PFJSUjBw4EAkJCTg66+/xv79+2Fqair+zsaNGzFs2DA0btwYBgYG6NChA5YvX67uwyIiIiKZUjvs2Nraon379hrZua+vr9JK6h9TKBSYOXMmZs6cmec2dnZ22LRpk0bqISIiIvlRO+ysW7dOG3UQERERaUXhp0EmIiIi0mFqH9lxd3f/5Hw66q6PRURERKRNaoedUaNGKV1/9+4d/v33X+zfvx/jxo3TVF1EREREGqF22Bk5cmSu7StXrsT58+cLXRARERGRJmmsz07z5s3x559/auruiIiIiDRCY2Fn+/btsLOz09TdEREREWmE2qexvvzyS6UOyoIgICYmBnFxcfjf//6n0eKIiIiICkvtsJO9VEM2AwMDODg4wNfXF+XLl9dUXUREREQaoXbYmTZtmjbqICIiItIKTipIREREsqbykR0DA4NPTiYIvF/LKiMjo9BFEREREWmKymHn77//zvO2iIgILF++HFlZWRopioiIiEhTVA47bdu2zdF269YtTJw4Ebt370ZAQMAnVycnIiIikkKB+uw8ffoUAwYMgLe3NzIyMnDp0iWEhITAzc1N0/URERERFYpaYScxMRETJkxAmTJlcO3aNYSFhWH37t2oVKmStuojIiIiKhSVT2MtWLAA8+fPh7OzMzZv3pzraS0iIiIiXaNy2Jk4cSLMzMxQpkwZhISEICQkJNft/vrrL40VR0RERFRYKoedXr165Tv0nIiIiEjXqBx2goODtVgGERERkXZwBmUiIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNYYdIiIikjWGHSIiIpI1hh0iIiKSNZ0OO9OnT4dCoVC6lC9fXrw9LS0NQ4cOhb29PSwtLdGhQwfExsZKWDERERHpGp0OOwBQsWJFPHv2TLycPHlSvG306NHYvXs3tm3bhmPHjuHp06do3769hNUSERGRrjGSuoD8GBkZwdnZOUd7YmIi1q5di02bNqFRo0YAgHXr1qFChQo4ffo0atWq9blLJSIiIh2k80d27ty5AxcXF3h4eCAgIAAPHz4EAFy4cAHv3r2Dn5+fuG358uVRqlQpREREfPI+09PTkZSUpHQhIiIiedLpsFOzZk0EBwdj//79WLVqFe7du4d69erh9evXiImJQZEiRWBra6v0O05OToiJifnk/c6dOxc2NjbixdXVVYuPgoiIiKSk06exmjdvLv5cuXJl1KxZE25ubvjjjz9gZmZW4PudNGkSxowZI15PSkpi4CEiIpIpnT6y8zFbW1t88cUXiIqKgrOzM96+fYuEhASlbWJjY3Pt4/MhExMTWFtbK12IiIhInvQq7CQnJyM6OhrFixdH9erVYWxsjLCwMPH2W7du4eHDh6hdu7aEVRIREZEu0enTWN999x1at24NNzc3PH36FNOmTYOhoSG6desGGxsb9OvXD2PGjIGdnR2sra0xfPhw1K5dmyOxiIiISKTTYefx48fo1q0bXr58CQcHB3z99dc4ffo0HBwcAABBQUEwMDBAhw4dkJ6eDn9/f/zvf/+TuGoiIiLSJToddrZs2fLJ201NTbFy5UqsXLnyM1VERERE+kav+uwQERERqYthh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGSNYYeIiIhkjWGHiIiIZI1hh4iIiGRNNmFn5cqVKF26NExNTVGzZk2cPXtW6pKIiIhIB8gi7GzduhVjxozBtGnTcPHiRVSpUgX+/v54/vy51KURERGRxGQRdpYsWYIBAwagT58+8PLywurVq2Fubo7ffvtN6tKIiIhIYkZSF1BYb9++xYULFzBp0iSxzcDAAH5+foiIiMj1d9LT05Geni5eT0xMBAAkJSWptM/Xr18jI+MdnkbfxpuU5EJUn7dXMU+RkfEOr1+/VrkudWn7ccjhMQB8HKqSw2MA+DhUJYfHAPBxqEpXH0P2doIgfHpDQc89efJEACCcOnVKqX3cuHGCj49Prr8zbdo0AQAvvPDCCy+88CKDy6NHjz6ZFfT+yE5BTJo0CWPGjBGvZ2VlIT4+Hvb29lAoFBrfX1JSElxdXfHo0SNYW1tr/P4/Fz4O3SGHxwDI43HI4TEAfBy6RA6PAfg8j0MQBLx+/RouLi6f3E7vw06xYsVgaGiI2NhYpfbY2Fg4Ozvn+jsmJiYwMTFRarO1tdVWiSJra2u9fuFm4+PQHXJ4DIA8HoccHgPAx6FL5PAYAO0/Dhsbm3y30fsOykWKFEH16tURFhYmtmVlZSEsLAy1a9eWsDIiIiLSBXp/ZAcAxowZg8DAQNSoUQM+Pj5YunQpUlJS0KdPH6lLIyIiIonJIux06dIFcXFxmDp1KmJiYlC1alXs378fTk5OUpcG4P1ps2nTpuU4daZv+Dh0hxweAyCPxyGHxwDwcegSOTwGQLceh0IQ8huvRURERKS/9L7PDhEREdGnMOwQERGRrDHsEBERkawx7BAREZGsMewQERGRrDHsEBERkazJYp4dXZWQkICzZ8/i+fPnyMrKUrqtV69eElVFRJqQlZWFqKioXN/f9evXl6gq0ndv377N9TVVqlQpiSqSB86zoyW7d+9GQEAAkpOTYW1trbTAqEKhQHx8vITVqe/t27e4d+8ePD09YWTEjPw57dq1S+Vt27Rpo8VKCqZ9+/Yqb/vXX39psRLNOX36NLp3744HDx7g449QhUKBzMxMiSpTX2ZmJnbs2IEbN24AACpWrIg2bdrA0NBQ4so+LSkpSeVt9WF9qTt37qBv3744deqUUrsgCHr3mgKA1NRUPHz4EG/fvlVqr1y5siT1MOxoyRdffIEWLVpgzpw5MDc3l7qcAktNTcXw4cMREhICALh9+zY8PDwwfPhwlChRAhMnTpS4wrwVLVpU5VXsdTl8GhiodrZZVz8Q1Vm2Zd26dVqsRHOqVq2KL774AjNmzEDx4sVzvM5UWZhQF0RFRaFly5Z4/PgxypUrBwC4desWXF1dsWfPHnh6ekpcYd4MDAzyfX/rU1CoW7cujIyMMHHixFxfU1WqVJGoMvXExcWhT58+2LdvX663S/VcMOxoiYWFBa5cuQIPDw+pSymUkSNHIjw8HEuXLkWzZs0QGRkJDw8P7Ny5E9OnT8e///4rdYl5yg5oqggMDNRiJSQ3FhYWuHz5MsqUKSN1KYXSokULCIKAjRs3ws7ODgDw8uVL9OjRAwYGBtizZ4/EFebt2LFjKm/boEEDLVaiGRYWFrhw4QLKly8vdSmFEhAQgAcPHmDp0qXw9fXF33//jdjYWMyaNQuLFy9Gy5YtJamL5yO0xN/fH+fPn9f7sLNjxw5s3boVtWrVUvqmUbFiRURHR0tYWf4YYHRXXFwcbt26BQAoV64cHBwcJK5IPTVr1kRUVJTeh51jx47h9OnTYtABAHt7e8ybNw9169aVsLL86UOAUYeXlxdevHghdRmFdvjwYezcuRM1atSAgYEB3Nzc0KRJE1hbW2Pu3LkMO3LTsmVLjBs3DtevX4e3tzeMjY2VbtfFvhW5iYuLg6OjY472lJQUlU8RSSUpKUk8V5/f+X19OKef7dixY1i0aJHYx8LLywvjxo1DvXr1JK4sfykpKRg+fDjWr18vdsA0NDREr169sGLFCr055Tt8+HCMHTsWMTExub6/peqXoC4TExO8fv06R3tycjKKFCkiQUUFl5CQgLVr1yr1Perbt6/enFKcP38+xo8fjzlz5uT6mtKXz6iUlBTxf0bRokURFxeHL774At7e3rh48aJ0hQmkFQqFIs+LgYGB1OWprF69esLy5csFQRAES0tL4e7du4IgCMKwYcMEf39/KUvLl4GBgRAbGysIgiD+3T++6NvzsWHDBsHIyEjo3LmzsGzZMmHZsmVC586dBWNjY2Hjxo1Sl5evgQMHCh4eHsLevXuFxMREITExUdizZ4/g6ekpDB48WOryVJbX+1rfXk89e/YUKlasKJw+fVrIysoSsrKyhIiICKFSpUpCYGCg1OWp7Ny5c4KdnZ1QokQJoV27dkK7du2EkiVLCvb29sKFCxekLk8lH76O9PkzqkaNGsL+/fsFQRCE1q1bCz179hQeP34sjB8/XvDw8JCsLvbZoU86efIkmjdvjh49eiA4OBiDBg3C9evXcerUKRw7dgzVq1eXusQ8HTt2TOz0l9/5fX05JF6hQgUMHDgQo0ePVmpfsmQJfvnlF/Fbra4qVqwYtm/fDl9fX6X2I0eOoHPnzoiLi5OmMDU9ePDgk7e7ubl9pkoKJyEhAYGBgdi9e7d4JCEjIwNt2rRBcHCw3hwVqVevHsqUKYNffvlFHC2akZGB/v374+7duzh+/LjEFeZPLp9Rv//+OzIyMtC7d29cuHABzZo1Q3x8PIoUKYLg4GB06dJFkroYdihf0dHRmDdvHi5fvozk5GRUq1YNEyZMgLe3t9SlqSQjIwNz5sxB3759UbJkSanLKRQTExNcu3YtR1+RqKgoVKpUCWlpaRJVphpzc3NcuHABFSpUUGq/du0afHx8kJKSIlFl6klJSYGFhYXUZWjMnTt3cOPGDSgUClSoUEHv+iKZmZnh33//zdG59/r166hRowZSU1MlqoxSU1Nx8+ZNlCpVCsWKFZOsDvbZ0aDly5dj4MCBMDU1xfLlyz+57YgRIz5TVYXn6emJX375ReoyCszIyAgLFy6UxUSOrq6uCAsLy/HPKDQ0FK6urhJVpbratWtj2rRpWL9+PUxNTQEAb968wYwZM1C7dm2Jq1Odk5MTOnfujL59++Lrr7+WupxCK1u2rPia0vW+eLmxtrbGw4cPc4SdR48ewcrKSqKq8hcZGYlKlSrBwMAAkZGRn9xWX/qBnTx5Uuk9YW5ujmrVqklY0Xs8sqNB7u7uOH/+POzt7eHu7p7ndgqFAnfv3v2MlRWOHGaKbdu2Ldq3b6/3I7RWrVqFUaNGoW/fvqhTpw4AIDw8HMHBwVi2bBkGDRokcYWfduXKFTRr1gzp6enivCGXL1+GqakpDhw4gIoVK0pcoWp27NiB4OBg7N27F6VLl0bfvn3Rq1cvuLi4SF2a2tauXYugoCDcuXMHwPvgM2rUKPTv31/iylQ3YsQI/P3331i0aJHS+2LcuHHo0KEDli5dKm2BeTAwMEBMTAwcHR3FeYNy+5esL3MFAUCRIkVQokQJdOvWDT169ICXl5fUJQFg2KF8yGWm2NWrV2PGjBkICAhA9erVc5yC0JfRcQDw999/Y/HixWL/nAoVKmDcuHFo27atxJWpJjU1FRs3bsTNmzcBvK8/ICAAZmZmElemvri4OGzYsAHBwcG4ceMG/P390bdvX7Rp00YvZhqfOnUqlixZguHDh4tH1iIiIvDTTz9h9OjRmDlzpsQVqubt27cYN24cVq9ejYyMDACAsbExvv32W8ybNw8mJiYSV5i7Bw8eoFSpUlAoFLLpB/bixQts2bIFmzdvRkREBCpXroyAgAB069ZN0m4EDDv0SXKZKfZTsxDrU2jTZ+/evUP58uXxzz//5OizIwcrVqzAuHHj8PbtWxQrVgyDBw/GxIkTdXo4vYODA5YvX45u3boptW/evBnDhw/Xu3lfUlNTxfm/PD09dfpv/19w7949bNq0CZs3b8bNmzdRv359HD58WJJaGHY0aMyYMSpvu2TJEi1WojlymSlWLh49egSFQiF+Qzp79iw2bdoELy8vDBw4UOLq8leiRAmEhobKJuzExsYiJCQEwcHBePDgAdq1a4d+/frh8ePHmD9/PlxcXHDw4EGpy8yTra0tzp07h7Jlyyq13759Gz4+PkhISJCmsP+op0+f4uTJk7l2GdCnfp4fyszMxL59+zBlyhRERkZK9sVS94+z6hFVl07Qpw6AcpkpVi66d++OgQMHomfPnoiJiYGfnx8qVaqEjRs3IiYmBlOnTpW6xE8aOnQo5s+fj19//VUvTvPk5a+//sK6detw4MABeHl5YciQIejRowdsbW3FberUqaPzoa5nz55YtWpVji9fa9asQUBAgERVqS8lJQXz5s1DWFhYrkFBH/pIZk/tUaRIEdjb2+dYPFrfwk54eDg2btyI7du3Iy0tDW3btsXcuXMlq0d/P2100JEjR6QuQePkMlMsAISFhSEoKEipr8uoUaPg5+cncWWqu3r1Knx8fAAAf/zxB7y9vREeHo6DBw9i8ODBOh92zp07h7CwMBw8eBDe3t45+k7py6rnffr0QdeuXREeHo6vvvoq121cXFwwefLkz1xZ/j48Aq1QKPDrr7/i4MGDqFWrFgDgzJkzePjwoV6NXuzfvz+OHTuGnj175nq6XR9MmTIFU6dOxaRJk1Re/FcXTZo0CVu2bMHTp0/RpEkTLFu2DG3btpX8lCJPY9En5famyx4xoE99Xf73v/9h5MiR6Nixo9gR8/Tp09i+fTuCgoIwdOhQiStUjaWlJa5evYrSpUujTZs2qFu3LiZMmICHDx+iXLlyePPmjdQlflJ+K6Dry6rnqampkn94F1TDhg1V2k6hUEjWv0Jdtra22LNnj86v5/Up9vb2OHv2rE6vNK+KunXrIiAgAJ07d5Z0Xp2PMexoScOGDT/57UJfPkTkMkKgZMmSmDhxIoYNG6bUvnLlSsyZMwdPnjyRqDL11KxZEw0bNkTLli3RtGlTnD59GlWqVMHp06fRsWNHPH78WOoS/xMuXrwIY2NjcWLNnTt3Yt26dfDy8sL06dP1bl0pfefu7o69e/fq/GnDTxk/fjzs7OwwceJEqUuRJYYdLfl4Ov93797h0qVLuHr1KgIDA7Fs2TKJKvtvsrS0xKVLl3L0Pbpz5w6+/PJLJCcnS1SZeo4ePYp27dohKSkJgYGB+O233wAA33//PW7evKkXp4EyMjJw9OhRREdHo3v37rCyssLTp09hbW0NS0tLqctTyVdffYWJEyeiQ4cOuHv3LipWrIh27drh3LlzaNmypc7O65KXqKgoREdHo379+jAzMxOP3OqL33//HTt37kRISIjeHnHLzMxEq1at8ObNm1y7DOjyoJZdu3ahefPmMDY2xq5duz65rVTTfDDsfGbTp09HcnIyFi1aJHUparl+/ToePnyIt2/fKrXry/w03bt3x5dffolx48YptS9atAjnz5/Hli1bJKpMfZmZmUhKSkLRokXFtvv378Pc3DzXFep1yYMHD9CsWTM8fPgQ6enpuH37Njw8PDBy5Eikp6dj9erVUpeoEhsbG1y8eBGenp6YP38+Dh8+jAMHDiA8PBxdu3bFo0ePpC5RJS9fvkTnzp1x5MgRKBQK3LlzBx4eHujbty+KFi2KxYsXS12iSr788ktER0dDEASULl06R1CQdLVtFc2aNQtTp05FuXLl4OTklKODsi6fDfh4csS8SNn1gR2UP7MePXrAx8dHb8LO3bt30a5dO1y5ckVpds/sN6K+9Nnx8vLC7NmzcfToUaU+O+Hh4Rg7dqzS8h66PurB0NBQKegAQOnSpaUpRk0jR45EjRo1cPnyZdjb24vt7dq1w4ABAySsTD2CIIgjfkJDQ9GqVSsA75fz0Ke5aUaPHg1jY2M8fPhQ6RRQly5dMGbMGL0JO998843UJRTa4sWL8dtvv6F3795Sl6K2D0e/fTwSTlcw7HxmERER4ppA+mDkyJFwd3dHWFgY3N3dcfbsWbx8+RJjx47Vm8AGvJ8Sv2jRorh+/TquX78uttva2mLt2rXidV0c4lmtWjWEhYWhaNGi+PLLLz95ekHXv8GeOHECp06dytGnpXTp0nrTbwoAatSogVmzZsHPzw/Hjh3DqlWrALyfRM3JyUni6lR38OBBHDhwIMfMtmXLls23v54umTZtmtQlFJqJiYled7AG3nfXaNasGVavXp1j7iapMexoSfv27ZWuC4KAZ8+e4fz585gyZYpEVakvIiIChw8fRrFixWBgYAADAwN8/fXXmDt3LkaMGKHy3EJSu3fvntQlFFjbtm3F6e7btm2rV30pPpaVlZXr0cDHjx/r9IKNH1u6dCkCAgKwY8cOTJ48WewLtn37dnFtJn2QkpKSax+X+Ph4nV1iQa5GjhyJFStW5LuItC4zNjbOd0FTqbDPjpZ8PMTWwMAADg4OaNSoEZo2bSpRVeorWrQoLl68CHd3d3h6euLXX39Fw4YNER0dDW9vb6SmpkpdIumRLl26wMbGBmvWrIGVlRUiIyPh4OCAtm3bolSpUnoz9DwvaWlpMDQ0zNFnRFe1aNEC1atXx48//ig+H25ubujatSuysrKwfft2qUvMk52dHW7fvo1ixYqhaNGin/wSEB8f/xkrK5h27drh8OHDsLe3R8WKFXO8hvRh8AHw/tSoiYkJ5s2bJ3UpSnhkR0v0/UM7W6VKlXD58mW4u7ujZs2aWLBgAYoUKYI1a9bAw8ND6vLU8vjxY+zatSvXjta6PNLhQx4eHjh37pxSfxcASEhIQLVq1XR+ptjFixfD398fXl5eSEtLQ/fu3XHnzh0UK1YMmzdvlrq8QtOnU9QAsGDBAjRu3Bjnz5/H27dvMX78eFy7dg3x8fEIDw+XurxPCgoKEo8G6tvot9zY2trmOCOgjzIyMvDbb78hNDQ010WXpfqs5ZGdzyA5OTlHpy1ra2uJqlHPgQMHkJKSgvbt2yMqKgqtWrXC7du3YW9vj61bt6JRo0ZSl6iSsLAwtGnTBh4eHrh58yYqVaqE+/fvQxAEVKtWTadHOnzow1EPH4qNjYWrq2uOEKeLMjIysHXrVly+fBnJycmoVq2a3q16npmZiaCgIPzxxx+5hmd9OJKQLTExET/99JPS8zF06FAUL15c6tJID31q0kopR5Ux7GjJvXv3MGzYMBw9ehRpaWliu77NPJyb+Pj4fA8b6xofHx80b94cM2bMgJWVFS5fvgxHR0cEBASgWbNm+Pbbb6Uu8ZOy56745ptvEBISorTafGZmJsLCwnDo0CHcunVLqhLz9GEH65kzZ+K7777T27lQsk2dOhW//vorxo4dix9++AGTJ0/G/fv3sWPHDkydOlXnOrn/F2RmZuLvv/8Wl4Px8vJC27Zt9XoNNtIchh0tqVu3LgRBwMiRI3PMmQAADRo0kKgy9SQmJiIzMxN2dnZK7fHx8TAyMtKbI1RWVla4dOkSPD09UbRoUZw8eRIVK1bE5cuX0bZtW9y/f1/qEj/pU3NXGBsbo3Tp0li8eLE4BFqXmJmZ4c6dOyhZsiQMDQ3x7NkznZ8PKD+enp5Yvnw5WrZsqfTaWr58OU6fPo1NmzZJXaJK1q1bB0tLS3Tq1Empfdu2bUhNTUVgYKBElann2rVraNOmDWJiYlCuXDkA71dud3BwwO7du1GpUiWJK1TN9u3b8zxaqOsjLXOTPd+Uq6urxJWwz47WXL58GRcuXBDfePqqa9euaN26NYYMGaLU/scff2DXrl3Yu3evRJWpx8LCQvzwKF68OKKjo1GxYkUA0Pl5USIjI/Hu3TsYGhrC3d0d586d06k1Z/JTtWpV9OnTB19//TUEQcCiRYvynClZ1xcyzZa9MC7wfnbuxMREAECrVq30arTl3Llz8fPPP+dod3R0xMCBA/Um7PTv3x8VK1bE+fPnxTmoXr16hd69e2PgwIE4deqUxBXmb/ny5Zg8eTJ69+6NnTt3ok+fPoiOjsa5c+f0Zu0+4P1p6hkzZmD58uXizPSWlpYYPnw4pk2bJl3nfYG0wtfXVzh06JDUZRRa0aJFhevXr+dov3HjhmBnZydBRQXTtm1bYc2aNYIgCMLYsWOFMmXKCLNmzRKqVasmNG7cWOLqPs3AwEB4/vy5IAiC4O7uLrx48ULiitRz8+ZNoUuXLkKNGjUEAwMDoVKlSkLVqlVzXL788kupS1XZF198IZw+fVoQBEGoW7euMHfuXEEQBGHLli2Cg4ODlKWpxcTERLh3716O9nv37gmmpqafv6ACMjU1Fa5evZqj/cqVK3rzOMqVKyds2rRJEARBsLS0FKKjowVBEIQpU6YIQ4cOlbI0tQwePFhwdHQUVq9eLVy+fFm4fPmysHr1asHZ2VkYPHiwZHUx7GhJVFSU4OfnJwQHBwvnz58Xn/Tsi74wNzcXIiMjc7RHRkYKZmZmElRUMNHR0eLfPTk5WRg0aJDg7e0ttG/fXrh//77E1X2anZ2d+I/1w+CjjxQKhRAbGyt1GYU2YcIEYfbs2YIgvA84RkZGQpkyZYQiRYoIEyZMkLg61bm6ugo7d+7M0b5jxw6hRIkSElRUMJUrVxbCwsJytIeFhQmVKlWSoCL1mZmZiZ9FDg4OwqVLlwRBEITbt2/r1RdLa2trYe/evTna9+zZI1hbW0tQ0Xs8jaUlcXFxiI6OVppvJ3u5BX3qoOzj44M1a9ZgxYoVSu2rV69G9erVJapKfR8Ok7ewsNCbNZgAoEOHDmjQoIE4OqZGjRowNDTMdVtdH3quq1PJq+vDOUS6dOmCUqVKISIiAmXLlkXr1q0lrEw93bp1w4gRI2BlZYX69esDAI4dO4aRI0eia9euElf3aUlJSeLP2ZOcTp8+HbVq1QLwfjmYmTNnYv78+VKVqBZnZ2fEx8fDzc0NpUqVwunTp1GlShXcu3dPXKZHH5iYmOS6fI27u3uOmdM/J3ZQ1hIvLy9UqFAB48ePz7WDspubm0SVqSc8PBx+fn746quv0LhxYwDvh3GfO3cOBw8eRL169SSuUDX6Pj/N/v37ERUVhREjRmDmzJl5zjY8cuTIz1xZ/vRhReT/qrdv36Jnz57Ytm2bOGopKysLvXr1wurVqyX955QfAwMDpc9V4aN1+z68rg9fLvv37w9XV1dMmzYNK1euxLhx41C3bl2cP38e7du3V1rWRpfNnDkTN2/exLp168RZuNPT09GvXz+ULVtWsqU9GHa0xMLCApcvXxankddnly5dwsKFC3Hp0iWYmZmhcuXKmDRpks6tffIpn5qfplSpUkhPT5eoMvX06dMHy5cv16ulFfRhRWRV5BfUPqRvoe327du4fPkyzMzM4O3trRdfxo4dO6bytvow+jUrKwtZWVli6NyyZQtOnTqFsmXLYtCgQTodPD/Url07hIWFwcTEBFWqVAHwfsDO27dvxS/M2T7nrNAMO1rSunVr9O7dGx06dJC6lP80fZ6fhnTLp4Lah3Q9tJFuevjwIVxdXXOcBRAEAY8ePUKpUqUkqkw9Hy+V9Cmfc6UBhh0tWbNmDWbNmoW+ffvC29s7x3A7Xf7ml5SUJM6f8+F58dzo+jw72f+gsvtLfUjX56fJy/nz5/Oci0Nf1s8h3SGHZVSOHz/+yduz+yPpsrzmoHr58iUcHR0ZoAuJYUdL9Plw/Ydvuo/Pi2fTt47W+jg/TW62bNmCXr16wd/fHwcPHkTTpk1x+/ZtxMbGol27dnqxJltYWBjCwsLw/PnzHB2Wf/vtN4mqKri0tDS9WxMrm5yWUfnYh59b+vA5ZWBggNjYWDg4OCi1P3jwAF5eXkhJSZGosoKJi4sTj5iXK1cux+P63DgaS0v0edTJ4cOHxRmTjxw5InE1mnHv3j3xZ33+5zRnzhwEBQVh6NChsLKywrJly+Du7o5BgwbpxVpGM2bMwMyZM1GjRg0UL15cr5Yc+VBmZibmzJmD1atXIzY2Frdv34aHhwemTJmC0qVLo1+/flKXqJJJkybhu+++E5dR+fPPP5WWUdEXr169Urr+7t07/Pvvv5gyZQpmz54tUVWqGTNmDID34WzKlClKS6lkZmbizJkzqFq1qkTVqS8lJQXDhw/H+vXrxf+DhoaG6NWrF1asWCHdUjGfe6w7kRQyMzOFmTNnCi4uLoKhoaE4YdcPP/wg/PrrrxJXpzpzc3NxEjg7OztxDqTr168Lzs7OElamGmdnZ2H9+vVSl1FoM2bMEDw8PITff/9dMDMzE19PW7ZsEWrVqiVxdaqztLQUoqKiBEEQBFtbW3FivkuXLglubm4SVqYZR48eFapVqyZ1GZ/k6+sr+Pr6CgqFQqhTp4543dfXV2jatKkwcOBA4fbt21KXqbKBAwcKHh4ewt69e4XExEQhMTFR2LNnj+Dp6SnppII8sqNFx44dw6JFi5QWphs3bpzeDNfOlpaWhsjIyFxPO+hy36MPzZo1CyEhIViwYAEGDBggtleqVAlLly7Vm2/iRYsWxevXrwEAJUqUwNWrV+Ht7Y2EhASkpqZKXF3+3r59izp16khdRqGtX78ea9asQePGjTF48GCxvUqVKrh586aElalHn5dRUYWTk5NODz5Yvnw59u7dCzMzM/Tp0wfLli3T+X6Q+fnzzz+xfft2+Pr6im0tWrSAmZkZOnfujFWrVklSF8OOlvz+++/o06cP2rdvL66AHB4ejsaNGyM4OBjdu3eXuELV7N+/H7169cr1g0+f+uzI5Z9T/fr1cejQIXh7e6NTp04YOXIkDh8+jEOHDuUY1qmL+vfvj02bNunV+lG5efLkSa7TSmRlZeHdu3cSVFQwtWrVwsmTJ1GhQgW0aNECY8eOxZUrV/DXX3+Jk/Ppg8jISKXrgiDg2bNnmDdvnk6fAhozZgy6du0KMzMzrF+/HvPnz9f7sJOamgonJ6cc7Y6OjpJ+IWPY0ZLZs2djwYIFGD16tNg2YsQILFmyBD/++KPehJ3hw4ejU6dOmDp1aq4vYH0hl39OP/30E9LS0gAAkydPhrGxMU6dOoUOHTrghx9+kLi6/KWlpWHNmjUIDQ1F5cqVc4xS1JfRP15eXjhx4kSO+Wi2b9+OL7/8UqKq1LdkyRJxscYZM2YgOTkZW7duRdmyZfXmuQDeLzab24jLWrVq6XSndxcXF/z5559o0aIFBEHA48ePxff3x/Rl6Hnt2rUxbdo0rF+/Xuwb+ebNG8yYMQO1a9eWrC6OxtISExMTXLt2Lcc/2KioKFSqVCnPF7Susba2xr///gtPT0+pSymU6tWrY/To0ejRowesrKxw+fJleHh4YObMmTh48CBOnjwpdYn/CQ0bNszzNoVCoTejf3bu3InAwEBMmjQJM2fOxIwZM3Dr1i2sX78e//zzD5o0aSJ1if8pDx48ULpuYGAABwcHnR+IsGbNGgwfPhwZGRl5biPo2cjXK1euoFmzZkhPT1eaVNDU1BQHDhwQT5N+bjyyoyWurq4ICwvLEXZCQ0Ph6uoqUVXq69ixI44ePar3YWfq1KkIDAzEkydPkJWVhb/++gu3bt1CSEgI/vzzT6nLy1deUwB8SKFQfPJDUxfIZXRf27ZtsXv3bsycORMWFhaYOnUqqlWrht27dzPofCZ2dna4ffs2ihUrhhkzZmDZsmV6NbM4AAwcOBDdunXDgwcPULlyZYSGhuZY0kbfeHt7486dO9i4caPYRaBbt24ICAiAmZmZZHXxyI6WrFq1CqNGjULfvn3FDpnh4eEIDg7GsmXLMGjQIIkrVE1qaio6deoEBweHXCdHzO6PpKuCgoLEU4knTpzAzJkzcfnyZSQnJ6NatWoYP3485s+fj/DwcIkr/bSdO3fmeVtERASWL1+OrKwsvTliCLyfzA4ASpYsKXEl/y1FixZVech/fHy8lqspOEtLS0RGRsLDwwOGhoaIiYmRfC6XwggJCUHXrl3F9aT00bt371C+fHn8888/qFChgtTlKGHY0aK///4bixcvFkdjVahQAePGjUPbtm0lrkx1a9euxeDBg2Fqagp7e3ulD0mFQqHzC2iamZnh559/Rq9evXLclpycDH9/f7x8+VKvOilnu3XrFiZOnIjdu3cjICAAM2fO1Pk1jbKysjBr1iwsXrxY7CtiZWWFsWPHYvLkySovySA1fV5YNiQkROVtAwMDtVhJ4TRp0gSxsbGoXr06QkJC0KVLlzyPHOhyv50PJSQkYPv27YiOjsa4ceNgZ2eHixcvwsnJCSVKlJC6PJWUKFECoaGhOhd2eBpLi9q1a4d27dpJXUahTJ48GTNmzMDEiRP15h/RhzZs2ICePXvC1tZWaZh8SkoKmjdvjhcvXujdqZWnT59i2rRpCAkJgb+/Py5duoRKlSpJXZZKJk+ejLVr12LevHmoW7cuAODkyZOYPn060tLSdH4CuGz379/PtQ9Feno6njx5IkFFqgsMDERmZiYWLVqEXbt2iQs0Tps2TdLTDOr6/fffERQUhOjoaCgUCiQmJurVkc2PRUZGws/PDzY2Nrh//z4GDBgAOzs7/PXXX3j48CHWr18vdYkqGTp0KObPn49ff/1VXNRUF/DIjpadP39eaZ6d6tWrS1yReuzs7HDu3Dm97rPz66+/YuTIkdizZw98fX2RkpKCZs2aISYmBkePHtWbb0yJiYmYM2cOVqxYgapVq2L+/Pl6N2eTi4sLVq9enWN+pp07d2LIkCE6HxTksrDsjz/+iOnTp8PPzw9mZmY4cOAAunXrpjdHQD7m7u6O8+fP63V/l8aNG6N69epYsGCB0iCKU6dOoXv37rh//77UJaoke9VzS0tLeHt7w8LCQul2qdbvY9jRksePH6Nbt24IDw+Hra0tgPeHKOvUqYMtW7boTT+F0aNHw8HBAd9//73UpRTKggULMHv2bOzcuRNTp07FkydPcOzYMb15HhYsWID58+fD2dkZc+bM0atToR8yNTVFZGQkvvjiC6X2W7duoWrVqnjz5o1ElalGLgvLli1bFt99953YdzA0NBQtW7bEmzdv9PIIrhzY2Njg4sWL8PT0VAo7Dx48QLly5fTmqFV+q55LtX6f7hxjkpn+/fvj3bt3uHHjBsqVKwfg/Qd6nz590L9/f+zfv1/iClWTmZmJBQsW4MCBA3o9L8r48eMRHx+Pxo0bo3Tp0jh69KjeBB0AmDhxIszMzFCmTBmEhITk2e9C11c9r1KlCn766ScsX75cqf2nn34Sh6nqsuwZxPV9YdmHDx+iRYsW4nU/Pz8oFAo8ffpUr94XH9L3BWZNTEyQlJSUo/327dt60fE6KysLCxcuxO3bt/H27Vs0atQI06dP15lToww7WnLs2DGcOnVKDDrA+5VfV6xYoVenHq5cuSJOknb16lWl2/RhEcf27dsrXTc2NkaxYsUwcuRIpXZdDwm9evXSi793fhYsWICWLVsiNDRUnGAsIiICjx49wt69eyWuLn8RERF4+fKl0sKy69evx7Rp05CSkoJvvvkGK1as0PkRNRkZGTnmoDE2NtarCTY/JIcFZtu0aYOZM2fijz/+APD+8/Xhw4eYMGECOnToIHF1+Zs9e7bSqdHly5cjLi5OZ4ImT2NpyRdffIHff/8dPj4+Su1nz55F9+7dERUVJVFl/y35HVLNJtWh1f+ip0+fYuXKleIIuAoVKmDIkCFwcXGRuLL8NWvWDA0bNsSECRMAvP8yUK1aNfTu3RsVKlTAwoULMWjQIEyfPl3aQvNhYGCA5s2bK4Wy3bt3o1GjRkp9LHT9S0C24sWLY8GCBejZs6fUpRRYYmIiOnbsiPPnz+P169dwcXFBTEwMatWqhX379uXo+6JrdP3UKMOOluzcuRNz5szBypUrUaNGDQDvOysPHz4cEyZMwDfffCNtgUSfUePGjTF06NAcR9qyvXjxAj4+Pjo9ZBt4/0919+7d4nt68uTJOHbsmDgD97Zt2zBt2jRcv35dyjLzJbcvAfb29jh79qxeD6TIFh4erjQXmJ+fn9QlqcTExARRUVFKk+aampoiKipKJ06NMuxoSdGiRZGamoqMjAxx+F32zx8ndF2euAt4H9L++OMPPHz4UFwhOZu+fPMjaRkYGMDAwECcyuBjsbGxcHFx0fkp8U1NTXHnzh3xA/3rr79G8+bNMXnyZADvh6R7e3uLK9PT5zFhwgRYWlrq5QKzhw8fxrBhw3D69Okci4AmJiaiTp06WL16tc53f8htYkcrKytERkbC3d1dwsreY58dLVm6dKnUJWjEli1b0KtXL/j7++PgwYNo2rQpbt++jdjYWL2fQ4g+r1WrVuG7775DZGQkfv/9d50/LJ8bJycn3Lt3D66urnj79i0uXryoFN5ev36doxM/aZ8+LzC7dOlSDBgwINfVzm1sbDBo0CAsWbJE58OOIAjo3bu30qnRtLQ0DB48WCdOjfLIDn1S5cqVMWjQIAwdOlQcDunu7o5BgwahePHiuX5LJ/qYgYEBYmJi8PLlS7Rt2xYmJibYuXMnPDw8AOjPkZ1vv/0Wly9fxvz587Fjxw6EhITg6dOnKFKkCABg48aNWLp0Kc6dOydxpf8tn1pgFtDtNdnc3Nywf//+PGccvnnzJpo2bYqHDx9+5srUo+unRhl2PoO0tLQcp39yS/G6yMLCAteuXUPp0qVhb2+Po0ePwtvbGzdu3ECjRo3w7NkzqUskPZAddhwdHZGYmIhu3brhzJkz2Lp1K/z8/PQm7Lx48QLt27fHyZMnYWlpiZCQEKUjnI0bN0atWrX0ZiZokp6pqSmuXr2aY9HobFFRUfD29tb5Oah0HU9jaUlKSgomTJiAP/74Ay9fvsxxu65/qGcrWrSo2P+gRIkSuHr1Kry9vZGQkIDU1FSJqyN9ZGNjgz179mDSpElo0aIF5s+fj+7du0tdlkqKFSuG48ePIzExEZaWljA0NFS6fdu2bbC0tJSouv+evDq8f0ihUODPP//8DNUUTPbnal5hJzIyEsWLF//MVckPw46WjB8/HkeOHMGqVavQs2dPrFy5Ek+ePMHPP/+MefPmSV2eyurXr49Dhw7B29sbnTp1wsiRI3H48GEcOnQIjRo1kro80hMfz3uiUCgwb948VK1aFf3798fhw4clqqxgPlwm4kN2dnafuZL/tryeB33SokULTJkyBc2aNcsx99GbN28wbdo0nZ+RWx/wNJaWlCpVCuvXr4evry+sra1x8eJFlClTBhs2bMDmzZv1YgI14P1IsbS0NLi4uCArKwsLFizAqVOnxDkV+I2DVPHhaayPXbp0Cd988w0ePXqkN0c8iTQlNjYW1apVg6GhIYYNGyZORHvz5k2sXLkSmZmZ4srnVHAMO1piaWmJ69evo1SpUihZsiT++usv+Pj44N69e/D29kZycrLUJRZYWloaVq5ciYULFyImJkbqckgPHDt2DHXr1s1zFeSXL19iz5496NWr12eujEh6Dx48wLfffosDBw6Ia64pFAr4+/tj5cqVOjF0W99JP62hTHl4eIhTypcvX16cAnz37t3iwqC6LD09HZMmTUKNGjVQp04d7NixA8D7nvSenp5YtmwZRo8eLW2RpDcaNGiQZ9AB3k8Kx6BD/1Vubm7Yu3cvXrx4gTNnzuD06dN48eIF9u7dy6CjITyyoyVBQUEwNDTEiBEjEBoaitatW0MQBLx9+xZBQUE51mbSNRMmTMDPP/8MPz8/nDp1CnFxcejTpw9Onz6N77//Hp06dcrROZOIiEgXMex8Jg8ePMCFCxdQtmxZeHt7S11Ovjw8PLB06VK0adMGV69eReXKldG7d2+sXbtWLxfZIyKi/y6extKww4cPw8vLC0lJSUrtbm5uaNy4Mbp27YoTJ05IVJ3qHj9+jOrVqwMAKlWqBBMTE4wePZpBh4iI9A7DjoapOvW3rsvMzBRnhQUAIyMjzh9CRER6iaexNEwuU38bGBigefPm4jonu3fvRqNGjXKsZ8SFQImISNdxUkENi42N/eRCgEZGRoiLi/uMFRVMYGCg0vUePXpIVAkREVHhMOxomFym/pZqsTYiIiJNY58dDcue+jstLS3HbZz6m4iI6PNjnx0N49TfREREuoVhRws49TcREZHuYNjRolevXiEqKgqCIKBs2bIoWrSo1CURERH95zDsEBERkayxgzIRERHJGsMOERERyRrDDhEREckaww4RERHJGsMOEVE+SpcujaVLl0pdBhEVEMMOEX1S7969oVAooFAoYGxsDCcnJzRp0gS//fYbsrKyJKvr/v37Yl0KhQJ2dnZo0KABTpw4ofF9nTt3DgMHDtT4/RLR58GwQ0T5atasGZ49e4b79+9j3759aNiwIUaOHIlWrVohIyMjz9979+6d1msLDQ3Fs2fPcPz4cbi4uKBVq1aIjY3V6D4cHBxgbm6u0fskos+HYYeI8mViYgJnZ2eUKFEC1apVw/fff4+dO3di3759CA4OFrdTKBRYtWoV2rRpAwsLC8yePRvBwcGwtbVVur8dO3ZAoVAotc2aNQuOjo6wsrJC//79MXHiRFStWjXf2uzt7eHs7IxKlSrh+++/R1JSEs6cOSPefvXqVTRv3hyWlpZwcnJCz5498eLFC/H2169fIyAgABYWFihevDiCgoLg6+uLUaNGidt8fBpLoVDg559/RqtWrWBubo4KFSogIiICUVFR8PX1hYWFBerUqYPo6GilWnfu3Ilq1arB1NQUHh4emDFjhlJYVCgU+PXXX9GuXTuYm5ujbNmy2LVrV75/AyL6NIYdIiqQRo0aoUqVKvjrr7+U2qdPn4527drhypUr6Nu3r0r3tXHjRsyePRvz58/HhQsXUKpUKaxatUqtet68eYP169cDAIoUKQIASEhIQKNGjfDll1/i/Pnz2L9/P2JjY9G5c2fx98aMGYPw8HDs2rULhw4dwokTJ3Dx4sV89/fjjz+iV69euHTpEsqXL4/u3btj0KBBmDRpEs6fPw9BEDBs2DBx+xMnTqBXr14YOXIkrl+/jp9//hnBwcGYPXu20v3OmDEDnTt3RmRkJFq0aIGAgADEx8er9bcgoo8IRESfEBgYKLRt2zbX27p06SJUqFBBvA5AGDVqlNI269atE2xsbJTa/v77b+HDj5+aNWsKQ4cOVdqmbt26QpUqVfKs6969ewIAwczMTLCwsBAUCoUAQKhevbrw9u1bQRAE4ccffxSaNm2q9HuPHj0SAAi3bt0SkpKSBGNjY2Hbtm3i7QkJCYK5ubkwcuRIsc3NzU0ICgpSepw//PCDeD0iIkIAIKxdu1Zs27x5s2Bqaipeb9y4sTBnzhylWjZs2CAUL148z/tNTk4WAAj79u3L8+9ARPkzkixlEZHeEwQhx+moGjVqqH0/t27dwpAhQ5TafHx8cPjw4Xx/d+vWrShfvjyuXr2K8ePHIzg4GMbGxgCAy5cv48iRI7C0tMzxe9HR0Xjz5g3evXsHHx8fsd3GxgblypXLd7+VK1cWf3ZycgIAeHt7K7WlpaUhKSkJ1tbWuHz5MsLDw5WO5GRmZiItLQ2pqalin6AP79fCwgLW1tZ4/vx5vvUQUd4YdoiowG7cuAF3d3elNgsLC6XrBgYGED5agk+THZddXV1RtmxZlC1bFhkZGWjXrh2uXr0KExMTJCcno3Xr1pg/f36O3ytevDiioqIKvN/sQAVADHy5tWWPWEtOTsaMGTPQvn37HPdlamqa6/1m34+Uo96I5IB9doioQA4fPowrV66gQ4cOn9zOwcEBr1+/RkpKith26dIlpW3KlSuHc+fOKbV9fF0VHTt2hJGREf73v/8BAKpVq4Zr166hdOnSKFOmjNLFwsICHh4eMDY2VtpXYmIibt++rfa+81OtWjXcunUrRx1lypSBgQE/iom0ie8wIspXeno6YmJi8OTJE1y8eBFz5sxB27Zt0apVK/Tq1euTv1uzZk2Ym5vj+++/R3R0NDZt2qQ0ggsAhg8fjrVr1yIkJAR37tzBrFmzEBkZmeMUWX4UCgVGjBiBefPmITU1FUOHDkV8fDy6deuGc+fOITo6GgcOHECfPn2QmZkJKysrBAYGYty4cThy5AiuXbuGfv36wcDAQO1952fq1KlYv349ZsyYgWvXruHGjRvYsmULfvjhB43uh4hyYtghonzt378fxYsXR+nSpdGsWTMcOXIEy5cvx86dO2FoaPjJ37Wzs8Pvv/+OvXv3wtvbG5s3b8b06dOVtgkICMCkSZPw3XffoVq1arh37x569+6tdHpHVYGBgXj37h1++uknuLi4IDw8HJmZmWjatCm8vb0xatQo2NraikdTlixZgtq1a6NVq1bw8/ND3bp1UaFChQLt+1P8/f3xzz//4ODBg/jqq69Qq1YtBAUFwc3NTaP7IaKcFMLHJ9OJiHRAkyZN4OzsjA0bNnzW/aakpKBEiRJYvHgx+vXr91n3TUTawQ7KRCS51NRUrF69Gv7+/jA0NMTmzZsRGhqKQ4cOaX3f//77L27evAkfHx8kJiZi5syZAIC2bdtqfd9E9Hkw7BCR5BQKBfbu3YvZs2cjLS0N5cqVw59//gk/P7/Psv9Fixbh1q1bKFKkCKpXr44TJ06gWLFin2XfRKR9PI1FREREssYOykRERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQkaww7REREJGsMO0RERCRrDDtEREQka/8H0X7JGG33TlkAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a bar plot showing the total number of rows (Mouse ID/Timepoints) for each drug regimen using Pandas.\n",
    "\n",
    "drug_counts = cleaned_data['Drug Regimen'].value_counts()\n",
    "\n",
    "# Plot the bar chart\n",
    "drug_counts.plot(kind='bar', color='skyblue', alpha=0.7, edgecolor='black')\n",
    "\n",
    "# Set chart title and labels\n",
    "plt.title('Total Number of Rows for Each Drug Regimen')\n",
    "plt.xlabel('Drug Regimen')\n",
    "plt.ylabel('Number of Rows')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a bar plot showing the total number of rows (Mouse ID/Timepoints) for each drug regimen using pyplot.\n",
    "\n",
    "\n",
    "# Calculate the total number of rows for each drug regimen\n",
    "drug_counts = cleaned_data['Drug Regimen'].value_counts()\n",
    "\n",
    "# Create a bar plot using pyplot\n",
    "plt.bar(drug_counts.index, drug_counts, color='skyblue', alpha=0.7, edgecolor='black')\n",
    "\n",
    "# Set chart title and labels\n",
    "plt.title('Total Number of Rows for Each Drug Regimen')\n",
    "plt.xlabel('Drug Regimen')\n",
    "plt.ylabel('Number of Rows')\n",
    "\n",
    "# Rotate x-axis labels for better readability (optional)\n",
    "plt.xticks(rotation=45, ha='right')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a pie plot showing the distribution of female versus male mice using Pandas\n",
    "gender_distribution = cleaned_data['Sex'].value_counts()\n",
    "\n",
    "# Plot the pie chart using Pandas\n",
    "gender_distribution.plot.pie(autopct='%1.1f%%', colors=['lightcoral', 'lightblue'], startangle=90)\n",
    "\n",
    "# Set chart title\n",
    "plt.title('Distribution of Female vs. Male Mice')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAawAAAGbCAYAAACYt6S5AAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8g+/7EAAAACXBIWXMAAA9hAAAPYQGoP6dpAABC5ElEQVR4nO3dd3hUVf4G8PdOb+kJhFASSGjSQURApCogoCJFQaUoC/uzrR1R1wKWdUWKhbWt4CIggigI0qQKighSLfSA9BJSJslk2vn9ETIypJBJJrlz576f58kDuXPnzndmkrxzzj33HEkIIUBERBTiNHIXQEREVB4MLCIiUgQGFhERKQIDi4iIFIGBRUREisDAIiIiRWBgERGRIjCwiIhIERhYRESkCAysErz00kuQJKlaHqtbt27o1q2b7/v169dDkiQsXLiwWh5/1KhRSElJqZbHqii73Y4xY8YgMTERkiTh0UcflbukoFLCexAKUlJSMGrUKLnLwKxZsyBJEtLT0+UuRXXCPrCKfriKvkwmE5KSktC7d2+8/fbbyMnJCcrjnDx5Ei+99BJ27twZlOMFUyjXVh6vvfYaZs2ahf/7v//D7Nmzce+995a6b0pKit/7ffmXw+GoxqrV5fLfs02bNhW7XQiBunXrQpIk9O/fX4YKi+vWrRskSULDhg1LvH316tW+51RdHyCpbDq5C6guEydORP369eFyuXD69GmsX78ejz76KKZMmYIlS5agZcuWvn2ff/55PPPMMwEd/+TJk3j55ZeRkpKC1q1bl/t+q1atCuhxKqKs2j766CN4vd4qr6Ey1q5di+uvvx4vvvhiufZv3bo1nnjiiWLbDQZDsEujK5hMJsydOxc33HCD3/YNGzbg+PHjMBqNMlVWMpPJhIMHD2Lr1q247rrr/G6bM2cOTCZTsQ869957L+66666Qey5qoJrA6tu3L6699lrf9xMmTMDatWvRv39/3Hrrrfj9999hNpsBADqdDjpd1b40eXl5sFgssv8R1ev1sj5+eZw9exbXXHNNufevXbs27rnnniqsiEpzyy23YMGCBXj77bf9fofmzp2Ldu3a4fz58zJWV1xqaircbjfmzZvnF1gOhwNfffUV+vXrhy+//NLvPlqtFlqttrpLJaigS7AsPXr0wD//+U8cPXoUn332mW97SeewVq9ejRtuuAHR0dGw2Wxo3Lgxnn32WQCF553at28PABg9erSvG2HWrFkACrsemjdvju3bt+PGG2+ExWLx3ffKc1hFPB4Pnn32WSQmJsJqteLWW2/Fn3/+6bdPaX36lx/zarWVdP4kNzcXTzzxBOrWrQuj0YjGjRtj8uTJuHJif0mS8NBDD+Hrr79G8+bNYTQa0axZM6xYsaLkF/wKZ8+exf3334+aNWvCZDKhVatW+PTTT323F53PO3LkCJYtW+arvbLnDjIzM/Hoo4/6nl9aWhreeOMNv5Zmeno6JEnC5MmT8d5776FBgwawWCy4+eab8eeff0IIgUmTJqFOnTowm8247bbbkJGR4fc4ixcvRr9+/ZCUlASj0YjU1FRMmjQJHo/nqjV6vV5MmzYNzZo1g8lkQs2aNTFu3DhcvHixzPtNnjwZkiTh6NGjxW6bMGECDAaD7xgHDhzAoEGDkJiYCJPJhDp16uCuu+5CVlZWeV7GEg0bNgwXLlzA6tWrfducTicWLlyI4cOHl1pzp06dEBcXB7PZjHbt2pW7C64872V5ap4/f77ffb755hvk5eVh6NChxfYv7RzW8uXL0bVrV0RERCAyMhLt27fH3Llz/fb56aef0KdPH0RFRcFisaBr167YvHlzuWtVO1UHFgDf+ZCyuuZ+/fVX9O/fHwUFBZg4cSLeeust3Hrrrb4ftKZNm2LixIkAgLFjx2L27NmYPXs2brzxRt8xLly4gL59+6J169aYNm0aunfvXmZdr776KpYtW4bx48fjkUcewerVq9GrVy/k5+cH9PzKU9vlhBC49dZbMXXqVPTp0wdTpkxB48aN8dRTT+Hxxx8vtv+mTZvwwAMP4K677sK///1vOBwODBo0CBcuXCizrvz8fHTr1g2zZ8/G3XffjTfffBNRUVEYNWoUpk+f7qt99uzZiI+PR+vWrX21JyQklHlsl8uF8+fP+33l5eUBKGzZdu3aFZ999hlGjBiBt99+G507d8aECRNKfH5z5szBjBkz8PDDD+OJJ57Ahg0bMHToUDz//PNYsWIFxo8fj7Fjx+Kbb77Bk08+6XffWbNmwWaz4fHHH8f06dPRrl07vPDCC+Xqbh43bhyeeuopdO7cGdOnT8fo0aMxZ84c9O7dGy6Xq9T7DR06FJIk4Ysvvih22xdffIGbb74ZMTExcDqd6N27N7Zs2YKHH34Y7733HsaOHYvDhw8jMzPzqvWVJiUlBR07dsS8efN825YvX46srCzcddddJd5n+vTpaNOmDSZOnIjXXnsNOp0OQ4YMwbJly8p8rEDfy9IMHz4cp06dwvr1633b5s6di549e6JGjRrlOsasWbPQr18/ZGRkYMKECfjXv/6F1q1b+314W7t2LW688UZkZ2fjxRdfxGuvvYbMzEz06NEDW7duLXe9qibC3MyZMwUA8fPPP5e6T1RUlGjTpo3v+xdffFFc/tJMnTpVABDnzp0r9Rg///yzACBmzpxZ7LauXbsKAOL9998v8bauXbv6vl+3bp0AIGrXri2ys7N927/44gsBQEyfPt23LTk5WYwcOfKqxyyrtpEjR4rk5GTf919//bUAIF555RW//QYPHiwkSRIHDx70bQMgDAaD37Zdu3YJAOKdd94p9liXmzZtmgAgPvvsM982p9MpOnbsKGw2m99zT05OFv369SvzeJfvC6DY14svviiEEGLSpEnCarWK/fv3+93vmWeeEVqtVhw7dkwIIcSRI0cEAJGQkCAyMzN9+02YMEEAEK1atRIul8u3fdiwYcJgMAiHw+HblpeXV6y+cePGCYvF4rffle/B999/LwCIOXPm+N13xYoVJW6/UseOHUW7du38tm3dulUAEP/73/+EEELs2LFDABALFiwo81jldfnv2bvvvisiIiJ8z3/IkCGie/fuQoiS38srXyen0ymaN28uevTo4bf9yp/38r6Xpenatato1qyZEEKIa6+9Vtx///1CCCEuXrwoDAaD+PTTT32/j5e/TkXP9ciRI0IIITIzM0VERITo0KGDyM/P93sMr9fr+7dhw4aid+/evm1Fz71+/fripptuKrNWKqT6FhYA2Gy2MkcLRkdHAyjs4qnoAAWj0YjRo0eXe/8RI0YgIiLC9/3gwYNRq1YtfPvttxV6/PL69ttvodVq8cgjj/htf+KJJyCEwPLly/229+rVC6mpqb7vW7ZsicjISBw+fPiqj5OYmIhhw4b5tun1ejzyyCOw2+3YsGFDhZ9Dhw4dsHr1ar+vESNGAAAWLFiALl26ICYmxq8F1qtXL3g8HmzcuNHvWEOGDEFUVJTfsQHgnnvu8TtH06FDBzidTpw4ccK3reicKADk5OTg/Pnz6NKlC/Ly8vDHH3+UWv+CBQsQFRWFm266ya/Gdu3awWazYd26dWU+/zvvvBPbt2/HoUOHfNvmz58Po9GI2267DQB8z2nlypW+1mewDB06FPn5+Vi6dClycnKwdOnSUrsDAf/X6eLFi8jKykKXLl3wyy+/lPk4gb6XZRk+fDgWLVrk677UarUYOHBgue67evVq5OTk4JlnnoHJZPK7rejUws6dO3HgwAEMHz4cFy5c8NWam5uLnj17YuPGjSE/+CkUqGbQRVnsdnuZTf8777wTH3/8McaMGYNnnnkGPXv2xB133IHBgwdDoylf5teuXTugARZXDrWVJAlpaWlVfu3H0aNHkZSU5BeWQGH3XNHtl6tXr16xY8TExFz1XMvRo0fRsGHDYq9faY8TiPj4ePTq1avE2w4cOIDdu3eX2q149uxZv++vfH5Ff+jr1q1b4vbLn/evv/6K559/HmvXrkV2drbf/mWdJzpw4ACysrJK/Zm8ssYrDRkyBI8//jjmz5+PZ599FkIILFiwAH379kVkZCQAoH79+nj88ccxZcoUzJkzB126dMGtt96Ke+65xy+gKyIhIQG9evXC3LlzkZeXB4/Hg8GDB5e6/9KlS/HKK69g586dKCgo8G2/2rWQgb6XZbnrrrvw5JNPYvny5ZgzZw769+9f7HegNEUfDJo3b15mrQAwcuTIUvfJyspCTExMuWtWI9UH1vHjx5GVlYW0tLRS9zGbzdi4cSPWrVuHZcuWYcWKFZg/fz569OiBVatWlWvE0OWfIoOltF9oj8dTbaOYSnscccUAjVDh9Xpx00034emnny7x9kaNGvl9X9rzu9rzzszMRNeuXREZGYmJEyciNTUVJpMJv/zyC8aPH1/mp2mv14saNWpgzpw5Jd5+tXN4SUlJ6NKlC7744gs8++yz2LJlC44dO4Y33njDb7+33noLo0aNwuLFi7Fq1So88sgjeP3117FlyxbUqVOnzMe4muHDh+Nvf/sbTp8+jb59+/p6Ka70/fff49Zbb8WNN96IGTNmoFatWtDr9Zg5c2axAQtXCvS9LEutWrXQrVs3vPXWW9i8eXOxkYGVVfR+v/nmm6Ve9mKz2YL6mOFI9YE1e/ZsAEDv3r3L3E+j0aBnz57o2bMnpkyZgtdeew3PPfcc1q1bh169egV9ZoyiT2RFhBA4ePCg3/ViMTExJZ4gP3r0KBo0aOD7PpDakpOT8d133yEnJ8fvE2ZRF1ZycnK5j3W1x9m9eze8Xq9fKyvYj3Ol1NRU2O32UltgwbJ+/XpcuHABixYt8hvgcuTIkaveNzU1Fd999x06d+5c4Q86d955Jx544AHs27cP8+fPh8ViwYABA4rt16JFC7Ro0QLPP/88fvjhB3Tu3Bnvv/8+XnnllQo9bpGBAwdi3Lhx2LJlC+bPn1/qfl9++SVMJhNWrlzpd13TzJkzr/oYwX4vhw8fjjFjxiA6Ohq33HJLue9X1CW+d+/eUj/4Fu0TGRlZ5T974UzV57DWrl2LSZMmoX79+rj77rtL3e/K4coAfJ+SirowrFYrAFRqhNXl/ve///mdV1u4cCFOnTqFvn37+ralpqZiy5YtcDqdvm1Lly4tNvw9kNpuueUWeDwevPvuu37bp06dCkmS/B6/Mm655RacPn3a74+Z2+3GO++8A5vNhq5duwblca40dOhQ/Pjjj1i5cmWx2zIzM+F2u4PyOEUtsMtbmk6nEzNmzChXjR6PB5MmTSp2m9vtLtf7OGjQIGi1WsybNw8LFixA//79fT8HAJCdnV3subZo0QIajcavW+7YsWNlnm8rjc1mw3/+8x+89NJLJQZlEa1WC0mS/Ib6p6en4+uvv77qYwT7vRw8eDBefPFFzJgxI6Du+5tvvhkRERF4/fXXi11kXPT+t2vXDqmpqZg8eTLsdnuxY5w7dy6gWtVKNS2s5cuX448//oDb7caZM2ewdu1arF69GsnJyViyZEmxk6WXmzhxIjZu3Ih+/fohOTkZZ8+exYwZM1CnTh3fFf2pqamIjo7G+++/j4iICFitVnTo0AH169evUL2xsbG44YYbMHr0aJw5cwbTpk1DWloa/va3v/n2GTNmDBYuXIg+ffpg6NChOHToED777DO/QRCB1jZgwAB0794dzz33HNLT09GqVSusWrUKixcvxqOPPlrs2BU1duxYfPDBBxg1ahS2b9+OlJQULFy4EJs3b8a0adPKff4gUE899RSWLFmC/v37Y9SoUWjXrh1yc3OxZ88eLFy4EOnp6YiPj6/043Tq1AkxMTEYOXIkHnnkEUiShNmzZ5erq7Rr164YN24cXn/9dezcuRM333wz9Ho9Dhw4gAULFmD69OllnhMCgBo1aqB79+6YMmUKcnJycOedd/rdvnbtWjz00EMYMmQIGjVqBLfbjdmzZ0Or1WLQoEG+/UaMGIENGzZUqIu3rPM1Rfr164cpU6agT58+GD58OM6ePYv33nsPaWlp2L17d5n3DfZ7GRUVhZdeeqnc+xeJjIzE1KlTMWbMGLRv3x7Dhw9HTEwMdu3ahby8PHz66afQaDT4+OOP0bdvXzRr1gyjR49G7dq1ceLECaxbtw6RkZH45ptvAn5s1ZFtfGI1KRqCWvRlMBhEYmKiuOmmm8T06dP9hk8XuXJY+5o1a8Rtt90mkpKShMFgEElJSWLYsGHFhtMuXrxYXHPNNUKn0/kNI798+OyVShvWPm/ePDFhwgRRo0YNYTabRb9+/cTRo0eL3f+tt94StWvXFkajUXTu3Fls27at2DHLqu3KIdVCCJGTkyMee+wxkZSUJPR6vWjYsKF48803/YbjClE4rP3BBx8sVlNpw+2vdObMGTF69GgRHx8vDAaDaNGiRYlD7wMd1n61fXNycsSECRNEWlqaMBgMIj4+XnTq1ElMnjxZOJ1OIcRfw9rffPNNv/uWNMxZiJIvn9i8ebO4/vrrhdlsFklJSeLpp58WK1euFADEunXrfPuV9B4IIcSHH34o2rVrJ8xms4iIiBAtWrQQTz/9tDh58mS5XouPPvpIABARERHFhlsfPnxY3HfffSI1NVWYTCYRGxsrunfvLr777ju//Youybia8lw+IkTJ789///tf0bBhQ2E0GkWTJk3EzJkzi/0OFt33yp+r8ryXpSnr97JIeYa1F1myZIno1KmTMJvNIjIyUlx33XVi3rx5fvvs2LFD3HHHHSIuLk4YjUaRnJwshg4dKtasWVNmHVRIEiJEz44TERFdRtXnsIiISDkYWEREpAgMLCIiUgQGFhERKQIDi4iIFIGBRUREisDAIiIiRWBgERGRIjCwiIhIERhYRESkCAwsIiJSBAYWEREpAgOLiIgUgYFFRESKwMAiIiJFYGAREZEiMLCIiEgRGFhERKQIDCwiIlIEBhYRESkCA4uIiBSBgUVERIrAwCIiIkVgYBERkSIwsIiISBEYWEREpAgMLCIiUgQGFhERKQIDi4iIFIGBRUREisDAIiIiRWBgERGRIjCwiIhIERhYRESkCAwsIiJSBAYWEREpAgOLiIgUgYFFRESKwMAiIiJFYGAREZEiMLCIiEgRGFhERKQIDCwiIlIEndwFEMlNOJ3wZmdD2O3w5uRA5ORA5OdDeL2AxwN4vYDXW/i914uMtCY4HZcISQI0kCBJ8Pu/UauBSaeFSaeBSVv4r17Lz4ZElcXAorAlXK7CIMrJKQyiywLp8u/hdAZ03OyadXFMnx/QfbQS/ELMqLss1C5tsxm00GkYbESlYWBRWBBOJzynTsFz8qTvy5uRIXdZPh4B5Lo8yHV5ALhK3S/CoEO0UYdok77wy6hn64zoEgYWKY5wueA5fdo/nC5cAISQu7RKy3G6keN0488ch2+bVa/1hVdRkBkZYqRCDCwKacLj+avldOlf77lzYRFO5VXUMjtxWYiZdVpEm3SIMemRYDYi1qyHJEkyVklU9RhYFHJEQQFcBw7AvW8fXAcOAAUFcpcUcvLdHuTbPThlLwBgh0GrQaLViESrETWtRnYjUlhiYFFI8GZnw7VvH9x//AF3enrhyDwqN6fHi2PZ+TiWnQ8JQLzFgESrEbVsJtgM/DWn8MCfZJKN58wZuP74A+59++A5dUrucsKGAHAuz4lzeU7sOZcDm16LRJsJtWxGxJkN0LDrkBSKgUXVRni98Bw7Btcff8C1bx9EZqbcJamC3eXBwYu5OHgxF3qNhJqXWl5JNhO0GoYXKQcDi6qc59QpOLdtg+v33yHyA7t+iYLL5RU4nuPA8RwHDFoJyZEW1I+2sNuQFIE/pVQlhNMJ1969cG7fDs/Jk3KXQyVwegQOXMzFgYu5SLAYUD/agiSbiV2GFLIYWBRUnjNn4Ny2Dc49ezi6T0GKznkZtRqkRJlRP9oCi55/Hii08CeSKk0IAfcff6BgyxZ4jh2TuxyqhAKPF/sycrEvIxc1rUbUj7agltXIa7woJDCwqMKE0wnnjh1w/vQTvBcvyl0OBdmZ3AKcyS2AWadBSpQFKdEWmHVaucsiFWNgUcC8WVko+OknOH/5hd1+KpDv9uL3C3bsy7AjJcqCJnE2mBhcJAMGFpWb125Hwfr1cO7YwQt7VcgrgMOZeTialY/UGAsaxdpg4IwaVI0YWHRVwulEwQ8/oODHHwNeioPCj0cI7M/IxZHMPKTFWNEw1splUahaMLCoVMLrhfOXX1CwYQOE3S53ORRiXF6B3y/YcTgzD41irWgQbeWFyFSlGFhUItcff8CxZg2858/LXQqFuAKPF3vO5eDAxVw0ibMhJcrCa7moSjCwyI/7+HE4Vq/m8HQKmMPtxc4z2TiQkYumcTbUjTRzODwFFQOLAACejAw41qyB+7ff5C6FFC7X5cG201nYn5GLFjUiUdNqlLskChMMLJXz5uaiYMMGOLdv58g/Cqpspxubj2egXqQZLWtEckQhVRoDS8WcO3Ygf+VKXktFVepYdj7O5Bagdc1I1I4wy10OKRgDS4W8djvyv/kG7v375S6FVKLA48VPJzORZHOgdc1IXnhMFcLAUhnXb78hf+lSLvNBsjhpd+B8XgFa1IhEcpRF7nJIYRhYKiHy85G/fDlce/bIXQqpnNMrsP10Fo7nONCmZhQsera2qHwYWCrgOngQ+UuWQOTkyF0Kkc+Z3AJ8l34OzeIj0CDawiHwdFUMrDAmnE44Vq0qHAFIFILcXoFdZ7NxPMeBtolRiODKx1QG/nSEKfexY8j/+msu+0GKcCHfiTXp59CyRiQaRFvlLodCFAMrzAi3G4516+D88UdACLnLISo3rwB2nslGpsOF1jWjOL0TFcPACiOe8+eRt2ABvGfPyl0KUYWlZ+Uju8CNDrVjuGAk+eGl52HCffgw7P/9L8OKwkKGw4W16edxPo/L2dBfGFhhoGDbNuTOmQM4HHKXQhQ0BR4vvv/zAg5dzJW7FAoR7BJUMCEEHCtXwvnTT3KXQlQlBIBdZ/86r8X1ttSNgaVQoqAAeV9+CfeBA3KXQlTljmbnI9vpRoekGF5orGLsElQgb2Ym7J98wrAiVbnocGHd0fM4l8fJmtWKgaUw7uPHYf/4Yw6uIFUq8Hix6c8MHOR5LVVil6CCOPfsQf6SJYDbLXcpRLIRAHafzUZOgRuta0ZySicVYWApgBACBevXo2DjRrlLIQoZR7Ly4PJ6cW2taF5krBIMrBAn3G7kf/01XL/+KncpRCHneI4Dbu9FdEiK4QhCFeA5rBAmXC7kzpnDsCIqw+ncAmw+ngGX1yt3KVTFGFghSrhcyJ07F570dLlLIQp55/Od2PRnBpwehlY4Y2CFIOF0InfOHIYVUQAuOlzYeOwCCtwMrXDFwAoxwuksbFkdPSp3KUSKk+10Y9Nxhla4YmCFEIYVUeVlFVwKLXYPhh0GVogQLhdy581jWBEFQVaBG5v+ZGiFGwZWCBAeD/IWLOA5K6IgYmiFHwaWzIQQyP/6a84LSFQFsgrc2PxnBtxerr4dDhhYMnMsXQrX3r1yl0EUtjILXNh26iKEYGgpHQNLRvmrV8P5yy9yl0EU9k7aC/Dr+Ry5y6BKYmDJxLFpE5w//CB3GUSqsT8jF+mZeXKXQZXAwJKBa98+FKxZI3cZRKqz40wW19NSMAZWNfNcuIC8r76SuwwiVRIAtpy4iBwnl+hRIgZWNRJOJ/LmzwcK+AmPSC4ur8APxzM43F2BGFjVKG/xYnjPnZO7DCLVy3V58NOJi/By5KCiMLCqScGmTXD/9pvcZRDRJefznfjldJbcZVAAGFjVwHXoEBxr18pdBhFd4Vh2PvZdsMtdBpUTA6uKeTMzkf/llwC7HohC0q/nc3AiJ1/uMqgcGFhVSLhcyJ0/HyKfvwxEoWzbqSyOHFQABlYVyl+6FN7Tp+Uug4iuwiMEtp3K5CCMEMfAqiIFP/0E1+7dcpdBROV00eHi+awQx8CqAu6jR+FYtUruMogoQH9csCMj3yl3GVQKBlaQifx85C1cCHh5USKR0ggA205lcjmSEMXACrL8Vasg7OxWIFIqu8uDveey5S6DSsDACiL34cNw7dwpdxlEVEmHM/NwJpdTqIUaBlaQCJcL+UuXyl0GEQXJ9tOZcHK+wZDCwAoSx/r18F68KHcZRBQkDrcXO85w6qZQwsAKAs+pU3D++KPcZRBRkJ3IceBYFhd9DBUMrEoSXi/ylizh1EtEYWrX2WzkuTxyl0FgYFWa84cfOJsFURhzeQW2n86E4IdS2TGwKsGTkQHHhg1yl0FEVexcnhPHcxxyl6F6DKxKyP/mG8DNCTOJ1ODX8znw8IJiWTGwKsj5yy/wpKfLXQYRVZM8lwcHL+bKXYaqMbAqwGu3w7F6tdxlEFE125dhR4GbAzDkwsCqAMeKFRAO9mcTqY3bK/AbZ3SXDQMrQJ6TJ+H69Ve5yyAimaRn5iG7wCV3GarEwAqQY/16uUsgIhkJAHvO5chdhioxsALgPn4c7gMH5C6DiGR2JrcAZzk5brVjYAWgYN06uUsgohCx51w2LyauZgyscnIfOwb34cNyl0FEISKrwI2jWflyl6EqDKxycrB1RURX+O18DtxcXbzaMLDKwZ2ezouEiagYh8eL/Rm8mLi6MLDKga0rIirNgYxcLvRYTRhYV+E6dAieY8fkLoOIQpRHCBzJ5JpZ1YGBdRUFvO6KiK7icGYuvBwxWOUYWGVwHTgAz/HjcpdBRCEu3+3FCS4/UuUYWGVg64qIyoszuVc9BlYpXPv2wXPypNxlEJFCXHS4cCHfKXcZYY2BVYqCLVvkLoGIFOYgh7hXKQZWCTznz/O6KyIK2Em7A7kurkJeVRhYJXBu2yZ3CUSkQALAoYsc4l5VGFhXEC4XXLt2yV0GESlUelYeXJyuqUowsK7g+vVXriZMRBXm9gpOiltFGFhXYHcgEVXWoYu5XHqkCjCwLuM5fRqeEyfkLoOIFC7X5cFJOxd4DDYG1mWcO3bIXQIRhYn0LA6+CDYG1iXC44Fr7165yyCiMHE2t4CzuAcZA+sS98GDEHn8REREwSEAnLJzAFcwMbAucXIoOxEFGSfEDS4GFgCRnw/3/v1yl0FEYeZsXgFc7BYMGgYWAOfevYDHI3cZRBRmvILdgsHEwALg2r1b7hKIKEwdZ7dg0Kg+sLx5ebz2ioiqDLsFg0f1geU+dAjgFelEVEW8AjiVy4uIg4GBdeiQ3CUQUZg7kcO5BYOBgcXAIqIqdia3gDO4B4GqA8tz5gyE3S53GUQU5rwCOM25BStN1YHF1hURVRd2C1YeA4uIqBqczi2Ax8sBXpWh2sASLhfcR4/KXQYRqYRXABcdTrnLUDTVBpY7PZ2zWxBRtbqQ75K7BEVTb2CxO5CIqtmFfLawKoOBRURUTTIcbGFVhioDy5uVBe/583KXQUQq4/R4keN0y12GYqkysNi6IiK5sFuw4lQZWC4GFhHJJIOBVWGqDCzP8eNyl0BEKsWRghWnusASDgdEdrbcZRCRSuU43XByuZEKUV1gec6elbsEIlI5dgtWDAOLiKiasVuwYlQXWF4GFhHJLINTNFWI6gLLc+6c3CUQkcpl5Lvg5UrnAVNdYLGFRURy8wiBnAJeQBwoVQWW126HyMuTuwwiIuS6OPl2oNQVWGxdEVGIyHWxhRUoVQUWz18RUajIYwsrYOoKLLawiChEsEswcKoKLHYJElGoYAsrcKoKLHYJElGoYAsrcKoJLG9WFlBQIHcZREQACoe2F7gZWoFQTWB5uGAjEYUYtrICo5rAErm5cpdAROSH57ECo57Ays+XuwQiIj9sYQWGgUVEJBMGVmAYWEREMsnjbBcBYWAREcmE57ACw8AiIpJJHoe1B4SBRUQkE68APN7wWxcrJSUF06ZNC/pxGVhERDJyVzKwRo0aBUmSin0dPHgwSBWGDp3cBVQXBhYRhSK38MJYybZDnz59MHPmTL9tCQkJlTpmKFJFC0sIAeFwyF0GkSos+vAdDGqShE9ee8G37fSxdLzx0H0Y3bE57mnXCJMfHYfM81ef23P5nJn4e4/rcFfL+nhmaD8c2L3D7/aZr7+EkR2uwdhu7bDxm0V+t/2w4hu89vcRwXlSVaiyLSwAMBqNSExM9PvSarVYvHgx2rZtC5PJhAYNGuDll1+G2/3XyERJkvDBBx+gf//+sFgsaNq0KX788UccPHgQ3bp1g9VqRadOnXDo0CHffQ4dOoTbbrsNNWvWhM1mQ/v27fHdd9+VWV9mZibGjBmDhIQEREZGokePHti1a1fAz1MVgYWCAkCEXz8xUag5uGcnVs//DMmNr/Ftc+TlYeL9wyBJEl6atQCvzl0Mt8uJ1/9vJLxeb6nH2vztYsz618sY+uDjeHPRSiQ3vgaTxgxH1oXCadZ+XrsKm5Z9hX9+PA/3Pvk8/vP8k8i+eAEAkJuTjblT38DfXnitap9wEFTVOazvv/8eI0aMwD/+8Q/89ttv+OCDDzBr1iy8+uqrfvtNmjQJI0aMwM6dO9GkSRMMHz4c48aNw4QJE7Bt2zYIIfDQQw/59rfb7bjllluwZs0a7NixA3369MGAAQNw7NixUmsZMmQIzp49i+XLl2P79u1o27YtevbsiYyMjICekyoCi92BRFUvPzcX0558CH+f9CZskVG+7X/8shXnTvyJh16fhuTGTZHcuCke/td0HNq7C3u2bCr1eN/M+hC9hgxHj0F3oW5aI4x7+Q0YTWas+XIeAODE4QNodl1HpLVohS79B8Jss+Hs8T8BALPffAW9h41AQlKdqn3SQRCMFtbSpUths9l8X0OGDMHLL7+MZ555BiNHjkSDBg1w0003YdKkSfjggw/87jt69GgMHToUjRo1wvjx45Geno67774bvXv3RtOmTfGPf/wD69ev9+3fqlUrjBs3Ds2bN0fDhg0xadIkpKamYsmSJSXWtmnTJmzduhULFizAtddei4YNG2Ly5MmIjo7GwoULA3qeqjiHxcAiqnofT3wW7br1RKtON+LL/0z3bXc5nYAkQW8w+LYZjEZIGg3+2L4VrTrdWOxYLqcTh37djYFj//pkr9Fo0LJjF+zfuR0AkNy4GVZ/MQf2rEyc+fMYnA4HEuul4PftP+Hwb3vwtxdfr8JnGzzBCKzu3bvjP//5j+97q9WKli1bYvPmzX4tKo/HA4fDgby8PFgsFgBAy5YtfbfXrFkTANCiRQu/bQ6HA9nZ2YiMjITdbsdLL72EZcuW4dSpU3C73cjPzy+1hbVr1y7Y7XbExcX5bc/Pz/fraiwPVQSWl4FFVKU2Lfsah3/bgzcWflvstkat28FktmD25Fdx92PPQAjgs7dehdfjwcVzJS+qmnMxA16PB9Fx/gMHouLjceJI4ei3Nl264cYBd2D8kFtgMJrw8L+mw2i24MOXJuCh16dh5bxPsfyzTxARE4u/T3wT9Ro2Dv4TDwIvKh9YVqsVaWlpftvsdjtefvll3HHHHcX2N5lMvv/r9Xrf/yVJKnVbUfftk08+idWrV2Py5MlIS0uD2WzG4MGD4XQ6S6zNbrejVq1afq20ItHR0eV7gpeoIrDgcsldAVHYOn/qBD557QW88MnnMBhNxW6Pio3DE9M+wIcvT8C3s/8LSaPBDf1uR4NrWkDSVO6sxJ0PP4k7H37S9/0X776Flp26QKvX4cv3p2PKkrXYvm413hn/CN5ctLJSj1VVqur0etu2bbFv375iQVZZmzdvxqhRozBw4EAAhYGUnp5eZh2nT5+GTqdDSkpKpR5bHYF16RNCKHp93Tq8sWGD37aGcXH4+eGHAQCztm3Dgj17sPvUKeQ4nUgfPx7RZvNVj/vR1q14e/NmnLXb0TwxEf/u2xft6vzVn//sihWYu3MnrAYDXuzVC0Mv6xb4+tdfMW/XLswfPjxIz5LC2aFfdyPrwnk8dUdv3zavx4Pftm3B8jkz8fnudLS+oRtmrP4R2RcvQKvVwRoZhftvaIWadeuVeMyImFhotFpkXvAfSZh1/jyi40sern388AFs+GYRJi9ahbVfzkPTa69HVGwcOvW9Fe899zjy7XaYbbbgPfEgEVWUWC+88AL69++PevXqYfDgwdBoNNi1axf27t2LV155pcLHbdiwIRYtWoQBAwZAkiT885//LHPwTK9evdCxY0fcfvvt+Pe//41GjRrh5MmTWLZsGQYOHIhrr7223I8tW2Clp6ejfv362LFjB1q3bl21DxbCgQUATRMS8PWIv4bf6i771JnncqFXWhp6paXh5TVrynW8RXv34rmVKzGlf39cW7s2/rNlC+747DNse+ghJNhsWL5vHxbu2YOv7r0XhzIy8NDixeiZmoo4qxVZDgcmrVnjVw9RWVpe3wVTl6z12/bus4+hdoM0DBzzILRarW97ZEzheYw9WzYh68J5tO9+c4nH1BsMSG3WEnt+3IQOvfoCKOyS2r1lE/reParY/kIIfPDCeIwa/yLMViu8Xi887sKelaJ/vd7QnAapqsYv9+7dG0uXLsXEiRPxxhtvQK/Xo0mTJhgzZkyljjtlyhTcd9996NSpE+Lj4zF+/HhkZ2eXur8kSfj222/x3HPPYfTo0Th37hwSExNx4403+s6ZlVdAgTVq1Ch8+umnGDduHN5//32/2x588EHMmDEDI0eOxKxZswIqospVstuhqmk1GtSMiCjxtgc6dgQAfH/kSLmP996PP2Jk27a4p00bAMDU/v2x6sABfLZjBx7r0gX7z53DDSkpaFO7NtrUro0JK1bgaGYm4qxWvLh6Ne5r3x51A+xbVhOpjE+TamS22VCvURO/bSazBRHRMb7ta7/8HHVSGyIyNg77dm7HJ6++gP4jx6J2g7+6q14aNRTX9eqDW+65DwAwYNRYvPPMo0ht3goNW7bB0k8/QkF+HnrccVexGr5bMBeRsXFo36MwAJu0bY8v3n0L+3duxy8b16JOWiNYLxu5GEoq28Aq6+9t79690bt371Jvv7J1l5KSUmxbt27d/LalpKRg7Vr/DygPPvig3/dXdhFGRETg7bffxttvv11qLeURcAurbt26+PzzzzF16lSYL3VNORwOzJ07F/Xqldy8l1tl+8mr2uGMDDSZPBlGnQ7X1a2LF3r2rHBgON1u7Dx5Eo/dcINvm0ajQdcGDbD1+HEAQPPERMzavh2Z+flIv3gRDpcLDWJj8ePRo9h16hTe6tcvGE8rbOmcBXKXoDgn0g9hztTXYc/KREJSXQz6+yMYMGqs3z6nj6Uj5+Jf1+V0vuU2ZGVcwOfvvInMc+dQv2kzPP/RnGJdgpnnz+HL96fjtXl/Datu2LINBoweh1fHjUBUXBwe/td0hCpeIVp+AQdW27ZtcejQISxatAh33303AGDRokWoV68e6tev79tvxYoVeOWVV7B3715otVp07NgR06dPR2pqaqnH3rt3L5566il8//33sFqtuPnmmzF16lTEx8dX4KldJoQD69o6dTDj9tuRFheHM3Y73li/Hn1nzsSPDzyACKMx4ONdyMuDRwjUuKKvvobVigPnCy+47JmWhqEtW6L7hx/CrNdjxsCBsOj1eGLZMsy4/Xb89+ef8eHWrYizWDBtwAA0rVEjKM81XGgdHHV6NRNnf+n3/b1PPId7n3iuzPu8v3ZrsW233HOfr8VVmuj4hBLvO/TBxzH0wcfLUa28vJzUoNwq9Jf8vvvu85u36pNPPsHo0aP99snNzcXjjz+Obdu2Yc2aNdBoNBg4cGCpJ+cyMzPRo0cPtGnTBtu2bcOKFStw5swZDB06tCIl+gvhc1g3NWyI25s1Q/PERPRMS8MXd9+NbIcDX/36a5U+7oTu3bHjH//ADw88gAFNm2LKpk3o2qABdBoNJm/ciBX33Yd727bF37/6qkrrUCIdA4uCSKsJ3b9PoaZCgy7uueceTJgwAUePHgVQOMzx888/9xtnP2jQIL/7fPLJJ0hISMBvv/2G5s2bFzvmu+++izZt2uC1117zu0/dunWxf/9+NGrUqCKlFgrhFtaVos1mpMbF4UiAU5YUibNYoJUknLXb/bafzc0t1uoqsv/cOXyxezc2jhuHz3bsQKfkZMRbrRjYrBkeWrwYOQUFFWrthSttXq7cJVAYMSjo75PcKvRKJSQkoF+/fpg1axZmzpyJfv36Feu2O3DgAIYNG4YGDRogMjLSN/6+rKuh161b5ze9SJMmhSdsA70a+krSZRfBhTp7QQGOZGSgZgWH3xp0OrROSsKGywZpeL1ebDx8GNfVKT5NjRACjy5dild794bNaIRHCLgutYJdnsJRVR4OMvCjy2VgUfDotWxhlVeFh7Xfd999vgkR33vvvWK3DxgwAMnJyfjoo4+QlJQEr9eL5s2bl3k19IABA/DGG28Uu61WrVoVLbPQZVPChJrnV65En8aNUTcqCqdzcvD6+vXQajQYfGlqlDM5OThjt/taXL+dPQubwYC6UVGIuTS1yq2ffor+TZpgbIcOAIAHO3bE/331FdokJaHdpWHtuS4X7r40avBy//vlF8RbLOjbuHAWgOvr1sUb69fj5z//xOqDB9EkIaFc132piS7XfvWdiMqJLazyq3Bg9enTB06nE5IkFRs2eeHCBezbtw8fffQRunTpAqBwAsSytG3bFl9++SVSUlKg0wX38jAphAPrZHY2xixciIz8fMRbLLi+Xj18N2YM4q1WAMAn27b5XVh8y6Vzh+/ddpsvgI5kZOBCXp5vnzuaN8f53Fy8tm4dztrtaJGYiC/vuadYl+BZux2TN27Eqvvv921rV6cOHuzYEUPnzkWC1Yr/3H57VT11xdLac+QugcKIXsvAKq8KJ4NWq8Xvv//u+//lYmJiEBcXhw8//BC1atXCsWPH8Mwzz5R5vAcffBAfffQRhg0bhqeffhqxsbE4ePAgPv/8c3z88cfFHiMQoRxYnwwZUubtE7p3x4Tu3cvcZ89jjxXbNrZDB1+LqzQ1bLYS7zu+WzeM79atzPuqmeT1QicBbg7uoiAwsEuw3CoV7ZGRkYiMjCx+UI0Gn3/+ObZv347mzZvjsccew5tvvlnmsZKSkrB582Z4PB7cfPPNaNGiBR599FFER0dDU9kms14f0iMFSXl0/HmiIJDgP7MNlU0SVTWRVYjJev11oJTzZ0SB2jp8LHI4FoUqyajVoF9aYNMTqZlqoj2UuwVJeXScn4CCgCMEA6OewLo0iIEoGPQhOpEqKQtHCAZGNa+WhpO5UhDpPG65S6AwwBGCgVHNq6WJiZG7BAojDCwKBgOnZQqIegKLLSwKIp2bq1hT5bGFFRjVvFpsYVEw6TnilILAwMAKiGpeLQYWBZPO6ZC7BAoDJgZWQFTzarFLkIJJW8BFHKnyIozBnYYu3KkmsCS9HlIFZ0AnuhLXxKJgiDAwsAKhmsAC2C1IwaPLz7v6TkRlMGg1MOkqPkeqGjGwiCqAizhSZUWydRUwdQUWz2NRkGjtXBOLKofdgYFTV2CxhUVBouUijlRJkRxwETB1BRZbWBQkuvw8cI4Cqgy2sAKnrsBiC4uCSMdpdagS2MIKnKoCS4qMBHT8IaHg0MtdACmWQSNxhGAFqCuwJAnaWrXkLoPChJ5rYlEF8YLhilFVYAGAtm5duUugMKETXHKYKobnrypGdYGlq1dP7hIoTOi4iCNVUKSRHcoVobrAYguLgkXPNbGogtjCqhjVBZbGYoEmPl7uMigMcE0sqqhotrAqRHWBBQBadgtSEDCwqCKijDoYdar801tpqnzVeB6LgkHn5BIjFLgaFqPcJSgWA4uognQFXMSRApdgNchdgmKpMrA0MTGQIiLkLoMUTsvAogBpJCDezMCqKFUGFgDoOFqQKkmXz0UcKTCxJgN0GtX+2a001b5yHHhBlcVFHClQCRa2ripDtYHF81hUWVzEkQJVw8oBF5Wh2sDS1KwJGPhphypOZ8+RuwRSEJ1GQqyJ119VhmoDS9JooKtTR+4ySMG46jAFIsFigCRxSZrKUG1gAYAuLU3uEkjBNG4XuCQWlRevv6o8VQeWvlkzuUsghdPzEzOVEwdcVJ6qA0sTGcnRglQpXBOLysOk03CG9iBQdWABbGVR5TCwqDzYHRgcDKxrrgHYrUMVxDWxqDxqR5jkLiEsqD6wNDYbtCkpcpdBCsXAoqsxajWoyeuvgkL1gQUAhubN5S6BFIqLONLV1Ik0QcNenKBgYAHQNW0KcH4vqgCdi2tiUdmSIy1ylxA2+FcagMZshi41Ve4ySIF0LqfcJVAIizToEM3ZLYKGgXUJRwtSRXARRypLcpRZ7hLCCgPrEn2TJoBOJ3cZpDAMLCqNBKBuJAMrmBhYl0hGI6dqooBpHVwTi0pWw2qESaeVu4ywwsC6jJ6jBSlAWq6JRaVIZusq6BhYl9E3asQlRyggujwGFhWn10ioZePFwsHGwLqMpNdz8AUFRJvLJUaouDoRZmg5lX/QMbCuYLz+erlLIAXhIo5UknocHVglGFhX0NaoAV2DBnKXQQrBFhZdyabXIs7MUwtVgYFVAkOHDnKXQAohgWtikb/60ZzZoqowsEqga9gQmrg4ucsghdAxr+gSg1bDwKpCDKwSSJLEVhaVG9fEoiJpMRboOC9pleErWwpDq1aQTByWSlenE165S6AQoNdISI22yl1GWGNglUIyGGBo317uMkgB9IJrYhHQIMYKvZZ/UqsSX90yGK6/HtBzpmUqm87DwFI7nSQhLYatq6rGwCqDxmKBoV07ucugEKdzc00stasfbYGRrasqx1f4KoydOgFaTmBJpeMijuqmkYCGsWxdVQcG1lVoIiJgaN1a7jIohHERR3VLibJwVvZqwsAqB2PnzgCHqlIpdE6H3CWQTCQAjWJtcpehGvwrXA6amBjoW7aUuwwKUboCBpZa1Ysyw6Jn66q6MLDKydSjB5ceoRLp8rmIoxpJABqzdVWtGFjlpImIgLFLF7nLoBDERRzVqU6ECTaDTu4yVIWBFQBjx47QxMbKXQaFGF1ertwlUDXTSsA1CRFyl6E6DKwASFotTL17y10GhRguMaI+jeNssOrZuqpuDKwA6Rs1gq5hQ7nLoBCizeEijmpiM2g5MlAmDKwKMPXuzYuJyUfrLOAvkoq0rhEFDddAkwV/zypAGxfH5UfIj07DP2BqUCfChBpWo9xlqBYDq4JMXbtCsrFbgArpmVdhT6eR0KJGpNxlqBoDq4IkgwGmXr3kLoNCBNfECn/XxEXAzCmYZMXAqgR9y5bQ1q0rdxkUAvQMrLAWZdQhNcYidxmqx8CqBEmSYO7TB+AJWNXTebkmVjhrXTMKEn/PZcfAqiRtUhL0bdrIXQbJTO9xy10CVZHkKDPizJyWLRQwsILA1LMnB2CoHBdxDE8GrYTmCRxoESoYWEGgsVhgGThQ7jJIRjon18QKR83iI7mScAjhOxEkugYNCtfNIlXiIo7hp4bFiJQos9xl0GUYWEFk7NED2tq15S6DZKDlmlhhxaTToH0tDrQINQysIJI0GlgGDQKMvBJebbiIY/iQAFxXKwZGXnMVchhYQaaJiYG5f3+5y6BqpuOaWGGjaXwE4i0cFRiKGFhVwNC8OYe6q4yWa2KFhRoWIxrHWuUug0rBwKoi5r59oYmPl7sMqia6PLawlI7nrUIfA6uKSHo9LIMHAzou8qYGWjvXxFKywvNW0TxvFeIYWFVIW7MmTDfdJHcZVA246rCyNY23Id7CwVKhjoFVxYzXXQdd48Zyl0FVTOPxQMueJEWqYTGgMVcQVgQGVjUw33YbpEhO7xLu9Dz3oTiF562ied5KIRhY1UBjNsMyZAjPZ4U5PYTcJVAAeN5KeRhY1URXp07hIAx+kgtbOgaWolwTH8HzVgrDwKpG+saNYe7XT+4yqIrouSaWYqREWdA4juetlIaBVc0M7drB2LWr3GVQFdB5GFhKkGg1ok1NnlNWIgaWDEzdukHftq3cZVCQ6TxcEyvUxZj0uC6JgyyUioElE3O/ftA1aiR3GRREXMQxtFn1WnSsHQOdhn/2lIrvnEwkjQaWwYOhrVNH7lIoSPRcxDFkGbQadK4TCxNHBCoaA0tGkl4Py7Bh0MTFyV0KBYHWWSB3CVQCnUZC5zoxsBl4WYnSMbBkprFYYL3nHkg2jlhSOq6JFXq0EtCpdixiTFwuJBwwsEKAJjoa1rvv5sKPCqdz5MtdAl1GIwHX147l2lZhhIEVIrSJibDeeSegZR+7Umm5iGPIkAC0rxWNmlZ+CAwnDKwQoqtfH5ZBgxhaCqXjIo4ho21iFGpHmOUug4KMgRVi9E2bwnLXXYBeL3cpFCAuMSI/CYVhlRxlkbsUqgIMrBCkT0vjOS0F0toZWHLSShKurx2DFIZV2GJghShdcjJsI0ZAMrNbQyl0+Xng/AnyMGgldKkbi1o2k9ylUBViYIUwbVISrKNGcci7gug0jKzqZtFp0bVuPGLNHA0Y7hhYIU5bowZs990HTWys3KVQOfDMY/WKNOjQNTkOEUZeFKwGDCwF0MTEwHr//dDWri13KXQVXMSx+sSbDehaLw5mTrekGgwshdBYLLCOHAld48Zyl0Jl0Amv3CWoQpLNhM51YqHX8k+YmvDdVhBJr4dl6FAYrr1W7lKoFDou4ljl6kdb0CEpGlqeL1QdBpbCSBoNzP36wdizp9ylUAn0HrfcJYS1a+JtaFMziutZqRQDS6FMN9wAy+DBvFYrxOgYWFVCAtCmZhSaxEXIXQrJiENrFEzfrBlstWohf+FCeE6dkrscAqBzOQF+hggqq16L9rWiOWyd2MJSOm1sLKz33w/DddfJXQoB0HFNrKCqHWFCj2ReY0WFGFhhQNJqYe7bF5ahQwETr/SXE9fECg6NBLSuGYkOSTEcCUg+7BIMI/qmTRFRqxbyFi6E58QJuctRJS0Dq9IiDFpcVysGUSZehk3++NElzGiio2EdPRqG66+XuxRV0jsYWJVRL9KM7snxDCsqEQMrDElaLcy9e8MybBgnz61mWq6JVSFaSUK7xChcWysaOg3/LFHJ+JMRxvSNGsE2bhy0devKXYpqMLACF2XUoUdKPNewoqtiYIU5TVQUrKNGwdi5s9ylqILOniN3CYpSP9qCbvXiEWHg6XS6Ov6UqICk0cDUqxd0jRoh/9tv4T1zRu6SwhYXcSwfq16LljUiuX4VBUQSQnB6aRURXi+cW7fCsX49UMBrhqrCumFj4eVvVYk0EtAo1obGsTbOBUgBYwtLZSSNBsbrr4e+eXM4Vq+Ga/duuUsKO3pJQgE/BxaTaDWiVY1IWNn9RxXEnxyV0thssAwcCHfbtshfvpzdhEGkhwDbrn+x6LVoxe4/CgJ2CRK7CYNs+/C/IdPL7i52/1GwsYVF7CYMMr3wAlD3Krjs/qOqwJ8m8mE3YXDoPG5Ao87Aslwa/ZfE7j+qAuwSpBIJrxfOn39GwcaNEHl5cpejKAcG3Y1jeqvcZVQrg0ZCaowVjdj9R1WILSwqkaTRwNihAwxt28L5yy8o+PFHiKwsuctSBJ3bBahkKjyTVoO0WCsaRFs4pRJVOQYWlUnS6wuD69pr4dqzBwWbN8N7/rzcZYU0ncsJhPkUjha9Fo1irUiOtLBFRdWGgUXlImm1MLRuDX2rVnDv24eCTZu4hEkpdGE80jLCoEPjWCvqRJqhkRhUVL0YWBQQSZKgb9IE+iZN4D5yBAWbNsF9+LDcZYUUbRiuOhxt0qNxrA1JNiMkBhXJhIFFFaarXx+6+vXhOXkSjs2b4f79d4BjeKBz5MtdQtDEmw1oHGdDTatR7lKIGFhUedqkJFiHDIHnwgUUbN5ceB2XxyN3WbLR5is7sDQSUMtmQlqMFXFmg9zlEPlwWDsFnTc3F649e+DctQve06flLqfa5TZoiC3XdZe7jIDFmfWoF2lB7QgTDFqO+KPQw8CiKuU5cwbOnTvh2rMHIlcdixs6atbC5u4D5C6jXKx6LepFmlEv0sxZKSjkMbCoWgivF+6DB+HavRuu/fsBl0vukqqMy2bDxv7D5S6jVAaNhNqRZiRHmhHLLj9SEH6komohaTTQN2oEfaNGEC4X3Pv3w/Xbb3AdOBB24aULwZakRiqc369upAW1bEYOSSdFYmBRtZP0euibNYO+WTMIlwuuS+HlDpPwkoSATpLglrnzwqCVEG82oqbVyPNSFBYYWCQrSa+HoVkzGJo1g/B44Dl5Eu70dHiOHoX7zz8Bp1PuEitELwHuas4rnSQhzmJADYsBCRYjoow6XjNFYYXnsChkCa8XnlOnCsPr6FG4jx0DHA65yyqXn4ePRba3ah9DIwGxJgNqWAsDKsakZ1cfhTW2sChkSRoNdLVrQ1e7NoydOkEIAe+ZM4XhdfQoPEePhuxM8jrhBRDcLjgJhTNOJFgMqGExIs5s4Dx+pCoMLFIMSZKgTUyENjERxg4dAACec+fgOXYMnnPn4M3IKPzKzJT9wmV9JQJLKwE2gw4RRV/Gwn9teh0DilSNgUWKpk1IgDYhwW+bEAIiKwvejAx4ikKs6OviRcDtrvK6dB43oC3718uglf4Kpcu+LHotzz0RlYCBRWFHkiRI0dHQREdD16CB321CCIjs7L8CLDsbwukEXC6IS1+44t8rtxWbL1GSAIMBkl4PyWAADAZESwJemxEGrQZGrQaGy76MWg1seh2MOo7aIwoEB10QBUi43YXhhcJRjpKOn/uIqgMDi4iIFIF9EkREpAgMLCIiUgQGFhERKQIDi4iIFIGBRUREisDAIiIiRWBgERGRIjCwiIhIERhYRESkCAwsIiJSBAYWEREpAgOLiIgUgYFFRESKwMAiIiJFYGAREZEiMLCIiEgRGFhERKQIDCwiIlIEBhYRESkCA4uIiBSBgUVERIrAwCIiIkVgYBERkSIwsIiISBEYWEREpAgMLCIiUgQGFhERKQIDi4iIFIGBRUREisDAIiIiRWBgERGRIjCwiIhIERhYRESkCAwsIiJSBAYWEREpAgOLiIgUgYFFRESKwMAiIiJFYGAREZEiMLCIiEgRGFhERKQIDCwiIlIEBhYRESkCA4uIiBSBgUVERIrw/34a01LGavW2AAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a pie plot showing the distribution of female versus male mice using Pyplot\n",
    "gender_distribution = cleaned_data['Sex'].value_counts()\n",
    "\n",
    "# Create a pie chart using Pyplot\n",
    "plt.pie(gender_distribution, labels=gender_distribution.index, autopct='%1.1f%%', colors=['lightcoral', 'lightblue'], startangle=90)\n",
    "\n",
    "# Set chart title\n",
    "plt.title('Distribution of Female vs. Male Mice')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Quartiles, Outliers and Boxplots"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Final Tumor Volume for Each Mouse:\n",
      "   Mouse ID Drug Regimen  Tumor Volume (mm3)\n",
      "0      a203    Infubinol           67.973419\n",
      "1      a251    Infubinol           65.525743\n",
      "2      a275     Ceftamin           62.999356\n",
      "3      a411     Ramicane           38.407618\n",
      "4      a444     Ramicane           43.047543\n",
      "..      ...          ...                 ...\n",
      "95     y769     Ceftamin           68.594745\n",
      "96     y793    Capomulin           31.896238\n",
      "97     y865     Ceftamin           64.729837\n",
      "98     z578     Ramicane           30.638696\n",
      "99     z581    Infubinol           62.754451\n",
      "\n",
      "[100 rows x 3 columns]\n"
     ]
    }
   ],
   "source": [
    "# List of treatment regimens\n",
    "selected_regimens = ['Capomulin', 'Ramicane', 'Infubinol', 'Ceftamin']\n",
    "\n",
    "# Filter the DataFrame for the selected regimens\n",
    "final_tumor_volume_df = cleaned_data[cleaned_data['Drug Regimen'].isin(selected_regimens)]\n",
    "\n",
    "# Get the last timepoint for each mouse\n",
    "last_timepoint_df = final_tumor_volume_df.groupby('Mouse ID')['Timepoint'].max().reset_index()\n",
    "\n",
    "# Merge with the original DataFrame to get the tumor volume at the last timepoint\n",
    "merged_df = pd.merge(last_timepoint_df, cleaned_data, on=['Mouse ID', 'Timepoint'], how='left')\n",
    "\n",
    "# Display the DataFrame with the final tumor volume for each mouse\n",
    "print(\"Final Tumor Volume for Each Mouse:\")\n",
    "print(merged_df[['Mouse ID', 'Drug Regimen', 'Tumor Volume (mm3)']])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Capomulin's potential outliers: Series([], Name: Tumor Volume (mm3), dtype: float64)\n",
      "Ramicane's potential outliers: Series([], Name: Tumor Volume (mm3), dtype: float64)\n",
      "Infubinol's potential outliers: 15    36.321346\n",
      "Name: Tumor Volume (mm3), dtype: float64\n",
      "Ceftamin's potential outliers: Series([], Name: Tumor Volume (mm3), dtype: float64)\n",
      "\n",
      "Tumor Volume Data for Box Plot:\n",
      "[9     38.982878\n",
      "12    38.939633\n",
      "24    30.485985\n",
      "25    37.074024\n",
      "26    40.159220\n",
      "32    47.685963\n",
      "33    37.311846\n",
      "34    38.125164\n",
      "35    38.753265\n",
      "45    41.483008\n",
      "49    38.846876\n",
      "51    28.430964\n",
      "53    33.329098\n",
      "64    46.539206\n",
      "65    32.377357\n",
      "68    41.581521\n",
      "70    23.343598\n",
      "72    40.728578\n",
      "73    34.455298\n",
      "78    31.023923\n",
      "82    40.658124\n",
      "83    39.952347\n",
      "88    36.041047\n",
      "90    28.484033\n",
      "96    31.896238\n",
      "Name: Tumor Volume (mm3), dtype: float64, 3     38.407618\n",
      "4     43.047543\n",
      "5     38.810366\n",
      "7     32.978522\n",
      "16    38.342008\n",
      "17    33.397653\n",
      "19    37.311236\n",
      "21    40.659006\n",
      "27    29.128472\n",
      "29    33.562402\n",
      "30    36.374510\n",
      "37    31.560470\n",
      "38    36.134852\n",
      "40    22.050126\n",
      "50    30.564625\n",
      "54    31.095335\n",
      "62    45.220869\n",
      "63    36.561652\n",
      "66    37.225650\n",
      "67    43.419381\n",
      "71    30.276232\n",
      "77    40.667713\n",
      "87    43.166373\n",
      "94    44.183451\n",
      "98    30.638696\n",
      "Name: Tumor Volume (mm3), dtype: float64, 0     67.973419\n",
      "1     65.525743\n",
      "6     57.031862\n",
      "8     66.083066\n",
      "14    72.226731\n",
      "15    36.321346\n",
      "18    60.969711\n",
      "20    62.435404\n",
      "22    60.918767\n",
      "31    67.289621\n",
      "41    66.196912\n",
      "42    62.117279\n",
      "52    47.010364\n",
      "55    60.165180\n",
      "57    55.629428\n",
      "58    45.699331\n",
      "60    54.656549\n",
      "69    55.650681\n",
      "79    46.250112\n",
      "80    54.048608\n",
      "81    51.542431\n",
      "85    50.005138\n",
      "86    58.268442\n",
      "93    67.685569\n",
      "99    62.754451\n",
      "Name: Tumor Volume (mm3), dtype: float64, 2     62.999356\n",
      "10    45.000000\n",
      "11    56.057749\n",
      "13    55.742829\n",
      "23    48.722078\n",
      "28    47.784682\n",
      "36    61.849023\n",
      "39    68.923185\n",
      "43    67.748662\n",
      "44    57.918381\n",
      "46    46.784535\n",
      "47    59.851956\n",
      "48    64.299830\n",
      "56    59.741901\n",
      "59    61.433892\n",
      "61    64.192341\n",
      "74    45.000000\n",
      "75    52.925348\n",
      "76    45.000000\n",
      "84    67.527482\n",
      "89    45.000000\n",
      "91    64.634949\n",
      "92    61.386660\n",
      "95    68.594745\n",
      "97    64.729837\n",
      "Name: Tumor Volume (mm3), dtype: float64]\n"
     ]
    }
   ],
   "source": [
    "# Put treatments into a list for for loop (and later for plot labels)\n",
    "selected_regimens = ['Capomulin', 'Ramicane', 'Infubinol', 'Ceftamin']\n",
    "\n",
    "# Create empty list to fill with tumor vol data (for plotting)\n",
    "tumor_vol_data = []\n",
    "\n",
    "# Loop through each regimen\n",
    "for regimen in selected_regimens:\n",
    "    # Locate the rows which contain mice on each drug and get the tumor volumes\n",
    "    tumor_vol = merged_df.loc[merged_df['Drug Regimen'] == regimen, 'Tumor Volume (mm3)']\n",
    "    \n",
    "    # Append subset to tumor_vol_data\n",
    "    tumor_vol_data.append(tumor_vol)\n",
    "    \n",
    "    # Calculate the IQR and quantitatively determine if there are any potential outliers\n",
    "    quartiles = tumor_vol.quantile([0.25, 0.5, 0.75])\n",
    "    lower_q = quartiles[0.25]\n",
    "    upper_q = quartiles[0.75]\n",
    "    iqr = upper_q - lower_q\n",
    "    \n",
    "    # Determine outliers using upper and lower bounds\n",
    "    lower_bound = lower_q - 1.5 * iqr\n",
    "    upper_bound = upper_q + 1.5 * iqr\n",
    "    \n",
    "    # Identify potential outliers\n",
    "    outliers = tumor_vol[(tumor_vol < lower_bound) | (tumor_vol > upper_bound)]\n",
    "    \n",
    "    # Print results\n",
    "    print(f\"{regimen}'s potential outliers: {outliers}\")\n",
    "\n",
    "# Display the tumor volume data for later use in box plot\n",
    "print(\"\\nTumor Volume Data for Box Plot:\")\n",
    "print(tumor_vol_data)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a box plot for each treatment group using tumor_vol_data\n",
    "plt.boxplot(tumor_vol_data, labels=selected_regimens, flierprops=dict(markerfacecolor='red', marker='D'))\n",
    "\n",
    "# Set chart title and labels\n",
    "plt.title('Distribution of Tumor Volume for Each Treatment Group')\n",
    "plt.xlabel('Drug Regimen')\n",
    "plt.ylabel('Tumor Volume (mm3)')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Line and Scatter Plots"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "\n",
    "# mouse treated with Capomulin \n",
    "selected_mouse_id = 'l509'\n",
    "capomulin_data_single_mouse = cleaned_data[(cleaned_data['Drug Regimen'] == 'Capomulin') & (cleaned_data['Mouse ID'] == selected_mouse_id)]\n",
    "\n",
    "# Check if data exists for the selected mouse\n",
    "if capomulin_data_single_mouse.empty:\n",
    "    print(f\"No data found for Mouse ID {selected_mouse_id} in the Capomulin regimen.\")\n",
    "else:\n",
    "    # Plot the line chart\n",
    "    plt.plot(capomulin_data_single_mouse['Timepoint'], capomulin_data_single_mouse['Tumor Volume (mm3)'], marker='o', color='b')\n",
    "\n",
    "    # Set chart title and labels\n",
    "    plt.title(f'Tumor Volume vs. Time Point for Mouse {selected_mouse_id} (Capomulin)')\n",
    "    plt.xlabel('Timepoint')\n",
    "    plt.ylabel('Tumor Volume (mm3)')\n",
    "\n",
    "    # Show the plot\n",
    "    plt.show()\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a scatter plot of mouse weight vs. the average observed tumor volume for the entire Capomulin regimen\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Filter data for the Capomulin regimen\n",
    "capomulin_data = cleaned_data[cleaned_data['Drug Regimen'] == 'Capomulin']\n",
    "\n",
    "# Calculate the average observed tumor volume for each mouse\n",
    "average_tumor_volume = capomulin_data.groupby('Mouse ID')['Tumor Volume (mm3)'].mean()\n",
    "\n",
    "# Merge the average tumor volume with the mouse metadata to get the corresponding weights\n",
    "merged_data = pd.merge(average_tumor_volume, mouse_metadata, on='Mouse ID', how='inner')\n",
    "\n",
    "# Create a scatter plot\n",
    "plt.scatter(merged_data['Weight (g)'], merged_data['Tumor Volume (mm3)'], marker='o', facecolors='blue', edgecolors='black', alpha=0.75)\n",
    "\n",
    "# Set chart title and labels\n",
    "plt.title('Mouse Weight vs. Average Tumor Volume (Capomulin)')\n",
    "plt.xlabel('Weight (g)')\n",
    "plt.ylabel('Average Tumor Volume (mm3)')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Correlation and Regression"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAjIAAAHHCAYAAACle7JuAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjguMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8g+/7EAAAACXBIWXMAAA9hAAAPYQGoP6dpAAB3sElEQVR4nO3deVhUZRsG8HvY91ERRBRl0URUxKUMEc19S80sM63cyh0V1MrSkHKpTyXNLbNSK01zzSz1cxfXTAXM3EWwxE9A2WWd9/tjYmSYAWdwVrh/18Wl854z5zycGeY8864SIYQAERERkRmyMHYARERERJXFRIaIiIjMFhMZIiIiMltMZIiIiMhsMZEhIiIis8VEhoiIiMwWExkiIiIyW0xkiIiIyGwxkSEiIiKzxUSGTNK6desgkUhw+/btSj/3jz/+0H1gRFXE0/yNmYoJEyage/fuxg7DpN2+fRsSiQTr1q1TlM2ZMwcSiaRSx/vyyy/RoEED5Ofn6yjCp8dERgdKPhAkEgmOHz+usl0IAS8vL0gkErz44otGiFA37t+/D4lEgilTpqhsmzJlCiQSCSIjI1W2vfXWW7C2tkZubq4hwtTKypUrlf7ATVlxcTE8PT0hkUiwZ88eY4djMkr+9p70c+TIEWOHWimFhYWoXbs2OnToUO4+JZ8xrVu3NmBkxpWQkICvv/4aH3zwgcq2zMxMREVFoWXLlnBycoK9vT2aN2+O9957D3fv3jVCtFXHiBEjUFBQgNWrVxs7FAUrYwdQldjZ2WHjxo0qHzhHjx7F33//DVtbWyNFphvu7u5o3Lix2mTtxIkTsLKywokTJ9Rua9WqFRwcHDQ+15tvvokhQ4bo/ZqtXLkStWvXxogRI/R6Hl04dOgQkpOT4e3tjQ0bNqB3797GDskkfP/990qPv/vuO+zfv1+lvGnTpoYMS2esra3x6quvYvXq1UhMTETDhg1V9jl27Bj+/vtvhIeHGyFC41i6dCl8fHzQuXNnpfJbt26hW7duSEpKwquvvooxY8bAxsYG8fHx+Oabb7Bjxw5cu3bNSFGbhlmzZuH999+v1HPt7OwwfPhwREdHIywsrNI1Ozol6KmtXbtWABAvv/yyqF27tigsLFTa/s4774g2bdqIhg0bir59+xopSt0YOXKksLS0FFlZWYqy7OxsYWVlJYYOHSqcnJxEUVGRYtvdu3cFABEeHm6wGEtej7Nnzz5x32bNmolOnTrpPygdeOutt0Tr1q3F0qVLhaOjo8jOzjZ4DMY4p7YmTpwozPGjTSaTidzcXLXbYmJiBACxYMECtdvHjBkjLCwsxD///KPx+Ur+ThISEioTrlEVFBSI2rVri1mzZimVFxYWipYtWwoHBwcRExOj8ryMjAzxwQcfGCpMk5CQkCAAiLVr1+rsmH/88YcAIA4ePKizYz4NNi3p0Ouvv460tDTs379fUVZQUICtW7di6NChap+Tk5ODadOmwcvLC7a2tmjSpAkWLVoEUWpRcnVtnCUkEgnmzJmjeJyVlYWpU6fC29sbtra2cHd3R/fu3XH+/Hml5505cwa9evWCVCqFg4MDOnXqpLY2pawOHTqguLgYp0+fVjpWUVERpk+fjuzsbMTGxiq2lRyzdC2VJudW134vk8kwZ84ceHp6wsHBAZ07d8Zff/0Fb29vtTUq+fn5iIiIgJubGxwdHTFw4ECkpKQotnt7e+PSpUs4evSoovnhhRdeUPt7FxYWolatWhg5cqTKtszMTNjZ2WH69OmKsmXLlqFZs2ZwcHBAzZo10bZtW2zcuFHtsTXx6NEj7NixA0OGDMHgwYPx6NEj/Pzzz4rtixYtgkQiQWJiospzZ86cCRsbGzx8+FBRpslrUNKO/tdff2Ho0KGoWbOm4nWMj4/HiBEj4OvrCzs7O3h4eGDUqFFIS0tTOf+RI0fQtm1b2NnZwc/PD6tXry63jf6HH35AmzZtYG9vj1q1amHIkCG4c+dOpa9bifLeIy+88ILSa37kyBFIJBL89NNPiIqKQr169eDs7IxXXnkFGRkZyM/Px9SpU+Hu7g4nJyeMHDlSpa9AUVERPvnkE/j5+cHW1hbe3t744IMPVPbz9vbGiy++iH379qFt27awt7cvt7o+JCQE3t7eat9DhYWF2Lp1Kzp37gxPT08A8tq70NBQODo6okaNGhgwYAAuX778xOtU9vOkdKylr1/J3+fx48cxefJkuLm5oUaNGhg7diwKCgqQnp6Ot956CzVr1kTNmjXx7rvvKn2mAfK/5yVLlqBZs2aws7NDnTp1MHbsWKX3aXmOHz+O1NRUdOvWTal827ZtiIuLw4cffqi2Kc7FxQXz5s1TPI6JicGrr76KBg0awNbWFl5eXggPD8ejR4+UnjdixAg4OTnh1q1b6NmzJxwdHeHp6YmPP/5Y5ffS5DMdkF/rSZMmYcuWLQgICIC9vT2Cg4Nx8eJFAMDq1avRqFEj2NnZ4YUXXlDpy6Tpe1oddX9/JfHs3LkTzZs3h62tLZo1a4a9e/eqPL9NmzaoVauW0meQMTGR0SFvb28EBwfjxx9/VJTt2bMHGRkZGDJkiMr+Qgj0798fn3/+OXr16oXo6Gg0adIEM2bMQERERKViGDduHFatWoVBgwZh5cqVmD59Ouzt7ZU+xA4dOoSOHTsiMzMTkZGRmD9/PtLT09GlSxf8/vvvFR6/5MOhdPPSiRMn8Mwzz6BVq1aoX7++0g2xbCLzNOeeOXMmoqKi0LZtWyxcuBCNGzdGz549kZOTo3b/sLAwxMXFITIyEuPHj8cvv/yCSZMmKbYvWbIE9evXh7+/P77//nt8//33+PDDD9Uey9raGgMHDsTOnTtRUFCgtG3nzp3Iz89XvMZr1qzB5MmTERAQgCVLliAqKgpBQUE4c+ZMhb9fRXbt2oXs7GwMGTIEHh4eeOGFF7BhwwbF9sGDBytuwGX99NNP6NGjB2rWrAlA+9fg1VdfRW5uLubPn4933nkHALB//37cunULI0eOxLJlyzBkyBBs2rQJffr0UfrAvnDhAnr16oW0tDRERUVh9OjR+Pjjj7Fz506V88ybNw9vvfUWGjdujOjoaEydOhUHDx5Ex44dkZ6eXulrVxkLFizAvn378P7772PUqFHYvn07xo0bh1GjRuHatWuYM2cOXn75Zaxbtw6fffaZ0nPffvttfPTRR2jdujU+//xzdOrUCQsWLFD7GXD16lW8/vrr6N69O5YuXYqgoCC18UgkEgwdOhQXL17EpUuXlLbt3bsXDx48wLBhwwAABw4cQM+ePXH//n3MmTMHEREROHnyJEJCQnTesTcsLAzXr19HVFQU+vfvj6+++gqzZ89Gv379UFxcjPnz56NDhw5YuHChSlPf2LFjMWPGDISEhGDp0qUYOXIkNmzYgJ49e6KwsLDC8548eRISiQStWrVSKt+1axcAedO0JrZs2YLc3FyMHz8ey5YtQ8+ePbFs2TK89dZbKvsWFxejV69eqFOnDv7zn/+gTZs2iIyMVOoXqO1nekxMDKZNm4bhw4djzpw5uHz5Ml588UWsWLECX3zxBSZMmIAZM2bg1KlTGDVqlEa/09M4fvw4JkyYgCFDhuA///kP8vLyMGjQILVfUFq3bq3Rl1+DMGJtUJVRuilj+fLlwtnZWVFF/Oqrr4rOnTsLIYRK09LOnTsFADF37lyl473yyitCIpGIGzduCCEqrhoEICIjIxWPpVKpmDhxYrmxymQy0bhxY9GzZ08hk8kU5bm5ucLHx0d07979ib+vu7u76Nq1q+Jxz549xciRI4UQQgwePFi8+uqrim1t27YVjRs31vrcZau97927J6ysrMRLL72kFMucOXMEADF8+HCV53br1k3pPOHh4cLS0lKkp6cryrRpWtq3b58AIH755Rel8j59+ghfX1/F4wEDBohmzZppdExNvfjiiyIkJETx+KuvvhJWVlbi/v37irLg4GDRpk0bpef9/vvvAoD47rvvhBDavQaRkZECgHj99ddV4lHXBPLjjz8KAOLYsWOKsn79+gkHBwelJo/r168LKysrpeaf27dvC0tLSzFv3jylY168eFFYWVmplFdEXdNSw4YNld4jJTp16qT0+h8+fFgAEM2bNxcFBQWK8tdff11IJBLRu3dvpecHBweLhg0bKh7HxsYKAOLtt99W2m/69OkCgDh06JBSTADE3r17Nfq9Ll26JACImTNnKpUPGTJE2NnZiYyMDCGEEEFBQcLd3V2kpaUp9omLixMWFhbirbfeUpSpa1oq+3lSOlZ1f2Nl30fBwcFCIpGIcePGKcqKiopE/fr1la5zSVPZhg0blM6zd+9eteVlvfHGG8LV1VWlvFWrVkIqlVb43NLUvY8XLFggJBKJSExMVJQNHz5cABBhYWGKMplMJvr27StsbGxESkqKEELzz3Qh5Nfa1tZW6fqvXr1aABAeHh4iMzNTUT5z5kyV10rT97S6+0fJ33ZpAISNjY1SjHFxcQKAWLZsmcp5xowZI+zt7VXKjYE1MjpWUu2/e/duZGVlYffu3eU2K/3222+wtLTE5MmTlcqnTZsGIUSlRqbUqFEDZ86cKbdnfmxsLK5fv46hQ4ciLS0NqampSE1NRU5ODrp27Ypjx45BJpNVeI6QkBCcOXMGxcXFkMlkOH36NNq3b6/YVpKl5+bmIjY2VlEb8zTnPnjwIIqKijBhwgSl8rCwsHLjHDNmjFL1aWhoKIqLi9U2v2iiS5cuqF27NjZv3qwoe/jwIfbv34/XXntNUVajRg38/fffOHv2bKXOU1ZaWhr27duH119/XVE2aNAglRqY1157DefOncPNmzcVZZs3b4atrS0GDBgAoHKvwbhx41Risre3V/w/Ly8PqampeP755wFA0YxZXFyMAwcO4KWXXlI0eQBAo0aNVDoqb9++HTKZDIMHD1bElJqaCg8PDzRu3BiHDx/W+ro9jZKRdiXatWsHIYTKt+J27drhzp07KCoqAiD/mwag8u172rRpAIBff/1VqdzHxwc9e/bUKKaAgAC0atUKmzZtUpTl5ORg165dePHFF+Hi4oLk5GTExsZixIgRqFWrlmK/wMBAdO/eXRGfrowePVrpb6zkOo0ePVpRZmlpibZt2+LWrVuKsi1btkAqlaJ79+5Kr3ebNm3g5OT0xNc7LS1NUcNYWmZmJpydnTWOv/T7OCcnB6mpqWjfvj2EELhw4YLK/qVrdEuaYgoKCnDgwAEA2n+md+3aFd7e3orH7dq1AyD/+y79e5SUl76G+tCtWzf4+fkpHgcGBsLFxUXteWvWrIlHjx6ZxGhUjlrSMTc3N3Tr1g0bN25Ebm4uiouL8corr6jdNzExEZ6enip/eCWjKypzw/3Pf/6D4cOHw8vLC23atEGfPn3w1ltvwdfXFwBw/fp1AMDw4cPLPUZGRobaD4kSHTp0wI4dOxAbGwtra2tkZGQgJCQEANC+fXvcvXsXt2/fRkJCAoqKihSJzNOcu+RaNGrUSKm8Vq1a5cbaoEEDpccl+2nSBq+OlZUVBg0ahI0bNyI/Px+2trbYvn07CgsLlRKZ9957DwcOHMBzzz2HRo0aoUePHhg6dKjiGmlr8+bNKCwsRKtWrXDjxg1Febt27bBhwwZMnDgRgLwJKCIiAps3b8YHH3wAIQS2bNmC3r17w8XFBUDlXgMfHx+VfR48eICoqChs2rQJ9+/fV3k+IB+u/+jRI5XXDFB9Ha9fvw4hBBo3bqw2ptJJhSGUfe9IpVIAgJeXl0q5TCZDRkYGXF1dkZiYCAsLC5Xfz8PDAzVq1FD5m1Z3bSsybNgwTJ8+HSdPnkT79u2xc+dO5ObmKpqVSo7fpEkTlec2bdoU+/btQ05ODhwdHbU6b3m0uU6l/+6uX7+OjIwMuLu7qz1u2feUOqJMnxMA5d50y5OUlISPPvoIu3btUvlcKHkfl7CwsFB8jpZ45plnAEDRZKftZ7o21w+o/GeXpsrGA8g/N9Wdt+T6m8KoJSYyejB06FC88847uHfvHnr37o0aNWo81fHKe6MUFxerlA0ePBihoaHYsWMH/vvf/2LhwoX47LPPsH37dvTu3VvxbXvhwoXltsc7OTlVGE/pfjI2NjaoVasW/P39AQBBQUFwcHDA8ePHkZCQoLS/Ls6tDUtLS7Xl6j4ANTVkyBCsXr0ae/bswUsvvYSffvoJ/v7+aNmypWKfpk2b4urVq9i9ezf27t2Lbdu2YeXKlfjoo48QFRWl9TlL+sKUlwjdunULvr6+8PT0RGhoKH766Sd88MEHOH36NJKSkpT6cFTmNSj9rbXE4MGDcfLkScyYMQNBQUFwcnKCTCZDr169nlijp45MJlPMj6PudXva90VFf0Pqzlfee0fT95SmH+7qrm1FXn/9dbz77rvYuHEj2rdvj40bN6JmzZro06ePVsfRlrrPGkC761T6GslkMri7uyv18yrNzc2twnhcXV3V3lz9/f1x4cIF3LlzRyUZKKu4uBjdu3fHgwcP8N5778Hf3x+Ojo74559/MGLEiEq9j7X1NO8zbd/TTxOPus/Mhw8fwsHBQev3sD4wkdGDgQMHYuzYsTh9+rRSM0RZDRs2xIEDB5CVlaWUwV+5ckWxHXhck1C2w2N5NTZ169bFhAkTMGHCBNy/fx+tW7fGvHnz0Lt3b0W1oYuLi0qPf021bt1akazY2toiODhY8UdlZWWFZ599FidOnEBCQgLc3d0V31qe5twl1+LGjRtK32LT0tKe6luKtt8mOnbsiLp162Lz5s3o0KEDDh06pLaDsKOjI1577TW89tprKCgowMsvv4x58+Zh5syZsLOz0/h8CQkJOHnyJCZNmoROnTopbZPJZHjzzTexceNGzJo1C4C8eWnChAm4evUqNm/eDAcHB/Tr10/xHF28/g8fPsTBgwcRFRWFjz76SFFeUttTwt3dHXZ2dkq1SCXKlvn5+UEIAR8fH8X7RZdq1qyptsNwYmKiyrfsp9GwYUPIZDJcv35dad6a//3vf0hPT1c7B4w2PD090blzZ2zZsgWzZ8/G/v37MWLECNjY2CjOD8g7EZd15coV1K5du8LaGHXXqaCgAMnJyU8Vd1l+fn44cOAAQkJCKnUj9Pf3x4YNG5CRkaGorQCAfv364ccff8QPP/yAmTNnVniMixcv4tq1a1i/fr1S597So05Lk8lkuHXrltL7s2Q+mpLmIU0/03XBUO/p8iQkJJjM3EzsI6MHTk5OWLVqFebMmaN0EymrT58+KC4uxvLly5XKP//8c0gkEkU/AhcXF9SuXRvHjh1T2m/lypVKj4uLi1WqQ93d3eHp6akY+tmmTRv4+flh0aJFyM7OVomp9PDk8lhZWaFdu3Y4ceIETpw4oegfU6J9+/Y4duwYTp8+rVSL8DTn7tq1K6ysrLBq1Sql8rLXTluOjo5ajYixsLDAK6+8gl9++QXff/89ioqKlJqVAKj08LexsUFAQACEEIrRGLm5ubhy5QpSU1MrPF/JN9Z3330Xr7zyitLP4MGD0alTJ6VvtYMGDYKlpSV+/PFHbNmyBS+++KLSjUsXr3/Jt7ay39KWLFmisl+3bt2wc+dOpT5bN27cUOkr8PLLL8PS0hJRUVEqxxVCqB01oQ0/Pz+cPn1aacTZ7t27dTK0u7SSmpGy1yI6OhoA0Ldv36c+x7Bhw3D//n2MHTsWhYWFimYlQP4lJigoCOvXr1d6X//555/473//+8SaGz8/P5XPma+++qrcGpnKGjx4MIqLi/HJJ5+obCsqKnri32RwcDCEEDh37pxS+SuvvIIWLVpg3rx5OHXqlMrzsrKyFF881L2PhRBYunRpuect/XkjhMDy5cthbW2Nrl27AtD8M10XDPWeLs/58+dVPvuNhTUyelJRH4QS/fr1Q+fOnfHhhx/i9u3baNmyJf773//i559/xtSpU5U6Xb399tv49NNP8fbbb6Nt27Y4duyYyuyUWVlZqF+/Pl555RXF1NwHDhzA2bNnsXjxYgDyG/HXX3+N3r17o1mzZhg5ciTq1auHf/75B4cPH4aLiwt++eWXJ8beoUMHRYe8sk0e7du3x4IFCxT7lXiac9epUwdTpkzB4sWL0b9/f/Tq1QtxcXHYs2cPateuXel22jZt2mDVqlWYO3cuGjVqBHd3d3Tp0qXC57z22mtYtmwZIiMj0aJFC5VvJT169ICHhwdCQkJQp04dXL58GcuXL0ffvn0V39J+//13dO7cGZGRkWrn7SixYcMGBAUFlVtN3r9/f4SFheH8+fNo3bo13N3d0blzZ0RHRyMrK0slydLF6+/i4oKOHTviP//5DwoLC1GvXj3897//VTQlljZnzhz897//RUhICMaPH6/4kG/evLnSfEN+fn6YO3cuZs6cidu3b+Oll16Cs7MzEhISsGPHDowZM0Zpnh5tvf3229i6dSt69eqFwYMH4+bNm/jhhx+U/sZ0oWXLlhg+fDi++uorpKeno1OnTvj999+xfv16vPTSSyqz0FbGoEGDMGHCBPz888/w8vJCx44dlbYvXLgQvXv3RnBwMEaPHo1Hjx5h2bJlkEqlFb7XAPl1GjduHAYNGoTu3bsjLi4O+/btQ+3atZ867tI6deqEsWPHYsGCBYiNjUWPHj1gbW2N69evY8uWLVi6dGm5fQsB+eeKq6srDhw4oPT3am1tje3bt6Nbt27o2LEjBg8ejJCQEFhbW+PSpUuKprh58+bB398ffn5+mD59Ov755x+4uLhg27Zt5dbw2tnZYe/evRg+fDjatWuHPXv24Ndff8UHH3ygaArT5jP9aRnqPa3OuXPn8ODBA8UgAqMz4AipKkvTmWTVzeyblZUlwsPDhaenp7C2thaNGzcWCxcuVBrSKIR8mODo0aOFVCoVzs7OYvDgweL+/ftKwyXz8/PFjBkzRMuWLYWzs7NwdHQULVu2FCtXrlSJ5cKFC+Lll18Wrq6uwtbWVjRs2FAMHjxY45kaS4YiW1lZiZycHKVtaWlpQiKRCADizJkzlTq3uqGhRUVFYvbs2cLDw0PY29uLLl26iMuXLwtXV1el4Z7lvR4lQ2sPHz6sKLt3757o27evcHZ2FgA0Gootk8mEl5eX2mGWQsiHUHbs2FHx+/n5+YkZM2YohseWjkXdUNcS586dEwDE7Nmzy93n9u3bKjMnr1mzRgAQzs7O4tGjR2qfp8lrUDJEs2RoaWl///23GDhwoKhRo4aQSqXi1VdfVcziXPZ3OnjwoGjVqpWwsbERfn5+4uuvvxbTpk0TdnZ2Ksfdtm2b6NChg3B0dBSOjo7C399fTJw4UVy9erXca1BWeTP7Ll68WNSrV0/Y2tqKkJAQ8ccff5Q7/HrLli1Kzy3vPaXuGhUWFoqoqCjh4+MjrK2thZeXl5g5c6bIy8tTeu7TzPT96quvCgDi3XffVbv9wIEDIiQkRNjb2wsXFxfRr18/8ddff6n9nUr/jRUXF4v33ntP1K5dWzg4OIiePXuKGzdulDv8WpPrIYR8+LKjo6NKnF999ZVo06aNsLe3F87OzqJFixbi3XffFXfv3n3iNZg8ebJo1KiR2m0PHz4UH330kWjRooVwcHAQdnZ2onnz5mLmzJkiOTlZsd9ff/0lunXrJpycnETt2rXFO++8oxhyXHq4ckn8N2/eFD169BAODg6iTp06IjIyUhQXFyudW9PPdAAqU2WUDJVeuHChUnl570tN3tPaDL9WN3WHumHe7733nmjQoIHK72QsEiGeoucjkZGlp6ejZs2amDt3brmT2ZHpeemll3Dp0iWVfjVEmrp16xb8/f2xZ88eRdOOvowYMQJbt25V2xxb3eTn58Pb2xvvv/++2gWEjYF9ZMhslJ02HHjcF+FJU3KT8ZR93a5fv47ffvuNrxk9FV9fX4wePRqffvqpsUOpVtauXQtra2u180sZC2tkyGysW7cO69atQ58+feDk5ITjx4/jxx9/RI8ePbBv3z5jh0flqFu3rmJdpsTERKxatQr5+fm4cOFCufPGEJkS1siYNnb2JbMRGBgIKysr/Oc//0FmZqaiA/DcuXONHRpVoFevXvjxxx9x7949xXD9+fPnM4khIp1gjQwRERGZLfaRISIiIrPFRIaIiIjMVpXvIyOTyXD37l04OzubxOJWRERE9GRCCGRlZcHT0xMWFuXXu1T5RObu3btPXDyMiIiITNOdO3dQv379crdX+USmZEr4O3fuwMXFxcjREBERkSYyMzPh5eWltACnOlU+kSlpTnJxcWEiQ0REZGae1C2EnX2JiIjIbDGRISIiIrPFRIaIiIjMFhMZIiIiMlsmk8h8+umnkEgkmDp1qlL5qVOn0KVLFzg6OsLFxQUdO3ZUuwoyERERVT8mMWrp7NmzWL16NQIDA5XKT506hV69emHmzJlYtmwZrKysEBcXV+HEOERERFR9GD2Ryc7OxrBhw7BmzRqVVYzDw8MxefJkvP/++4qyJk2aGDpEIiIiMlFGr9qYOHEi+vbti27duimV379/H2fOnIG7uzvat2+POnXqoFOnTjh+/HiFx8vPz0dmZqbSDxEREVVNRk1kNm3ahPPnz2PBggUq227dugUAmDNnDt555x3s3bsXrVu3RteuXXH9+vVyj7lgwQJIpVLFD5cnICIiqrqMlsjcuXMHU6ZMwYYNG2BnZ6eyXSaTAQDGjh2LkSNHolWrVvj888/RpEkTfPvtt+Ued+bMmcjIyFD83LlzR2+/AxERUXUlk8kQGxuLgwcPIjY2VnHfNjSj9ZE5d+4c7t+/j9atWyvKiouLcezYMSxfvhxXr14FAAQEBCg9r2nTpkhKSir3uLa2trC1tdVP0ERERISYmBgsXrwSV67cQ34+YGsL+Pt7YNq0CQgNDTVoLEarkenatSsuXryI2NhYxU/btm0xbNgwxMbGwtfXF56enoqEpsS1a9fQsGFDI0VNRERUvcXExCAsLBKxsb5wcVkBL6/f4OKyAnFxvggLi0RMTIxB4zFajYyzszOaN2+uVObo6AhXV1dF+YwZMxAZGYmWLVsiKCgI69evx5UrV7B161ZjhExERFStyWQyLF68EunpwfD2nqtY0NHRMQAODnORmDgL0dGrEBISYrCpUow+/LoiU6dORV5eHsLDw/HgwQO0bNkS+/fvh5+fn7FDIyIiqnbi4+Nx5co9uLvPVlmVWiKRwM1tKC5fnoT4+HgEBQUZJCaTSmSOHDmiUvb+++8rzSNDRERExpGWlob8fMDOzkftdjs7H6SmyvczFKPPI0NERETmwdXVFba2QF5egtrteXkJsLGR72coTGSIiIhII4GBgfD390BKygYIIZS2CSGQkrIRTZvWVVlySJ+YyBAREZFGLCwsMG3aBEilp5CYOAs5OZdQXJyLnJxLSEycBan0FCIixht0TUSJKJtSVTGZmZmQSqXIyMiAi4uLscMhIiIye6XnkSkoAGxsgKZN6yIiYrzO5pHR9P7NRIaIiIi0JpPJEB8fj7S0NLi6uiIwMFCnNTGa3r9NatQSERERmQcLCwuDDbGuMA5jB0BERERUWUxkiIiIyGwxkSEiIiKzxUSGiIiIKqdePUAiAW7eNFoITGSIiIhIOwcOyBOYu3fljzt2NFooHLVEREREmhECUDfE+soVw8fyL9bIEBER0ZPNm6eaxEil8uTG2dk4MYE1MkRERFSRrCxA3YR0//wDeHoaPp4yWCNDRERE6nXooJrEjBghr4UxgSQGYI0MERERlfXXX0CzZqrlBQWAtbXh46kAa2SIiIjoMYlENYlZt05eC2NiSQzAGhkiIiICgM2bgSFDVMtNfG1pJjJERETVWVGR+pqW2FigZUuDh6MtNi0RERFVVxMmqCYxQUHyWhgzSGIA1sgQERFVP/fvA3XqqJY/fAjUqGHwcJ4Ga2SIiIiqk3r1VJOYDz+U18KYWRIDsEaGiIioejh1CmjfXrW8uFj9sgNmwnwjJyIiIs1IJKpJzK+/lr92khlhjQwREZGRyWQyxMfHIy0tDa6urggMDISFLhKMZcuAyZNVy018SLU2mMgQEREZUUxMDBYvXokrV+4hPx+wtQX8/T0wbdoEhIaGVu6gjx4BDg6q5bduAT4+TxewiTHv+iQiIiIzFhMTg7CwSMTG+sLFZQW8vH6Di8sKxMX5IiwsEjExMdof9MUXVZOYAQPktTBVLIkBAIkQVah+SY3MzExIpVJkZGTARd3qnUREREYgk8nw8svDEBvrC2/vuZBIJIptQggkJs5CUFACtm37QbNmplu3AD8/1fJHjwA7Ox1Gbhia3r9ZI0NERGQE8fHxuHLlHtzdhyklMQAgkUjg5jYUly8nIz4+/skHk0hUk5hly+S1MGaYxGiDfWSIiKhceuuESkhLS0N+PmBnp765x87OB6mp8v3K9euv8qaksqp2Y4sSJjJERKSWXjqhkoKrqytsbYG8vAQ4OgaobM/LS4CNjXw/FTIZYGmpWn7qFPD883qI1nQxrSYiIhV66YRKSgIDA+Hv74GUlA0o211VCIGUlI1o2rQuAgMDlZ/4wQeqSYyXl7wWppolMQATGSIiKkMmk2Hx4pVITw+Gt/dcODoGwNLSHo6OAWjYcC4yMoIRHb0KMpnM2KGaNQsLC0ybNgFS6SkkJs5CTs4lFBfnIifnEhITZ0EqPYWIiPGPm/IePpT3hVmwQPlA9+8DSUmG/wVMBBMZIiJSotNOqFSh0NBQLFsWhZYtbyEzcxL+/rsvMjMnISgoAcuWRT1uwmvRAqhVS/nJEyfKa2Hc3AwfuAlhHxkiIlKik06oRmRuHZRDQ0MREhKiPuYLF4DWrVWfVFSkvo9MNcREhojIQMzlBvtUnVCNzFw7KFtYWCAoKEi5sExtGABg82Zg8GCDxGQumMgQERmAOd1gSzqhxsVtgIOD6kRtKSkbERSkphOqkZV0UE5PD4a7+2zY2fkgLy8BcXEbEBYWqdxUY8rWrgVGjVItr0ZDqrVhel8FiIiqGHMbAaR1J1QTUCU6KBcUyGthyiYxf/3FJKYCpvMuJCKqgsz1BqtxJ1QTYfYdlF1c5NV0pYWGyhOYpk2NE5OZYNMSEZEePb7Bzq7gBjsJ8fHxqn0kjKzCTqgmxmw7KF++DASo9kNCVhbg5GT4eMwQExkiIj0y2xvsv9R2QjVBZtlBWV1n3l69gD17DB+LGTO9tJqIqAopfYNVxyRvsGao0rPkGsO336pPYmQyJjGVwESGiEiPzOoGa8bMooOyEPIEZvRo5fI1ax5vI60xkSEi0iOzuMFWESbdQfnFFwF1r7EQwNtvGz6eKkQiyn5FqGIyMzMhlUqRkZEBFxcXY4dDRNVU6XlkCgoAGxugadO6iIgYb3IjgMydSU08+OABoK7Z8PJlwN/f8PGYEU3v30xkiIgMxKRusKR/6pqK7O2B3FzDx2KGNL1/c9QSEZGBmMsIIHpKx4/L54Ap69EjwM7O8PFUcfwqQEREpCsSiWoSU7JKNZMYvTCZRObTTz+FRCLB1KlTVbYJIdC7d29IJBLs3LnT4LERERFVKCpKfVOSEMDy5YaPpxoxiaals2fPYvXq1eUOP1yyZInKjJhERERGV1go77ld1q+/An36GD6easjoNTLZ2dkYNmwY1qxZg5o1a6psj42NxeLFi/Htt98aIToiIqJyNG6sPokRgkmMARk9kZk4cSL69u2Lbt26qWzLzc3F0KFDsWLFCnh4eBghOiIiojISE+XNSDduKJffvctVqo3AqE1LmzZtwvnz53H27Fm128PDw9G+fXsMGDBA42Pm5+cjPz9f8TgzM/Op4yQiIgKgvh9M27ZAOfcx0j+jJTJ37tzBlClTsH//ftip6cm9a9cuHDp0CBcuXNDquAsWLEBUVJSuwiQiIgK2bQNeeUW1vLhY/Yy9ZDBGmxBv586dGDhwICwtLRVlxcXFkEgksLCwwPjx47FixQqlyaKKi4thYWGB0NBQHDlyRO1x1dXIeHl5cUI8IiKqHHW1MAsXAtOnGz6WasTkZ/bNyspCYmKiUtnIkSPh7++P9957D7Vr10ZqaqrS9hYtWmDp0qXo168ffHx8NDoPZ/YlIqJKGTECWL9etZz9YAzC5Gf2dXZ2RvPmzZXKHB0d4erqqihX18G3QYMGGicxREREWsvOBpydVcvPnpX3hyGTYhLzyBAREZmE8uYsYy2MyTKpRKa8fi8lqvj6lkREZCyxsUCrVqrlmZnqa2fIZLCrNRERVW8SiWoS8/rr8loYJjEmj4kMERFVT198Uf76SBs3Gj4eqhSTaloiIiLSO5kMKDX1h8KmTcBrrxk+HnoqTGSIiKj66NABOHFCtZx9MM1WpRKZwsJC3Lt3D7m5uXBzc0OtWrV0HRcREZHu/O9/gLo1+27eBHx9DR8P6YzGfWSysrKwatUqdOrUCS4uLvD29kbTpk3h5uaGhg0b4p133il3zSQiIiKjkUhUkxgvL3ktDJMYs6dRIhMdHQ1vb2+sXbsW3bp1w86dOxEbG4tr167h1KlTiIyMRFFREXr06IFevXrh+vXr+o6biIioYvv3q+/MW1AAJCUZPh7SC42WKHj99dcxa9YsNGvWrML98vPzsXbtWtjY2GDUqFE6C/JpcIkCIqJqSF0C8+GHwNy5ho+FKsXk11oyFCYyRETVCGfmNRiZTIb4+HikpaXB1dUVgYGBSgs9Py2TX2uJiIhIZzIzAalUtfzwYeCFFwweTlUXExODxYtX4sqVe8jPB2xtAX9/D0ybNgGhoaEGjUWr1Onrr7/G8OHDsXbtWgDA5s2b0bRpU/j6+iIyMlIvARIREVVIIlGfxAjBJEYPYmJiEBYWidhYX7i4rICX129wcVmBuDhfhIVFIiYmxqDxaJzILFmyBFOnTkV2djY+/PBDzJs3DxMnTsQbb7yBESNGYMmSJfjqq6/0GSsREdFjv/6qvinpyhU2JemJTCbD4sUrkZ4eDG/vuXB0DIClpT0cHQPQsOFcZGQEIzp6FWQymcFi0rhpafXq1fjqq68wdOhQXLhwAc899xy+/PJLjB49GgBQr149rFq1CmPGjNFbsERE5kzffQqqFfaFMYr4+HhcuXIP7u6zISnzGkgkEri5DcXly5MQHx+PoKAgg8SkcSKTmJiIDh06AABatWoFS0tLPP/884rtnTp1wvTp03UfIRFRFWBKfQrMWo8e8mHVZRUXA0wK9S4tLQ35+YCdnY/a7XZ2PkhNle9nKBq/6g4ODsjJyVE8dnNzg5OTk9I+RUVFuouMiKiKMLU+BWZJCHktTNkkpnVr+TYmMQbh6uoKW1sgLy9B7fa8vATY2Mj3MxSNX3l/f3/Ex8crHt+5cwcNGzZUPL5y5Qq8vb11GhwRkbkzxT4FZkciUZ+oCAGcO2f4eKqxwMBA+Pt7ICVlA8rO3iKEQErKRjRtWheBgYEGi0njROazzz5DkyZNyt2elJSEsWPH6iQoIqKq4nGfgmEV9ClIVvqiSP+6fVt9X5hNm9gXxkgsLCwwbdoESKWnkJg4Czk5l1BcnIucnEtITJwFqfQUIiLGG7Tvl8Z9ZEJCQircPmHChKcOhoioqjHFPgVmgZ15TVZoaCiWLYv6t8/XJKSmAjY2QFBQXURERBm8z9dTTYiXnZ2tUh3K2XOJiB4r3afA0TFAZbsx+hSYtCVLgPBw1fLUVIDXyGSEhoYiJCTEJEbhaZ3IJCQkYNKkSThy5Ajy8vIU5UIISCQSFBcX6zRAIiJzVtKnIC5uAxwc5io1L5X0KQgKMmyfApPFWhizYmFhYbAh1hXROpF54403IITAt99+izp16qi0+RIR0WMlfQrCwiKRmDgLbm5DYWfng7y8BKSkbPy3T0FU9Z5PxtkZyM5WLWcCQxrQetFIJycnnDt3rsKOv6aEi0YSkSkoPY9MQYG8T0HTpnURETG++s4jI+88pFo+ZgywerXh4yGTordFI5999lncuXPHbBIZIiJTYEp9CkwCm5FIR7ROZL7++muMGzcO//zzD5o3bw5ra2ul7WznJSJSz1T6FBjVqVNA+/aq5adPA+3aGT4eMntaJzIpKSm4efMmRo4cqSiTSCTs7EtERBUzUC0M17SqXrROZEaNGoVWrVrhxx9/ZGdfIiJ6slGjgLVrVcvz8+WdhXSIa1pVP1p39nV0dERcXBwaNWqkr5h0ip19iYiMSN2X3Zo1gQcPdH6qkjWt0tOD4e4+rNTosA2QSk9h2TLDT9ZGlafp/VvrurYuXbogLi7uqYIjIqIqTiJRn8QIoZckhmtaVV9aNy3169cP4eHhuHjxIlq0aKHS2bd///46C46IiMxMairg5qZa/sUXQFiY3k77eE2r2RWsaTUJ8fHx7HBdxWidyIwbNw4A8PHHH6tsY2dfIqJqzIhDqrmmVfWlddOSTCYr94dJDBFRNbRxo/okJjHRYPPClF7TSh2uaVV1PdWikUREVM2ZyMR2XNOq+qpUInP27FkcPnwY9+/fV+k4FR0drZPAiIjIhAUGAhcvqpbLZOUnN3rENa2qL60Tmfnz52PWrFlo0qSJyjwynFOGyDxxAjHSmEwGWFqqlvfuDfz2m+HjKSU0NBTLlkX9O4/MJKSmyqepCQqqi4gIDr2uqrSeR6ZOnTr47LPPMGLECD2FpFucR4aoYpxAjDRmIs1IT8LEvGrQ2zwyFhYWCAkJeargiMg0lEwgFhvrCxeXFfDy+g0uLisQF+eLsLBIxMTEGDtEMgUXL6pPYvbsMbkkBni8plXXrl0RFBTEJKaK0/rVDQ8Px4oVK/QRCxEZECcQI41IJPL+MGUJAfTqZfh4iMrQuo/M9OnT0bdvX/j5+SEgIEBlQrzt27frLDgi0h9OIEYVmjYNUDd4IysLcHIyfDxE5dA6kZk8eTIOHz6Mzp07w9XVlR18icwUJxCjcplJXxgioBKJzPr167Ft2zb07dtXH/EQkYGUnkDM0TFAZTsnEKuGmMCQGdK6j0ytWrXg5+enj1iIyIBKJhBLSdmAsoMXSyYQa9qUE4hVC1lZ6pOYyZOZxJDJ0zqRmTNnDiIjI5Gbm6uPeIjIQEomEJNKTyExcRZyci6huDgXOTmXkJg4698JxMZzxEdVJ5EA6oa2CgEsXWr4eIi0pPU8Mq1atcLNmzchhIC3t7dKZ9/z58/rNMCnxXlkiCpWeh6ZggL5BGJNm9ZFRMR4ziNTle3eDfTrp1oeGwu0bGnwcIjK0vT+rXUfmZdeeulp4iIiExMaGoqQkBBOIFadsC8MVSFa18iYG9bIEBH9KzQUOH5ctbyoSP2yA0RGpNMaGSEEh1kTEZkrIQB1NWx16wJ37xo+HiId0qjuuFmzZti0aRMKCgoq3O/69esYP348Pv30U50ER0RET0kiUZ/ECMEkhqoEjWpkli1bhvfeew8TJkxA9+7d0bZtW3h6esLOzg4PHz7EX3/9hePHj+PSpUuYNGkSxo8fr++4iYioIomJgLe3avmaNcDbbxs8HCJ90aqPzPHjx7F582bExMQgMTERjx49Qu3atdGqVSv07NkTw4YNQ82aNfUZr9bYR4aIqh125qUqQC+rX3fo0AHLli1DbGwsHj58iLy8PPz999/45ZdfMGnSpKdKYj799FNIJBJMnToVAPDgwQOEhYWhSZMmsLe3R4MGDTB58mRkZGRU+hxEpJ5MJkNsbCwOHjyI2NhYLhRprhYtUp/EJCcziaEqS+vh1/pw9uxZrF69WmkG0bt37+Lu3btYtGgRAgICkJiYiHHjxuHu3bvYunWrEaMlqlpKzyOTnw/Y2gL+/h6YNm0C55ExJ3qqhZHJZByaTybN6MOvs7Oz0bp1a6xcuRJz585FUFAQlixZonbfLVu24I033kBOTg6srDTLwdi0RFS+mJgYhIVFIj09GO7uw2Bn54O8vASkpGyAVHoKy5ZFMZkxdXpsRmKSS8akl6YlfZg4cSL69u2Lbt26PXHfkl+moiQmPz8fmZmZSj9EpEomk2Hx4pVITw+Gt/dcODoGwNLSHo6OAWjYcC4yMoIRHb2KzUymqqBAfRIzaJDOkpiwsEjExvrCxWUFvLx+g4vLCsTF+SIsLBIxMTFPfQ4iXTBqIrNp0yacP38eCxYseOK+qamp+OSTTzBmzJgK91uwYAGkUqnix8vLS1fhElUp8fHxuHLlHtzdh6nMEyWRSODmNhSXLycjPj7eSBFSuSQSefVIWUIAOmh6Z5JL5sRoicydO3cwZcoUbNiwAXZ2dhXum5mZib59+yIgIABz5sypcN+ZM2ciIyND8XPnzh0dRk1UdaSlpSE/H7Cz81G73c7OBwUF8v3IRJw8qb4W5sgRnXbmZZJL5qRSnX1v3ryJtWvX4ubNm1i6dCnc3d2xZ88eNGjQAM2aNdPoGOfOncP9+/fRunVrRVlxcTGOHTuG5cuXIz8/H5aWlsjKykKvXr3g7OyMHTt2qCxSWZatrS1s1X1TISIlrq6usLUF8vIS4OgYoLI9Ly8BNjby/cgEGHBItSZJbmoqk1wyDVrXyBw9ehQtWrTAmTNnsH37dmRnZwMA4uLiEBkZqfFxunbtiosXLyI2Nlbx07ZtWwwbNgyxsbGwtLREZmYmevToARsbG+zateuJNTdEpLnAwED4+3sgJWUDyvb5F0IgJWUjmjatqzSakIzgzTfVJzGPHultSHXpJFcdJrlkSrROZN5//33MnTsX+/fvh42NjaK8S5cuOH36tMbHcXZ2RvPmzZV+HB0d4erqiubNmyuSmJycHHzzzTfIzMzEvXv3cO/ePRQXF2sbNhGVYWFhgWnTJkAqPYXExFnIybmE4uJc5ORcQmLiLEilpxARMZ5DbY1JIgF++EG1XAhAj1/smOSSOdH6E+rixYsYOHCgSrm7uztSU1N1EhQAnD9/HmfOnMHFixfRqFEj1K1bV/HDfi9EuhEaGoply6LQsuUtZGZOwt9/90Vm5iQEBSVw6LUxSSTqa2GEMMjEdkxyyZxo3UemRo0aSE5Oho+PctvphQsXUK9evacK5siRI4r/v/DCCyrfBIhI90JDQxESEsJJz0xBairg5qZa/sknwKxZBg2lJMmVzyMzCampgI0NEBRUFxERTHLJdGidyAwZMgTvvfcetmzZAolEAplMhhMnTmD69Ol466239BEjEemZhYUFgoKCjB1G9WaC6yMxySVzoPXMvgUFBZg4cSLWrVuH4uJiWFlZobi4GEOHDsW6detgaWmpr1grhTP7EpGpUDvd/4YNgLovgTduAH5+hg+SyERoev+u9BIFSUlJ+PPPP5GdnY1WrVqhcePGlQ5Wn5jIEJEpUDfd/5WrR9TvzGZ1Io3v35VeNLJBgwZo0KBBZZ9ORFRtKK9pNRvbL/ZH/bybqjvKZOU3MRGRWlonMkIIbN26FYcPH8b9+/dVpqjevn27zoIjIjJ3paf792n4MQ4fU/3YvSmtCZ8HqbBgEkOkNa17bE2dOhVvvvkmEhIS4OTkpLSukVQq1UeMRERmq2S6/9uJ89UmMc89+yf6erTkdP9ElaR1jcz333+P7du3o0+fPvqIh4ioSsk7f15tX5jIZltxzG0Q7IpzOd0/0VPQOpGRSqXw9fXVRyxERFWLRILn1RR3fuFxZ15O9697akeHcch4laV1IjNnzhxERUXh22+/hb29vT5iIiIyb++/D3z2mUpxn/ZpuJ+fhKKHB2Fl5QpHxxZISdmIoCBO968r6kaH+ft7YNq0CZzEr4rSevj1o0ePMHDgQJw4cQLe3t4qq1GfP39epwE+LQ6/JiKDKqfDbiO/Vrh7txhCOEIIG0gkBZBIcuDpaYm1a5fyJqsDyqPDhsHOzgd5eQlISdkAqfQUl90wM3obfj18+HCcO3cOb7zxBurUqQMJe9kTEVU4M29MTAwwchqAthCiJwBPCHEXFhb7AMQaLsYqrPToMG/vuYp7k6NjABwc5iIxcRaio1chJCSEzUxVjNaJzK+//op9+/ahQ4cO+oiHiMi85OQATk6q5ePGAatWKW6wRUXd8dxznyAnJweFhUWwtm4OR8eBSEyczRusDpSMDnN3n63yBVsikcDNbSguX56E+Ph4LsdRxWidyHh5ebGJhogI0Gh9JOUbrAWcnJyVduUNVjfS0tKQnw/Y2fmo3W5n58PRYVWU1un/4sWL8e677+L27dt6CIeIyAzs3as+iTl3TmV5AU1usAUFvME+LVdXV9jaykeBqcPRYVWX1jUyb7zxBnJzc+Hn5wcHBweVzr4PHjzQWXBERCZHy1WqS99gHR0DVLbzBqsbgYGB8Pf3QFzcBjg4zFVqXhJCcHRYFaZ1IrNkyRI9hEFEZOK6dwcOHFAtLywErMr/KOUN1jAsLCwwbdoEhIVFIjFxFtzchpYatbQRUukpREREsR9SFVTp1a/NBYdfE9FTU1cLI5UC6ekaPb1kWHBGRrDaGyyHBetO6XlkCgoAGxugadO6iIgYz2tsZjS9f2udyCQlJVW43dRWxGYiQ0SVpmUzUkV4gzUczuxbNegtkbGwsKhw7pji4mJtDqd3TGSISGt//w14eamWr1gBTJhQ6cPyBkukOb1NiHfhwgWlx4WFhbhw4QKio6Mxb9487SMlIjIlOqyFKcvCwoJDrIl0TOtEpmXLliplbdu2haenJxYuXIiXX35ZJ4ERERnUF18AU6aolv/zD+Dpafh4iEgjWicy5WnSpAnOnj2rq8MRERmOHmthiEi/tE5kMjMzlR4LIZCcnIw5c+agcePGOguMiEjvHByAR49Uy5nAEJkNrROZGjVqqHT2FULAy8sLmzZt0llgRER6U1goHzZUVu/ewG+/GT4eIqo0rROZw4cPKz22sLCAm5sbGjVqBKsKJoUiIjIJbEYiqlK0zjw6deqkjziIiPTr99+Bdu1Uy/fvB7p1M3w8RKQTGiUyu3bt0viA/fv3r3QwRER6wVoYoipLo0TmpZde0uhgEonE5CbEI6JqbPRo4NtvVctzcuQdfYnI7GmUyMhkMn3HQUSkW6yFIaoW2DuXiKoWJjBE1UqlFvk4evQo+vXrh0aNGqFRo0bo378/YmJidB0bEZHmHjxQn8TMns0khqgK0zqR+eGHH9CtWzc4ODhg8uTJmDx5Muzt7dG1a1ds3LhRHzESEVVMIgFcXVXLhQA+/tjw8RCRwWi9+nXTpk0xZswYhIeHK5VHR0djzZo1uHz5sk4DfFpc/ZqoCtu0CXj9ddXyq1eBZ54xfDxEpDOa3r+1TmRsbW1x6dIlNGrUSKn8xo0baN68OfLy8ioXsZ4wkSGqotgXhqhK0/T+rXXTkpeXFw4ePKhSfuDAAXh5eWl7OCIi7bz4ovokRiZjEkNUDWk9amnatGmYPHkyYmNj0b59ewDAiRMnsG7dOixdulTnARIRAZAnKRZqvnv16gXs2WP4eIjIJGicyDx48AC1atXC+PHj4eHhgcWLF+Onn34CIO83s3nzZgwYMEBvgRJRNcZmJCIqh8aJjKenJ1566SWMHj0aAwcOxMCBA/UZFxERcPs24OOjWv7rr0CfPgYPh4hMj8Z9ZNasWYOUlBT06tUL3t7emDNnDhITE/UZGxFVZxKJ+iRGCCYxRKSgcSLz5ptv4uDBg7hx4waGDx+O9evXw8/PD927d8fmzZtRUFCgzziJqLr44gv1TUnp6WxKIiIVWg+/Lu3AgQNYu3Ytdu7cCTs7OwwbNgxffPGFLuN7ahx+TWRG2BeGiP6lt3lk1Nm2bRvGjBmD9PR0k1v9mokMkRmoUwe4f1+1nAkMUbWlt3lkSiQmJmLOnDnw8fHBa6+9htatW2PDhg2VPRwRVUd5efJamLJJzAcfMIkhIo1oNY9Mfn4+tm3bhm+//RZHjhxBvXr1MGLECIwcORLe3t56CpGIqiQ2IxGRDmicyEyYMAGbNm1Cbm4uBgwYgN9++w3du3eHpLwPIyIidU6dAv6dTFNJfDzQooXh4yEis6ZxInP8+HFERkbijTfegKu6VWaJiJ6EtTBEpGMaJzLx8fH6jIOIqrKxY4GvvlItLywErLReKcVsyWQyxMfHIy0tDa6urggMDISFumUXiEhj1ecThIiMQ10tTGAgEBdn+FiMKCYmBosXr8SVK/eQnw/Y2gL+/h6YNm0CQkNDjR0ekdniVwEi0g+JRH0SI0S1TGLCwiIRG+sLF5cV8PL6DS4uKxAX54uwsEjExMQYO0Qis2Uyicynn34KiUSCqVOnKsry8vIwceJEuLq6wsnJCYMGDcL//vc/4wVJRE+WkqI+gVm/vlr2hZHJZFi8eCXS04Ph7T0Xjo4BsLS0h6NjABo2nIuMjGBER6+CTCYzdqhEZkmrRKaoqAgff/wx/v77b50GcfbsWaxevRqBgYFK5eHh4fjll1+wZcsWHD16FHfv3sXLL7+s03MTkQ5JJIC7u2q5EMBbbxk+HhMQHx+PK1fuwd19mMooT4lEAje3obh8OZn9EIkqSatExsrKCgsXLkRRUZHOAsjOzsawYcOwZs0a1KxZU1GekZGBb775BtHR0ejSpQvatGmDtWvX4uTJkzh9+rTOzk9EOrBpk/pamOTkalkLU1paWhry8wE7OzULYEJeXlAg34+ItKd101KXLl1w9OhRnQUwceJE9O3bF926dVMqP3fuHAoLC5XK/f390aBBA5w6darc4+Xn5yMzM1Pph8yXTCZDbGwsDh48iNjYWFa/myKJBHj9ddVyIQAPD8PHY2JcXV1hawvk5SWo3Z6XlwAbG3BaC6JK0nrUUu/evfH+++/j4sWLaNOmDRwdHZW29+/fX+Njbdq0CefPn8fZs2dVtt27dw82NjaoUaOGUnmdOnVw7969co+5YMECREVFaRwDmS6O8jBxzz4L/PGHank1r4EpKzAwEP7+HoiL2wAHh7lKzUtCCKSkbERQUF2VpnUi0ozWicyECRMAANHR0SrbJBKJxotG3rlzB1OmTMH+/fthZ2enbRjlmjlzJiIiIhSPMzMz4eXlpbPjk2GUjPJITw+Gu/ts2Nn5IC8vAXFxGxAWFolly6KYzBhLcbH6uV9GjADWrjV4OKbOwsIC06ZNQFhYJBITZ8HNbaji/ZySshFS6SlERERxPhmiStLJ6teVsXPnTgwcOBCWlpaKsuLiYkgkElhYWGDfvn3o1q0bHj58qFQr07BhQ0ydOhXh4eEanYerX5sfmUyGl18ehthYX3h7q36DTUychaCgBGzb9gM//A2NM/NWWukaxoICwMYGaNq0LiIixjMpJ1JD0/u30SbE69q1Ky5evKhUNnLkSPj7++O9996Dl5cXrK2tcfDgQQwaNAgAcPXqVSQlJSE4ONgYIZOBPB7lMbuCUR6TEB8fj6CgIOMEWd389RfQrJlq+bFjAG/CGgkNDUVISAhn9iXSsUolMkePHsWiRYtw+fJlAEBAQABmzJih1bcKZ2dnNG/eXKnM0dERrq6uivLRo0cjIiICtWrVgouLC8LCwhAcHIznn3++MmGTmdBklEdqKkd5GAxrYXTGwsKCyTeRjmn9VeCHH35At27d4ODggMmTJ2Py5Mmwt7dH165dsXHjRp0G9/nnn+PFF1/EoEGD0LFjR3h4eGD79u06PQeZHo7yMBFRUeqTmNxcJjFEZDK07iPTtGlTjBkzRqWPSnR0NNasWaOopTEV7CNjfkr6yMTF+aJhQ/aRMQp1CYyLC5CRYfhYiKha0vT+rfVd4NatW+jXr59Kef/+/ZGQoP4bNJE2SkZ5SKWnkJg4Czk5l1BcnIucnEtITJz17yiP8Uxi9KGi9ZGYxBCRCdL6TuDl5YWDBw+qlB84cIDDnElnQkNDsWxZFFq2vIXMzEn4++++yMychKCgBA691oesLPUJzKJFbEYiIpOmdWffadOmYfLkyYiNjUX79u0BACdOnMC6deuwdOlSnQdI1RdHeRgIO/MSkRnTOpEZP348PDw8sHjxYvz0008A5P1mNm/ejAEDBug8QKreOMpDj/bvB3r0UC2/fh1o1Mjw8RARVYLRJsQzFHb2JVKDtTBEZOL01tm3tOzsbC7QSGROBg1Sn8QUFzOJISKzpHUik5CQgL59+8LR0RFSqRQ1a9ZEzZo1UaNGDdSsWVMfMRLR0xJCnsCUnYepWzf5NvY7IiIzpXUfmTfeeANCCHz77beoU6eOyhTyRGRi2IxERFWY1olMXFwczp07hyZNmugjHiIlMpmMo5YqKykJaNhQtXznToAd84moitA6kXn22Wdx584dJjKkd6VXC87PB2xtAX9/D0ybNoHzyDwJa2GIqJrQOpH5+uuvMW7cOPzzzz9o3rw5rK2tlbYHBgbqLDiqvmJiYhAWFon09GC4u8+GnZ0P8vISEBe3AWFhkZwUrzyrVgETJqiWP3gAsA8bEVVBWicyKSkpuHnzJkaOHKkok0gkEEJAIpGguLhYpwFS9SOTybB48UqkpwfD2/vxWkuOjgFwcJiLxMRZiI5ehZCQEDYzlcZaGCKqhrROZEaNGoVWrVrhxx9/ZGdf0ov4+HhcuXIP7u6zVd5fEokEbm5DcfnyJMTHx3OyPADw8gL+/lu1nAkMEVUDWicyiYmJ2LVrFxpx5k/Sk7S0NOTnA3Z2Pmq329n5IDVVvl+1Jr9IquXTpsnXSCIiqga0TmS6dOmCuLg4JjKkN66urrC1BfLyEuDoGKCyPS8vATY28v2qLTYjcUQbEQGoRCLTr18/hIeH4+LFi2jRooVKZ9/+/fvrLDiqngIDA+Hv74G4uA1wcJir1LwkhEBKykYEBdWtnh3Lf/8daNdOtfz8eaBVK8PHYyQc0UZEJbRea6mibzym2NmXay2Zp5JRSxkZwXBzG6oYtZSSshFS6anqOWqJtTAAyo5oG1bqvbGh+r43iKogTe/fXDSSTFbpb90FBYCNDdC0aV1ERIyvXjeqsDBg+XLV8oICoEyNaGWZSzONTCbDyy8PQ2ysr9KINkBeW5eYOAtBQQnYtu0Hk4yfiDSn6f1b66YlIkMJDQ1FSEiIWdxg9UZdLYy/P3D5ss5OYU7NNBzRRkRlaZ3IfPzxxxVu/+ijjyodDFFZFhYW1fOGZKBmJHObeJAj2oioLK0TmR07dig9LiwsREJCAqysrODn58dEhuhppKUBtWurln/7LVBqEkpdMMeJBzmijYjK0jqRuXDhgkpZZmYmRowYgYEDB+okKKJqycCdec2xmYYj2oioLJ18zXJxcUFUVBRmz56ti8MRVS9bt6pPYv75R68jkjRppikoMK1mGgsLC0ybNgFS6SkkJs5CTs4lFBfnIifnEhITZ0EqPYWIiPEmU4NERPqns86+GRkZyMjI0NXhiKoHIw6pNtdmmtDQUCxbFvVvB+VJSE2Vj2gLCqqLiAjT6tNDRPqncSKTlJSE+vXrY3mZYaBCCCQnJ+P7779H7969dR4gUZUUGgocP65aLpOVn9zomDk303BEGxGV0HgeGUtLSyQnJ6NdmVlFLSws4Obmhi5dumDmzJlwdnbWS6CVxXlkyKQUFwNWar4/DBsG/PCDwcPhxINEZKp0PiGehYUF7t27B3d3d50FaQhMZMhkmOjMvJx4kIhMkV4mxCs7soGINHD1qnwSu7IOHwZeeMHg4ZTFZhoiMmdaJTKzZ8+Gg4NDhftER0c/VUBEVYqJ1sKUVW0nHiQis6dVInPx4kXY2NiUu501NkT/mj8f+PBD1fLsbMDR0fDxEBFVUVolMjt27DC7PjJEBqcuobezAx49MnwsRERVnMaJDGtbiJ7AxgYoLFQtN7FmJCKiqkTj3nwaDm4iqn5ycuS1MGWTmAULmMQQEemZxjUya9euhVQq1WcsRCpkMplpj6Yxk868RERVlcaJzPDhw/UZB5GK0vOb5OcDtraAv78Hpk2bYPz5TQ4dArp2VS2/ehV45hnDx0NEVE2Z0FdbosdKZpyNjfWFi8sKeHn9BheXFYiL80VYWCRiYmKMF5xEoj6JEYJJDBGRgTGRIZMjk8mwePFKpKcHw9t7LhwdA2BpaQ9HxwA0bDgXGRnBiI5eBZlMZtjAhg5V35RUXMymJCIiI2EiQyYnPj4eV67cg7v7MJXRchKJBG5uQ3H5cjLi4+MNE5AQ8gTmxx+Vyzt2lG8zpT47RETVTKU+gdPT0/H1119j5syZePDgAQDg/Pnz+Oeff3QaHFVPaWlpyM8H7Ox81G63s/NBQYF8P72TSNQnKkIAR4/q//xERFQhrROZ+Ph4PPPMM/jss8+waNEipKenAwC2b9+OmTNn6jo+qoZcXV1hawvk5SWo3Z6XlwAbG/l+evPPP+qbkbZuZTMSEZEJ0TqRiYiIwIgRI3D9+nXY2dkpyvv06YNjx47pNDiqngIDA+Hv74GUlA0q8xcJIZCSshFNm9ZFYGCgfgKQSID69VXLhQAGDdLPOYmIqFK0TmTOnj2LsWPHqpTXq1cP9+7d00lQVL1ZWFhg2rQJkEpPITFxFnJyLqG4OBc5OZeQmDgLUukpRESM1/18Mt98o74WJjWVtTBERCZKq7WWAMDW1haZmZkq5deuXYObm5tOgiIKDQ3FsmVR/84jMwmpqfIVAIKC6iIiIkr388hwYjsiIrOkdSLTv39/fPzxx/jpp58AyEeRJCUl4b333sMgVruTDoWGhiIkJES/M/s2aQJcu6ZazgSGiMgsSISWiyhlZGTglVdewR9//IGsrCx4enri3r17CA4Oxm+//QZHR0d9xVopmZmZkEqlyMjIgIuLi7HDIVNRUCCfKrisKVOAJUsMHg4RESnT9P6tdY2MVCrF/v37cfz4ccTHxyM7OxutW7dGt27dnipgIoNhMxIRUZWhdY2MuWGNDCmcPw+0aaNafvYs0Lat4eMhIqJy6a1G5osvvlBbLpFIYGdnh0aNGqFjx46wtLTU9tBE+sNaGCKiKknrRObzzz9HSkoKcnNzUbNmTQDAw4cP4eDgACcnJ9y/fx++vr44fPgwvLy8dB4wkVZmzAAWLVItz8+XD4MiIiKzpvXwj/nz5+PZZ5/F9evXkZaWhrS0NFy7dg3t2rXD0qVLkZSUBA8PD4SHhz/xWKtWrUJgYCBcXFzg4uKC4OBg7NmzR7H93r17ePPNN+Hh4QFHR0e0bt0a27Zt0zZkqq4kEtUkpmFDeS0MkxgioipB6z4yfn5+2LZtG4KCgpTKL1y4gEGDBuHWrVs4efIkBg0ahOTk5AqP9csvv8DS0hKNGzeGEALr16/HwoULceHCBTRr1gw9evRAeno6li9fjtq1a2Pjxo2IjIzEH3/8gVatWmkUL/vIVENsRiIiMnua3r+1rpFJTk5GUVGRSnlRUZFiZl9PT09kZWU98Vj9+vVDnz590LhxYzzzzDOYN28enJyccPr0aQDAyZMnERYWhueeew6+vr6YNWsWatSogXPnzmkbNlUHDx6oT2K+/JJJDBFRFaV1ItO5c2eMHTsWFy5cUJRduHAB48ePR5cuXQAAFy9ehI+P+pWLy1NcXIxNmzYhJycHwcHBAID27dtj8+bNePDgAWQyGTZt2oS8vDy88MIL5R4nPz8fmZmZSj9UDUgkgLpFJIUA1CypQUREVYPWicw333yDWrVqoU2bNrC1tYWtrS3atm2LWrVq4ZtvvgEAODk5YfHixRod7+LFi3BycoKtrS3GjRuHHTt2ICAgAADw008/obCw8N/VkG0xduxY7NixA40aNSr3eAsWLIBUKlX8sMNxFbdzp/pamKQk1sIQEVUDlZ5H5sqVK7j279TuTZo0QZMmTSoVQEFBAZKSkpCRkYGtW7fi66+/xtGjRxEQEICwsDD8/vvvmD9/PmrXro2dO3fi888/R0xMDFq0aKH2ePn5+cjPz1c8zszMhJeXF/vIVEXsC0NEVGVp2kfG5CbE69atG/z8/PDuu++iUaNG+PPPP9GsWTOl7Y0aNcKXX36p0fHY2bcK6toVOHRItVwmKz+5ISIis6K3CfEA4O+//8auXbuQlJSEgoICpW3R0dGVOaSCTCZDfn4+cnNzAUBlgUBLS0vIZLKnOgeZKZkMUDfR4uDBwObNho+HiIiMTutE5uDBg+jfvz98fX1x5coVNG/eHLdv34YQAq1bt9bqWDNnzkTv3r3RoEEDZGVlYePGjThy5Aj27dsHf39/NGrUCGPHjsWiRYvg6uqKnTt3Yv/+/di9e7e2YZO5YzMSERGpoXVn35kzZ2L69Om4ePEi7OzssG3bNty5cwedOnXCq6++qtWx7t+/j7feegtNmjRB165dcfbsWezbtw/du3eHtbU1fvvtN7i5uaFfv34IDAzEd999h/Xr16NPnz7ahk3mKjdXfRKzfz+TGCIi0r6PjLOzM2JjY+Hn54eaNWvi+PHjaNasGeLi4jBgwADcvn1bT6FWDvvImLFvvwVGj1YtZwJDRFTl6a2PjKOjo6JfTN26dXHz5k1FZ9zU1NRKhktUSkoK4O6uWp6ZCTg7Gz4eIiIyWVo3LT3//PM4fvw4AKBPnz6YNm0a5s2bh1GjRuH555/XeYBUzYSHqyYxsbHyWhgmMUREVIbWNTLR0dHIzs4GAERFRSE7OxubN29G48aNn3rEElVjFy8CgYHKZRMnAsuXGyceIiIyC1olMsXFxfj7778R+O8Nx9HRUeP5XIjUksmATp2Af2v5FO7dA+rUMU5MRERkNrRqWrK0tESPHj3w8OFDfcVD1cmvv8rnhSmdxKxeLW9GYhJDREQa0LppqXnz5rh165bWi0ISKeTkALVrA3l5j8vq1gVu3QLs7IwXFxERmR2tO/vOnTsX06dPx+7du5GcnMyVpkk7ixcDTk7KScyhQ8Ddu0xiiIhIa1rPI1N6yQBJqYnKhBCQSCQoLi7WXXQ6wHlkTERSEtCwoXJZv37Azz9zfSQiIlKht3lkDh8+/FSBUTX05pvADz8ol12/DjRqZJx4iIioytA6kenUqZM+4qCq6PRpIDhYueyjj4CoKOPEQ0REVY7WfWQAICYmBm+88Qbat2+Pf/75BwDw/fffKybKo2qusBBo2lQ1iXn4kEkMERHplNaJzLZt29CzZ0/Y29vj/PnzyM/PBwBkZGRg/vz5Og+QzMzGjYCNDXDlyuOyTZvkQ6pr1DBaWEREVDVVatTSl19+iTVr1sDa2lpRHhISgvPnz+s0ODIjDx/KO+0OG/a4rEULee3Ma68ZLy4iIqrStE5krl69io4dO6qUS6VSpKen6yImMjcffgjUqqVc9vvvQHw8YKV1NywiIiKNaZ3IeHh44MaNGyrlx48fh6+vr06CIjNx9aq8FqZ0k+KIEfJmpGefNVpYRERUfWidyLzzzjuYMmUKzpw5A4lEgrt372LDhg2YPn06xo8fr48YydQIAfTqBfj7K5ffuQOsXWucmIiIqFrSut7//fffh0wmQ9euXZGbm4uOHTvC1tYW06dPR1hYmD5iJFNy4ADQvbty2ZIlwJQpRgmHiIiqN61n9i1RUFCAGzduIDs7GwEBAXByctJ1bDrBmX115NEjwMsLSEt7XObsLF+l2sHBeHEREVGVpOn9W+umpR9++AG5ubmwsbFBQEAAnnvuOZNNYkhHVq6UJyulk5jffgMyM5nEEBGRUWmdyISHh8Pd3R1Dhw7Fb7/9ZnJrK5EOJSfLO/NOnPi4rHNnoLgY6N3beHERERH9S+tEJjk5GZs2bYJEIsHgwYNRt25dTJw4ESdPntRHfGQs48YBnp7KZZcuyVeqtqjUhNBEREQ6p/UdycrKCi+++CI2bNiA+/fv4/PPP8ft27fRuXNn+Pn56SNGMqQLF+S1MKtXPy6bNk0+UikgwHhxERERqfFUs5U5ODigZ8+eePjwIRITE3H58mVdxUWGVlwMtGsHnDunXJ6SAtSubZyYiIiInqBSbQS5ubnYsGED+vTpg3r16mHJkiUYOHAgLl26pOv4yBC2b5fPwFs6iVm3Tl4LwySGiIhMmNY1MkOGDMHu3bvh4OCAwYMHY/bs2Qguu8oxmYfMTEAqVS7z8ZEv+GhjY5yYiIiItKB1jYylpSV++uknJCcnY/ny5UpJzJ9//qnT4EiP5s1TTWJiYoBbt5jEEBGR2dC6RmbDhg1Kj7OysvDjjz/i66+/xrlz5zgc29QlJABl18R69VVg82Z5J18iIiIzUulxtMeOHcPw4cNRt25dLFq0CF26dMHp06d1GRvpkhDAK6+oJjG3bgE//cQkhoiIzJJWNTL37t3DunXr8M033yAzMxODBw9Gfn4+du7ciQAOzTVdMTFAx47KZfPnAzNnGiceIiIiHdG4RqZfv35o0qQJ4uPjsWTJEty9exfLli3TZ2z0tAoKAG9v5STGwkLeyZdJDBERVQEaJzJ79uzB6NGjERUVhb59+8LS0lKfcdHTWrsWsLUFEhMfl+3YIZ8vxtnZeHERERHpkMaJzPHjx5GVlYU2bdqgXbt2WL58OVJTU/UZG1VGaqq8v8uoUY/LnnsOKCoCXnrJaGERERHpg8aJzPPPP481a9YgOTkZY8eOxaZNm+Dp6QmZTIb9+/cjKytLn3GSJqZNA9zclMsuXADOnAFYg0ZERFWQRAghKvvkq1ev4ptvvsH333+P9PR0dO/eHbt27dJlfE8tMzMTUqkUGRkZcHFxMXY4+nHpEtC8uXLZhAnAihXGiUeHioqKsG3bNiQlJaFBgwYYNGgQrKyeamUNIiIyA5rev58qkSlRXFyMX375Bd9++y0TGUOSyYAuXYCjR5XLk5MBDw/jxKRDy5cvx7x5S5GWJoMQ1pBICuHqaoEPP5yCSZMmGTs8IiLSI03v35WeR6Y0S0tLvPTSSyaXxFRpv/0mby4qncSsWiWfL6aKJDEzZixESkp3WFtvhoPDH7C23oyUlO6YMWMhli9fbuwQiYjIBOikRsaUVbkamZwcoE4d+b8l3N3lo5Ps7IwXlw4VFRXBy6spUlK6w9FxOSwsHufbMpkMOTmT4O6+H0lJl9nMRERURRm0RoYM5PPPAScn5STm4EHgf/+rMkkMAGzbtg1paTLY2o5SSmIAwMLCAra2I5GaKsO2bduMFCEREZkKfp01B3//DXh5KZf16QPs3l0llxZISkqCENawsvJXu93Kyh8FBdZISkoycGRERGRqWCNj6kaMUE1irl0Dfv21SiYxANCgQQNIJIUoKrqidntR0RVIJIVo0KCBgSMjIiJTw0TGVP3+uzxRWb/+cdmsWfLOvI0bGy8uAxg0aBBcXS2Qn/8tZDKZ0jaZTIb8/LWoXdsCgwYNMlKERERkKti0ZGqKioCgIPncMKU9eADUrGmUkAzNysoKH344BTNmLERODmBrOxJWVv4oKrqC/Py1sLb+FR98MIMdfYmIiDUylSGTyRAbG4uDBw8iNjZWpdag0jZtAqytlZOYH3+U18JUkySmxKRJk7Bw4Qy4ue1HYeEQ5OY+i8LCIXB334+FC2dwHhkyDxIJsHOn6RyHqApiIqOlmJgYvPzyMAwZEo63356LIUPC8fLLwxATE1P5g6anyz+oXn/9cVmzZkBhITBkyFPHbK4mTZqEO3cu4/vv52P+/NH4/vv5SEq6zCSG1Lt3DwgLA3x95QumenkB/frJR/aZizlz5DWyZSUnA717Gzoa+Zeojz4C6tYF7O2Bbt2A69crfk5xMTB7NuDjI3+Onx/wySfyY6kzbpz882/JEp2HT9UD6+a1EBMTg7CwSKSnB8PdfTbs7HyQl5eAuLgNCAuLxLJlUQgNDdXuoB99JP8jL+3MGflCjwQrKyu89tprxg6DTN3t20BICFCjBrBwIdCihfyLwL59wMSJwBX1HcefqKAAsLFRLS8slNeeGoqxJrn8z3+AL76Q99Xz8ZEnKD17An/9Vf6UD599Jp+cc/16+ReyP/4ARo4EpFJg8mTlfXfsAE6fBjw99f+7UJXFGhkNyWQyLF68EunpwfD2ngtHxwBYWtrD0TEADRvORUZGMKKjV2nezHT9uvxbSOkk5q235N9amMQQaWfCBPnf0++/A4MGAc88I7+JRkTIb5QlkpKAAQPk8zG5uACDB8vnYSpRUiPy9dfyG3fJzVoikd+c+/cHHB2BefPk5T//DLRuLd/P1xeIipL3cyvPe+/JY3NwkO8/e7Y8KQKAdevkz4+Lk59PIpGXlZy/dNPSxYvy5Uns7QFXV2DMGCA7+/H2ESPkq90vWiSvTXF1lSd0JefShBDyWpJZs+TXLDAQ+O474O7dipu5Tp6U79+3L+DtDbzyCtCjh/y1Ke2ff+Q1aBs2GDYppCqHiYyG4uPjceXKPbi7D4OkzLBniUQCN7ehuHw5GfHx8RUfSAjgxRflH2alJSUpj1AiIs08eADs3Su/UTs6qm6vUUP+r0wmv8E+eCBf2mP/fuDWLaBsjd+NG8C2bcD27UBs7OPyOXOAgQPlScSoUUBMjPzLx5Qp8hqK1avliUdJkqOOs7N8n7/+ApYuBdaskU90CcjjmDZNnoAlJ8t/1NVG5uTIa0Vq1gTOngW2bAEOHADKNrkePgzcvCn/d/16+XlLEqOS38fbu/xYExLkzXXduj0uk0qBdu2AU6fKf1779vLmvGvX5I/j4oDjx5WbxmQy4M03gRkz5L8v0VNg05KG0tLSkJ8P2Nn5qN1uZ+eD1FT5fuU6eFD5QwEAoqOB8HAdRkpUzdy4If+C4K9+AkWFgwflSUhCwuO5mb77Tn4jPXsWePZZeVlBgbzczU35+UOHyptISowaBbz/PjB8uPyxr6+8hvXdd4HISPUxzJr1+P/e3sD06fJO/u++K69dcXICrKwqbkrauBHIy5PHWJK4LV8u7w/02WfyJUwAeaKzfLl8TTZ/f3kNycGDwDvvyLfXri3vv1Kee/fk/5Ycr0SdOo+3qfP++0BmpvyclpbyPjPz5gHDhj3e57PP5L9n2aYmokpgIqMhV1dX2NoCeXkJcHQMUNmel5cAGxv5fmo2Ag0bAvfvPy5zdJRXaav7BklEmtN0ubjLl+UJTOkJJgMC5DU2ly8/TmQaNlRNYgCgbVvlx3FxwIkTyjUwxcXyv/fcXHnzUVmbN8v7nNy8KW8KKiqSN3Fp4/JloGVL5c+OkBB5LcfVq48Tj2bN5IlEibp15YlciUmTVGtxdOGnn+TNRRs3ymOIjQWmTpX3gxk+HDh3Tl4bdf58lZ3UkwzLqE1Lq1atQmBgIFxcXODi4oLg4GDs2bNHaZ9Tp06hS5cucHR0hIuLCzp27IhHjx4ZPNbAwED4+3sgJWUDyq6zKYRASspGNG1aF4GBgcpPXL1a/k2rdBLz66/yDzEmMURPr3Fj+Q2xsh16yyrv77JseXa2vE9LbOzjn4sX5f3f1HWEPXVKXitRsrzIhQvAhx/Ka4D0oWy/E4lEnuxoqqRWqHQfopLHFdUYzZghr5UZMkTe6frNN+W1zgsWyLfHxMg/Dxs0kNfKWFnJF72dNq3ipi6ichg1kalfvz4+/fRTnDt3Dn/88Qe6dOmCAQMG4NK/86icOnUKvXr1Qo8ePfD777/j7NmzmDRpkspCgoZgYWGBadMmQCo9hcTEWcjJuYTi4lzk5FxCYuIsSKWnEBEx/nFs//uf/INj3LjHB+nUSf6NrU8fg8dPVGXVqiXvM7JihfKCqiXS0+X/Nm0K3Lkj/ynx11/y7QGqtaxP1Lq1vAakUSPVH3WfUSdPymt7PvxQXrvTuLH8Bl6ajY38M6IiTZvKa4NK/64nTsjP2aSJ9r9HeXx85AlL6eHrmZnyUZXBweU/LzdX9fe3tHycRL35JhAfr5wAenrKE6B9+3QXP1UfwsTUrFlTfP3110IIIdq1aydmzZr1VMfLyMgQAERGRoYuwhPHjh0TAwYMEU2avCB8fF4QTZq8IF566XVx7NixxztNmCCEvML78c+ff+rk/ESkxs2bQnh4CBEQIMTWrUJcuybEX38JsXSpEP7+8n1kMiGCgoQIDRXi3DkhzpwRok0bITp1enycyEghWrZUPT4gxI4dymV79wphZSXEnDnyv++//hLixx+F+PBD9c/7+Wf5/j/+KMSNG/LYatUSQip9vP+GDUI4Ogpx4YIQKSlC5OWpHicnR4i6dYUYNEiIixeFOHRICF9fIYYPf3yc4cOFGDBAOd4pU5R/12XLhOjSRe3lVPj0UyFq1JDHHh8vP6aPjxCPHj3ep0sX+bFKn7tePSF27xYiIUGI7duFqF1biHffLf88DRsK8fnnFcdC1Y6m92+T6SNTXFyMLVu2ICcnB8HBwbh//z7OnDmDYcOGoX379rh58yb8/f0xb948dOjQodzj5OfnIz8/X/E4MzNTp3GGhoYiJCQE8fHxSEtLg6urKwIDA+U1MXFxqpNZRUQAixfrNAYiKsPXV97nYt48eRNFcrK8n0ubNvJh04C8hvTnn+VDfjt2lNca9OoFLFtWuXP27ClvIvr4Y3nnVWtreQfXt99Wv3///vImlkmTgPx8eefb2bPlo4dKDBokHy3VubO8pmjtWvlQ6tIcHOQ1F1OmyPv1ODjInxcdrV38qanyvjoVefddec3PmDHyeDp0kI8QK910dvOm/Fglli2T/14TJsibkDw9gbFj5XNmEemBRAhNe8rpx8WLFxEcHIy8vDw4OTlh48aN6NOnD06fPo3g4GDUqlULixYtQlBQEL777jusXLkSf/75JxqXs3DinDlzEBUVpVKekZEBF2071WmquFje2e7MGeXy+/fVdxokIiKiCmVmZkIqlT7x/m30RKagoABJSUnIyMjA1q1b8fXXX+Po0aNIT09HSEgIZs6cifnz5yv2DwwMRN++fbGgpONYGepqZLy8vPSXyOzcKZ9borRvv1UepklERERa0TSRMXrTko2NDRo1agQAaNOmDc6ePYulS5fi/fffBwAElOmE17RpUyQlJZV7PFtbW9ja2uov4BKPHsnnfCg9CqBhQ3nnP0Ocn4iIiExvZl+ZTIb8/Hx4e3vD09MTV69eVdp+7do1NGzY0EjRlbJypXISc+yYfL0XJjFEREQGY9QamZkzZ6J3795o0KABsrKysHHjRhw5cgT79u2DRCLBjBkzEBkZiZYtWyIoKAjr16/HlStXsHXrVmOGLRcSIh8+2aIFsHUrJ3YiIiIyAqMmMvfv38dbb72F5ORkSKVSBAYGYt++fejevTsAYOrUqcjLy0N4eDgePHiAli1bYv/+/fCraFptQ3n++cdriRAREZFRGL2zr75p2lmIiIiITIem92+T6yNDREREpCkmMkRERGS2mMgQERGR2WIiQ0RERGaLiQwRERGZLSYyREREZLaYyBAREZHZYiJDREREZouJDBEREZktJjJERERktpjIEBERkdliIkNERERmi4kMERERmS0mMkRERGS2mMgQERGR2WIiQ0RERGaLiQwRERGZLSYyREREZLaYyBAREZHZYiJDREREZouJDBEREZktJjJERERktqyMHQBRRWQyGeLj45GWlgZXV1cEBgbCwoL5NxERyTGRIZMVExODxYtX4sqVe8jPB2xtAX9/D0ybNgGhoaHGDo+IiEwAv9qSSYqJiUFYWCRiY33h4rICXl6/wcVlBeLifBEWFomYmBhjh0hERCaAiQyZHJlMhsWLVyI9PRje3nPh6BgAS0t7ODoGoGHDucjICEZ09CrIZDJjh0pEREbGRIZMTnx8PK5cuQd392GQSCRK2yQSCdzchuLy5WTEx8cbKUIiIjIVTGTI5KSlpSE/H7Cz81G73c7OBwUF8v2IiKh6YyJDJsfV1RW2tkBeXoLa7Xl5CbCxke9HRETVGxMZMjmBgYHw9/dASsoGCCGUtgkhkJKyEU2b1kVgYKCRIiQiIlPBRIZMjoWFBaZNmwCp9BQSE2chJ+cSiotzkZNzCYmJsyCVnkJExHjOJ0NERJCIsl95q5jMzExIpVJkZGTAxcXF2OGQFmJiYrBo0QrExd1Afn4RbG2tEBTUmPPIEBFVA5revzkhHpk0+aAla8jfqhIAVTrvJiIiLbFunkzS4wnx/ODu/g0aNz4Md/dvEBfnxwnxiIhIgYkMmRxOiEdERJpiIkMmhxPiERGRppjIkMnhhHhERKQpJjJkcjghHhERaYqJDJkcTohHRESaYiJDJocT4hERkaY4IR6ZrJiYGCxevBJXrtxDQQFgYwM0bVoXERHjOSEeEVEVp+n9m4kMmTSZTIb4+HikpaXB1dUVgYGBrIkhIqoGOLMvVQkWFhYICgoydhhERGSi+NWWiIiIzBYTGSIiIjJbTGSIiIjIbDGRISIiIrPFRIaIiIjMllETmVWrViEwMBAuLi5wcXFBcHAw9uzZo7KfEAK9e/eGRCLBzp07DR8oERERmSSjJjL169fHp59+inPnzuGPP/5Aly5dMGDAAFy6dElpvyVLlqisgkxERERk1Hlk+vXrp/R43rx5WLVqFU6fPo1mzZoBAGJjY7F48WL88ccfqFu3rjHCJCIiIhNlMhPiFRcXY8uWLcjJyUFwcDAAIDc3F0OHDsWKFSvg4eFh5AiJiIjI1Bg9kbl48SKCg4ORl5cHJycn7NixAwEBAQCA8PBwtG/fHgMGDND4ePn5+cjPz1c8zsjIACCf6piIiIjMQ8l9+0krKRk9kWnSpAliY2ORkZGBrVu3Yvjw4Th69Chu3LiBQ4cO4cKFC1odb8GCBYiKilIp9/Ly0lXIREREZCBZWVmQSqXlbje5RSO7desGPz8/2Nvb44svvlBaILC4uBgWFhYIDQ3FkSNH1D6/bI2MTCbDgwcP4Orqyg7DkGe4Xl5euHPnDhfR1CNeZ8PgdTYMXmfD4HVWJoRAVlYWPD09K1ws2Og1MmXJZDLk5+cjKioKb7/9ttK2Fi1a4PPPP1fpJFyara0tbG1tlcpq1Kihj1DNWsmQd9IvXmfD4HU2DF5nw+B1fqyimpgSRk1kZs6cid69e6NBgwbIysrCxo0bceTIEezbtw8eHh5qO/g2aNAAPj4+RoiWiIiITI1RE5n79+/jrbfeQnJyMqRSKQIDA7Fv3z50797dmGERERGRmTBqIvPNN99otb+JdecxS7a2toiMjFRpfiPd4nU2DF5nw+B1Ngxe58oxuc6+RERERJriopFERERktpjIEBERkdliIkNERERmi4kMERERmS0mMlXQsWPH0K9fP3h6ekIikWDnzp0q+1y+fBn9+/eHVCqFo6Mjnn32WSQlJRk+WDP2pOucnZ2NSZMmoX79+rC3t0dAQAC+/PJL4wRrxhYsWIBnn30Wzs7OcHd3x0svvYSrV68q7ZOXl4eJEyfC1dUVTk5OGDRoEP73v/8ZKWLz9KTr/ODBA4SFhaFJkyawt7dHgwYNMHnyZMV6dqQ5Td7TJYQQ6N27d7mf5cREpkrKyclBy5YtsWLFCrXbb968iQ4dOsDf3x9HjhxBfHw8Zs+eDTs7OwNHat6edJ0jIiKwd+9e/PDDD7h8+TKmTp2KSZMmYdeuXQaO1LwdPXoUEydOxOnTp7F//34UFhaiR48eyMnJUewTHh6OX375BVu2bMHRo0dx9+5dvPzyy0aM2vw86TrfvXsXd+/exaJFi/Dnn39i3bp12Lt3L0aPHm3kyM2PJu/pEkuWLOHyOk8iqEoDIHbs2KFU9tprr4k33njDOAFVUequc7NmzcTHH3+sVNa6dWvx4YcfGjCyquf+/fsCgDh69KgQQoj09HRhbW0ttmzZotjn8uXLAoA4deqUscI0e2Wvszo//fSTsLGxEYWFhQaMrOop71pfuHBB1KtXTyQnJ6v9jCE51shUMzKZDL/++iueeeYZ9OzZE+7u7mjXrh2rLPWgffv22LVrF/755x8IIXD48GFcu3YNPXr0MHZoZq2kKaNWrVoAgHPnzqGwsBDdunVT7OPv748GDRrg1KlTRomxKih7ncvbx8XFBVZWJrdsn1lRd61zc3MxdOhQrFixQu1yPfQYE5lq5v79+8jOzsann36KXr164b///S8GDhyIl19+GUePHjV2eFXKsmXLEBAQgPr168PGxga9evXCihUr0LFjR2OHZrZkMhmmTp2KkJAQNG/eHABw79492NjYqCwOW6dOHdy7d88IUZo/dde5rNTUVHzyyScYM2aMgaOrWsq71uHh4Wjfvj0GDBhgxOjMA9PoakYmkwEABgwYgPDwcABAUFAQTp48iS+//BKdOnUyZnhVyrJly3D69Gns2rULDRs2xLFjxzBx4kR4enoq1R6Q5iZOnIg///wTx48fN3YoVdqTrnNmZib69u2LgIAAzJkzx7DBVTHqrvWuXbtw6NAhXLhwwYiRmQ8mMtVM7dq1YWVlhYCAAKXypk2b8uagQ48ePcIHH3yAHTt2oG/fvgCAwMBAxMbGYtGiRUxkKmHSpEnYvXs3jh07hvr16yvKPTw8UFBQgPT0dKVamf/973+skq+E8q5ziaysLPTq1QvOzs7YsWMHrK2tjRBl1VDetT506BBu3rypUss4aNAghIaG4siRI4YN1MSxaamasbGxwbPPPqsy1O/atWto2LChkaKqegoLC1FYWAgLC+U/MUtLS0WtGGlGCIFJkyZhx44dOHToEHx8fJS2t2nTBtbW1jh48KCi7OrVq0hKSkJwcLChwzVbT7rOgLwmpkePHrCxscGuXbs40rGSnnSt33//fcTHxyM2NlbxAwCff/451q5da4SITRtrZKqg7Oxs3LhxQ/E4ISEBsbGxqFWrFho0aIAZM2bgtddeQ8eOHdG5c2fs3bsXv/zyC7N8LT3pOnfq1AkzZsyAvb09GjZsiKNHj+K7775DdHS0EaM2PxMnTsTGjRvx888/w9nZWdHvRSqVwt7eHlKpFKNHj0ZERARq1aoFFxcXhIWFITg4GM8//7yRozcfT7rOJUlMbm4ufvjhB2RmZiIzMxMA4ObmBktLS2OGb1aedK09PDzU1iY2aNBAbYJZ7Rl30BTpw+HDhwUAlZ/hw4cr9vnmm29Eo0aNhJ2dnWjZsqXYuXOn8QI2U0+6zsnJyWLEiBHC09NT2NnZiSZNmojFixcLmUxm3MDNjLprDECsXbtWsc+jR4/EhAkTRM2aNYWDg4MYOHCgSE5ONl7QZuhJ17m89zsAkZCQYNTYzY0m72l1z+Hwa/UkQgih51yJiIiISC/YR4aIiIjMFhMZIiIiMltMZIiIiMhsMZEhIiIis8VEhoiIiMwWExkiIiIyW0xkiIiIyGwxkSEik3DkyBFIJBKkp6dr/Jw5c+YgKChIZzFcvXoVHh4eyMrK0vg5X375Jfr166ezGIhIO0xkiEgrX375JZydnVFUVKQoy87OhrW1NV544QWlfUuSk5s3bz7xuO3bt0dycjKkUqlO433hhRcwdepUjfadOXMmwsLC4OzsrPHxR40ahfPnzyMmJqaSERLR02AiQ0Ra6dy5M7Kzs/HHH38oymJiYuDh4YEzZ84gLy9PUX748GE0aNAAfn5+TzyujY0NPDw8IJFI9BL3kyQlJWH37t0YMWKEVs+zsbHB0KFD8cUXX+gnMCKqEBMZItJKkyZNULduXaVFRo8cOYIBAwbAx8cHp0+fVirv3LkzAEAmk2HBggXw8fGBvb09WrZsia1btyrtW7Zpac2aNfDy8oKDgwMGDhyI6Oho1KhRQyWm77//Ht7e3pBKpRgyZIiiaWjEiBE4evQoli5dColEAolEgtu3b6v9vX766Se0bNkS9erVUyrXJIZ+/fph165dePTokQZXkIh0iYkMEWmtc+fOOHz4sOLx4cOH8cILL6BTp06K8kePHuHMmTOKRGbBggX47rvv8OWXX+LSpUsIDw/HG2+8gaNHj6o9x4kTJzBu3DhMmTIFsbGx6N69O+bNm6ey382bN7Fz507s3r0bu3fvxtGjR/Hpp58CAJYuXYrg4GC88847SE5ORnJyMry8vNSeLyYmBm3btq1UDG3btkVRURHOnDmjwdUjIl2yMnYARGR+OnfujKlTp6KoqAiPHj3ChQsX0KlTJxQWFuLLL78EAJw6dQr5+fno3Lkz8vPzMX/+fBw4cADBwcEAAF9fXxw/fhyrV69Gp06dVM6xbNky9O7dG9OnTwcAPPPMMzh58iR2796ttJ9MJsO6desU/VrefPNNHDx4EPPmzYNUKoWNjQ0cHBzg4eFR4e+UmJiokshoGoODgwOkUikSExM1vYREpCOskSEirb3wwgvIycnB2bNnERMTg2eeeQZubm7o1KmTop/MkSNH4OvriwYNGuDGjRvIzc1F9+7d4eTkpPj57rvvyu0IfPXqVTz33HNKZWUfA4C3t7dS59y6devi/v37Wv9Ojx49gp2dXaViAAB7e3vk5uZqfV4iejqskSEirTVq1Aj169fH4cOH8fDhQ0WNiqenJ7y8vHDy5EkcPnwYXbp0ASAf1QQAv/76q0ofFFtb26eKxdraWumxRCKBTCbT+ji1a9fGw4cPKx3HgwcP4ObmVunnE1HlMJEhokrp3Lkzjhw5gocPH2LGjBmK8o4dO2LPnj34/fffMX78eABAQEAAbG1tkZSUpLYZSZ0mTZrg7NmzSmVlH2vCxsYGxcXFT9yvVatW+OuvvyoVw82bN5GXl4dWrVppHR8RPR0mMkRUKZ07d8bEiRNRWFiolJx06tQJkyZNQkFBgaKjr7OzM6ZPn47w8HDIZDJ06NABGRkZOHHiBFxcXDB8+HCV44eFhaFjx46Ijo5Gv379cOjQIezZs0fr4dne3t44c+YMbt++DScnJ9SqVQsWFqqt6j179sTbb7+N4uJiWFpaahVDTEwMfH19NRpmTkS6xT4yRFQpnTt3xqNHj9CoUSPUqVNHUd6pUydkZWUphmmX+OSTTzB79mwsWLAATZs2Ra9evfDrr7/Cx8dH7fFDQkLw5ZdfIjo6Gi1btsTevXsRHh6u0o/lSaZPnw5LS0sEBATAzc0NSUlJavfr3bs3rKyscODAAa1j+PHHH/HOO+9oFRcR6YZECCGMHQQRkSbeeecdXLlyRW+z6K5YsQK7du3Cvn37NI7h0qVL6NKlC65du6bzWYmJ6MnYtEREJmvRokXo3r07HB0dsWfPHqxfvx4rV67U2/nGjh2L9PR0ZGVlKUZCPSmG5ORkfPfdd0xiiIyENTJEZLIGDx6MI0eOICsrC76+vggLC8O4ceOqXQxEVD4mMkRERGS22NmXiIiIzBYTGSIiIjJbTGSIiIjIbDGRISIiIrPFRIaIiIjMFhMZIiIiMltMZIiIiMhsMZEhIiIis8VEhoiIiMzW/wEZko3QfDvchwAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Calculate the correlation coefficient and a linear regression model \n",
    "# for mouse weight and average observed tumor volume for the entire Capomulin regimen\n",
    "from scipy.stats import linregress\n",
    "\n",
    "# Calculate the correlation coefficient\n",
    "correlation = merged_data['Weight (g)'].corr(merged_data['Tumor Volume (mm3)'])\n",
    "\n",
    "# linear regression\n",
    "slope, intercept, r_value, p_value, std_err = linregress(merged_data['Weight (g)'], merged_data['Tumor Volume (mm3)'])\n",
    "\n",
    "# Create a scatter plot\n",
    "plt.scatter(merged_data['Weight (g)'], merged_data['Tumor Volume (mm3)'], marker='o', facecolors='blue', edgecolors='black', alpha=0.75)\n",
    "\n",
    "# Add the linear regression line to the plot\n",
    "regress_values = merged_data['Weight (g)'] * slope + intercept\n",
    "plt.plot(merged_data['Weight (g)'], regress_values, color='red')\n",
    "\n",
    "# chart title and labels\n",
    "plt.title('Mouse Weight vs. Average Tumor Volume (Capomulin)')\n",
    "plt.xlabel('Weight (g)')\n",
    "plt.ylabel('Average Tumor Volume (mm3)')\n",
    "\n",
    "# Display the correlation coefficient\n",
    "plt.annotate(f'Correlation: {correlation:.2f}', (20, 36), color='red')\n",
    "\n",
    "# Show plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "anaconda-cloud": {},
  "kernelspec": {
   "display_name": "PythonData",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
